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Abstract 
 
 This dissertation describes the process of optimizing a Fluorescence Lifetime 
Imaging Microscopy (FLIM) system in order to observe the dynamics of enzymes in live 
cancer cells. The enzyme studied throughout this research is Membrane Type 1 Matrix 
Metalloproteinase (MT1-MMP) which is a membrane-bound protein principally 
responsible for degrading extra-cellular matrix (ECM) proteins in the local environment 
of a migrating cell. However, MT1-MMP has an intricate role in the regulation of the 
cell’s migration separate from its simple proteolytic functions. In addition, the increased 
expression of MT1-MMP has been positively correlated with the invasive potential of 
tumor cells. In spite of the importance of MT1-MMP in understanding a cancer cell’s 
decision making as it leaves a tumor, very few reports have quantitatively studied the 
activity of this enzyme in live cells. Even fewer reports have examined the 
spatiotemporal activity of MT1-MMP in live cells cultured in 3-dimensional settings such 
as matrices of ECM proteins. These 3-dimensional settings can parallel the environment 
encountered by metastasizing cells in tissues. Studying live cells in 3-dimensional 
matrices is crucial for biologically relevant investigations. A cell’s morphology and 
migratory behavior can vary significantly when comparisons are made between cells 
cultured on two dimensional substrates and those cultured in 3-dimensional matrices. The 
purpose of this project was to understand the coordinated functions of MT1-MMP as live 
cancer cells interact with and move through a 3-dimensional matrix of ECM proteins. 
Specifically, we are ultimately interested in the spatiotemporal activation patterns of 
MT1-MMP in live cancer cells in order to build a quantitative (systems-level) model  
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describing MT1-MMP’s role in the cell’s decision making as it is leaves a tumor site. 
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Chapter 1 
 
Overview and Background of the Dissertation 
 
Introduction 
The MT1-MMP enzyme can be monitored in a live cell using an intracellular 
genetically-encoded biosensor developed in the lab of Yingxiao Wang [1, 2]. The 
biosensor contains two fluorescent proteins and a protein sequence specific for the 
catalytic domain of MT1-MMP. The fluorescence emission of the biosensor changes in 
both color and intensity when a nearby active MT1-MMP enzyme interacts with it, 
allowing for the active and inactive states of the enzyme to be detected.  
 In order to obtain a physically robust mapping of the biosensor’s configuration in 
images of live cells, Fluorescence Lifetime Imaging Microscopy (FLIM) was used to 
monitor the activation of the biosensor [3-5]. Unlike methods that detect the average 
(steady-state) fluorescence emitted by a sample [6-10], a lifetime measurement relates the 
time an electron spends in the excited state by recording time-dependent features of the 
fluorescence emission [11-14]. Lifetime measurements are absolute measurements and 
therefore, do not require the extensive corrections needed to equate measured steady-state 
intensities to physical parameters describing the sample. However, measuring lifetimes in 
an image often requires multiple exposures of the sample to the exciting light in order to 
generate a single lifetime image. As a result, the temporal resolution of lifetime imaging 
is fundamentally degraded and live samples can be readily damaged by the effects of 
photoxicity and photobleaching during imaging sessions. Throughout the literature 
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describing the study of live cells with lifetime imaging, extended imaging sessions that 
regularly monitor the activity of proteins for periods of an hour are simply not possible.                
In the course of this research, considerable work has been undertaken to improve 
the speed and contrast of the FLIM system with a technique referred to as phase 
suppression [3-5, 15-20]. Phase suppression requires only two brief exposures of the 
sample to spatially highlight features in an image according to phase (indicative of the 
lifetime). This technique was crucial to monitoring the kinetics of our biosensor without 
incurring excessive photo-damage to the cells. New instrument control software has 
reduced the image acquisition to one tenth of that of the original system. In parallel, 
improved analysis of spatial frequencies within the image has increased the certainty 
when assigning pixels to specific configurations of the biosensor.  With the lifetime 
distributions of the fluorescent proteins used in this project (mOrange2/mCherry), I was 
able to quantitatively show an equivalence between the traditional analysis of each 
configuration of the biosensor using the polar plot and separately using phase 
suppression. At this time, the activity of the MT1-MMP enzyme can be monitored with 
images acquired at nearly twenty time points over the period of an hour.  
 Furthermore, in this dissertation, a novel combination of computational analysis 
and experimentation has provided new insights for selecting fluorescent proteins for these 
types of applications. The selection of fluorescent proteins dictates the contrast and 
resolution of the two configurations of the biosensor when detected in live cells. With a 
combination of quantitative steady-state, lifetime and spectral imaging, new conclusions 
are presented about the problems and complications that arise specifically when the 
enhanced cyan fluorescent protein (ECFP) and the yellow fluorescent protein for FRET 
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(Förster Resonance Energy Transfer) (YPet) proteins are used for FRET-based studies in 
live cells. This research furthermore addresses the long-standing problem about why 
apparent large changes in energy transfer are observed when the proteins are examined 
with steady-state techniques, but not when studied with lifetime imaging.  
 This chapter begins with an introduction to the MT1-MMP enzyme and the 
biology of cancer. Following sections establish the fundamentals behind the theory and 
instrumentation for measuring lifetimes in the microscope. In the second chapter, the 
analysis of the MT1-MMP biosensor containing the cyan and yellow fluorescent proteins 
is presented in conjunction with the theory of measuring energy transfer. The third 
chapter of the dissertation describes the experiments and optimization of the existing 
FLIM system to study the dynamics of live cancer cells containing the long wavelength 
variant (mOrange2/mCherry) of the MT1-MMP biosensor.  A final chapter is provided 
where a series of new experiments developed for teaching graduate students the 
principles of measuring time-dependent fluorescence are presented. 
 
Biological Motivation 
MT1-MMP and the Biology of Cancer 
When cancerous cells become metastatic, they migrate from a tumor and invade 
neighboring tissues. In order to migrate and eventually invade neighboring tissues, a 
cancer cell must initially break through the matrix of proteins surrounding a tumor and 
migrate toward a blood vessel. Dense mesh works of collagen located throughout tissues 
comprise the most abundant mechanical barriers for invading cells. Consequently, these 
metastatic cells must be able to negotiate through the extra-cellular matrix (ECM) 
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surrounding the cell as well as coordinate the activity of the cell’s own migratory 
mechanism. Collagen-I, being the most abundant protein in the ECM, represents a 
substantial barrier for metastatic cells. Recently, the enzyme MT1-MMP has generated 
great interest in the study of metastasis because of its ability to not only degrade collagen 
in the ECM but also to regulate signaling cascades responsible for migration and the 
cell’s communications with its local environment [21-25]. However, MT1-MMP’s role in 
regulating and promoting invasiveness is not established but at the same time, the over-
expression of MT1-MMP has been positively correlated with metastatic potential of 
tumor cells [26-28]. 
Structurally, MT1-MMP is a membrane-bound enzyme consisting of three 
domains which include a cytosolic domain, an ECM protein binding domain referred to 
as the hemopexin domain and a catalytic domain containing the active zinc site (Fig. 1.1) 
[29]. It is known that many functions and interactions of MT1-MMP not directly 
associated with the degradation of ECM proteins can inhibit and enhance an invasive 
cell’s migration [24]. More specifically, the functions of MT1-MMP during metastatic 
events stem from MT1-MMP’s effect on and relationships to other proteins and enzymes 
in various signal transduction cascades. Kinases such as Src [30] which are responsible 
the turnover and development of adhesion sites, have been implicated as possibly 
interacting with MT1-MMP’s cytosolic tail to modulate its function. In addition, MT1-
MMP’s role regulating migration has been linked to its internalization at the membrane 
[31], its ability to control the shedding of other membrane proteins such as CD44 [32] 
and syndecan-I [33] and possibly its processing of the products of ECM destruction. 
Some have even suggested that the site of proteolysis of collagen for cells containing 
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MT1-MMP is not along the leading edge at all, but posterior to it [34]. In any case, 
understanding the spatiotemporal activation patterns of MT1-MMP is crucial in order to 
develop a complete model of its biochemical functions in cells that direct events 
necessary for metastasis and invasion.  
Previous Studies of MT1-MMP in Live Cells 
Recent studies have emphasized the importance of studying live cells in 3-
dimensional settings [35-37]. Striking differences in the morphology, migratory patterns 
and adhesion formation exist when comparing cells cultured in 2-dimensional settings to 
those growing in 3-dimensional constructs. In this research, the adhesion sites which 
mediate the cell’s contact with the ECM are essential areas to study in order to learn 
MT1-MMP’s role in translating features from the local environment into cues directing 
the cell’s behavior.  
Previous attempts to study the activity of MT1-MMP in live cells have included 
novel sensors tethered to collagen as well as a set of intracellular biosensors. 
Interestingly, studies using sensors tethered to the collagen to monitor a variety of cancer 
cells migrating in 3D matrices of collagen indicated that MT1-MMP is likely active along 
the leading edge of the cell [36]. The biosensor used in this study was targeted for 
multiple MMPs including but not exclusively specific for MT1-MMP. An intracellular 
biosensor developed by Ouyang et al. monitored the activation of MT1-MMP following 
stimulation by the Epidermal Growth Factor (EGF) [2]. This biosensor was genetically 
encoded and labeled the cell’s entire membrane simplifying the process of correlating 
MT1-MMP’s activity to specific sub-cellular structures and organelles. The active MT1-
MMP enzyme, visualized with this biosensor was present primarily along the periphery 
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of HeLa cells. In this case however, the active MT1-MMP enzyme was exogenously 
introduced into the HeLa cells. However, in this dissertation, the activity of MT1-MMP 
was monitored using the biosensor developed by Ouyang et al (Fig. 1.2). Although other 
reports exist that studied the localization of MT1-MMP in live cells, very few have 
quantitatively examined its activity in settings similar to those encountered by invasive 
cancer cells (e.g. matrix of collagen).  
HT-1080 cells 
 Throughout this research, the MT1-MMP biosensor has been and will continue to 
be examined in HT1080 cells [38]. These cells were originally derived from a cancer in 
the soft tissue of a human male and have been established as a stable cell line. Although 
similar to fibroblasts, HT1080 cells lack contact inhibition potentially forming 
microtumors in the culture and endogenously express MT1-MMP. The metastatic 
potential of the HT1080 cells was demonstrated by early experiments where the cells 
were transplanted into NIH Swiss mice. Within a period of days of the transplantation, 
large tumors grew which demonstrated invasion of their surrounding tissues. As a result, 
HT1080 cells are characterized by many properties indicative of cancerous and metastatic 
cells, making them well-suited as the broad biological system to study for this work.  
 
Fluorescence Lifetimes 
Introduction 
 Fluorescence requires that electrons within a molecule change energies between 
singlet states referred to as the lowest unoccupied molecule orbital (LUMO) and the 
highest occupied molecular orbital (HOMO). Energy loss during this transition of 
 
 
7 
 
energies results in a lower energy photon being emitted after a higher energy photon was 
absorbed. In steady-state imaging, a continuous light source excites a volume of 
fluorescent molecules and the average intensity of the emitted fluorescence is detected.  
However, unlike steady-state measurements, a measured lifetime indicates the amount of 
time an electron spends in the excited state before returning to the ground state. 
Therefore, detailed information about the time-dependent emission of the fluorescent 
molecule is necessary to determine a lifetime. Lifetimes are very susceptible to factors in 
the local environment of the fluorescent molecule and as a result, make excellent 
measured criteria for analyzing complex biological systems.   
Furthermore, lifetimes are absolute measurements that are characteristic of a 
molecule and require minimal corrections to extract. Intensities recorded from steady-
state measurements vary from instrument to instrument. Careful control measurements 
and corrections can translate these intensities into an absolute (quantitative) form but at 
the same time, introduce cumulative uncertainties from each of the corrections applied.  
The Fundamental Fluorescence Response 
 The lifetime of the fluorophore (fluorescent molecule) is the average amount of 
time that the fluorophore spends in the excited state. The manner by which a molecule 
returns to the ground state after being excited is physically modeled as a competitive first 
order kinetic rate process [11, 13].  Essentially, this model assumes that once a molecule 
has been excited, it reaches an approximate steady-state with respect to energy (at lowest 
vibrational level of lowest excited singlet state) before returning to the ground state. As 
this “steady-state” occurs, all available pathways of de-excitation are simultaneously 
competing to return the molecule to the ground state. These pathways are often indicative 
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of the fluorophore’s local environment and represent processes such as non-radiative de-
excitation, collisional quenching, FRET and possibly intersystem crossing to a triplet 
state. As a result, each pathway of de-excitation has an associated rate constant indicating 
how often it is used to return a molecule to the ground state. This rate constant is simply 
the probability per unit time that a pathway will be implemented to return an excited 
molecule to the ground state. Therefore, the probability that a fluorophore will remain in 
the excited state following a brief excitation decays exponentially in time. 
 Experimentally, the lifetime can be measured directly by exciting the molecule 
with a very brief (with respect to the lifetime) pulse of light and recording the fluorescent 
decay. The measured intensity at any point along the decay is proportional to the number 
of molecules remaining in the excited state at that time. The general equation for the 
fluorescent decay of a sample containing a set of fluorophores with different lifetimes is 
written Eq. (1), 
  iti
i
F t e
       (1) 
In Eq. (1), the factor  i  is proportional to the normalized concentration (referred to as 
species fraction) of fluorophore  i  with lifetime  i .  
In the above hypothetical experiment, the presence of additional pathways of de-
excitation such as FRET does not change the magnitude of the rate constant associated 
with fluorescence emission. Therefore, at any specific time along the decay curve of the 
fluorescence emission, the number of molecules in the excited state is always 
proportional to the fluorescence intensity with the proportionality constant being the rate 
constant of the fluorescence emission. However, the presence of additional pathways of 
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de-excitation will increase the total probability that an excited molecule will leave the 
excited state and consequently, will shorten the lifetime of the observed decay.  
Time-Domain 
 Most fluorophores studied in biology such as the fluorescent proteins [39], have 
lifetimes on the order of nanoseconds. Detecting the decay of fluorescence can be done 
with a technique referred to as time-correlated single photon counting (TCSPC) [12]. 
This technique requires extremely short pulses of excitation light and carefully 
synchronized detectors. Each detected photon needs to be correlated with the specific 
pulse that generated it. In other words, the system must be able to know the precise pulse 
that generated each detected photon. Likewise, the excitation pulses must be sufficiently 
spaced in time so that the decay instigated by a given pulse will have dampened in 
intensity sufficiently prior to the arrival of the next exciting pulse. Without sufficient 
spacing of the exciting pulses of light, the effects from the “pulse pile-up” can add 
significant artifacts to a measured lifetime.  
Frequency Domain 
 A fluorophore’s lifetime can be measured in the frequency domain by exciting the 
sample with light having its intensity repetitively modulated. Any waveform that 
consistently repeats over a given period can be used to modulate the intensity of the 
excitation light. This is because any sinusoidal constituent of an arbitrary repetitive 
waveform can be analyzed independently by Fourier analysis. However, for simplicity, 
the waveform modulating the intensity of the exciting light  E t  can be assumed 
sinusoidal,  
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( ) cos( )o E EE t E E t         (2) 
 
In response to  E t , the intensity fluorophore’s emitted fluorescence  S t  will also be 
sinusoidally modulated at a radial frequency  E . However, the fluorescence emission 
of the sample is shifted in phase and de-modulated with respect to the excitation light.  
 
      ( ) cos( ( ))o E ES t S S t          (3) 
 
De-modulation refers to a change in the amplitude of oscillation of the sinusoid with 
respect to the DC offset.  
 Both the shift in phase delay   and modulation ratio  M  are functionally 
dependent on the lifetime of the sample.  
 
1tan ( )E
        (4) 
    2
/ 1
/ 1 ( )

    
o
o E M
S SM
E E
    (5) 
 
The relationships described in Eqs. (4) and (5)  can be derived by convoluting the 
fluorophore’s fundamental fluorescence response (Eq. 1) with the waveform of the 
exciting light’s intensity (Eq. 2). The convolution assumes that at each infinitesimally 
small piece of  E t  produces an exponential decay indicative of the sample’s lifetime. 
Equivalent equations relating the measured lifetime to the phase shift and de-modulation 
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of the sample’s emitted fluorescence can be obtained by taking the Fourier Transform of 
the fundamental fluorescence response. 
 Very often, the equation describing the intensity modulated fluorescence of the 
sample  S t , presented with a multiplicative constant accounting for the brightness or 
concentration of the sample. In this derivation, this factor has been omitted because the 
division by the DC offset in the calculation of the modulation ratio  M eliminates this 
dependence.  
Correcting Measurements taken in the Frequency Domain 
 Extracting the actual phase delay    and modulation ratio  M  of an unknown 
fluorophore requires knowledge about the amplitude of oscillation and phase of the 
waveform modulating the intensity of the excitation light. For example, the value 
experimentally measured for the phase of an unknown fluorophore is equal to ( )E  . 
In order to find the phase delay of the fluorophore   , the phase of the excitation light 
 E  must be added to the experimentally recorded value of the phase. Likewise, the 
calculation of a sample’s modulation ratio  M involves dividing the ratio of the 
amplitude of oscillation and the DC offset measured from the unknown fluorophore 
   o
S
S  by that of the excitation light 
   o
E
E . Values for 
   o
E
E and  E  can be 
determined by measuring a fluorophore (referred to as the reference) with a known single 
lifetime. Several papers highlight fluorophores spanning a variety of excitation and 
emission wavelengths that can be used as references [12, 40].  In some cases, 
instrumental drift, changes in the gain of a detector or the output of the excitation source 
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can alter the values of    o
E
E and  E  during an experiment. It is therefore, prudent to 
measure the reference often during experiments.  
Characterizing Different Lifetime Distributions 
 If a sample containing fluorophores is characterized by a single lifetime, the 
lifetime derived from the phase delay and modulation ratio will both equal the lifetime of 
the fluorophore itself. However, many of fluorophores applied to study biological 
systems are characterized by multiple discrete lifetimes as well as by continuous 
distributions of lifetimes. Examples of multi-component lifetimes include many of the 
fluorescent proteins such as the Enhanced Cyan Fluorescent Protein (ECFP) [16, 41-43]. 
In these cases, the lifetime extracted from the phase delay and the lifetime determined 
from the modulation ratio will not be equal.  Neither of these lifetimes will equal the 
lifetime of any constituent of the sample.  
 Mathematically, the phase delay    and modulation ratio  M detected for the 
sample must be related to the constituent lifetimes present and their relative 
contributions. In order to make these relationships, the intensity-modulated fluorescence 
of the sample  S t detected can be re-written with dependencies on the constituent 
lifetimes as shown below, 
 
 2( ) cos( ( ))1
i i
o i i E i E
i i
E i
S t E E t   
 
     
 
  (6) 
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In this equation, the coefficients  oS and  S from equation (2) are simply replaced by 
the functional dependencies that arise from the convolution integral. Each constituent 
lifetime contributes independently to the DC offset, amplitude of oscillation and detected 
phase shift. Therefore, regardless of the number of lifetimes present in the sample, only 
one modulation ratio and phase delay characteristic of the sample can be recorded. This 
can be seen by normalizing  S t by its DC offset  DC . 
 
 
 21 cos( ( ))1
i
E i E
io E i
S t E a t
DC E
   

   
 
   (7) 
  1 cos( ( ))E E
o
S t E M t
DC E
           (8) 
 
In equation (7), the factor  ia is the fractional contribution of the fluorescent emission 
from the species with lifetime  i to the steady-state intensity.  
 By measuring the phase, amplitude of oscillation and DC signal from  S t  at a 
large set of modulation frequencies  E , iterative fitting can determine the constituent 
lifetimes and their contributions to the measured signal [44-46]. The relationships 
between these features of the fluorescence emission of a sample resulting from intensity-
modulated excitation and the corresponding constituent lifetimes of a fluorescent sample 
can be derived from Fourier analysis [11, 12, 14]. The fluorescence emission of a sample 
resulting from a repetitive excitation can be expressed as the Fourier transform of the 
normalized fundamental fluorescence response ( )F t . The real part of the fluorescence 
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emission of sample at a modulation frequency ( )n  can then be expressed as a sum of 
orthogonal basis functions weighted by the coefficients (A) and (B), defined as the cosine 
and sine transforms from the Fourier transform [47, 48]. 
 
                                            
0
cos   nA F t t dt                  (9) 
               
0
sin   nB F t t dt        (10) 
 
The integrals in equations (9) and (10) do converge regardless of the lifetime distribution 
being analyzed1. Therefore, the fluorescence response of samples with extremely 
complicated lifetime distributions can be expressed in the frequency domain as a single 
sinusoidal function oscillating at a repetition frequency  n  with a single amplitude of 
oscillation 2 2 M A B and phase 1tan      
B
A
. These relationships can be derived 
from the trigonometric identity,      2 2cos sin cos      n n nA t B t A B t  and are 
shown as a function of the constituent lifetimes and their fractional contributions in the 
following equations. 
 
                                                 
1 The factor of 
   
1
2π has been omitted in equations (9) and (10). In frequency-domain FLIM, the 
harmonic response of the sample is compared to that of a fluorophore with a known single lifetime to 
compute the phase delay and modulation ratio. Therefore, this factor is not necessary. 
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     
 
tan
a
a
2
1
2
1
1

        


s n s
s n s
s
s n s
 
 
 
    (11) 
      
 
   
              
 
2 2
2 21 1
s s n s
s sn s n s
a aM   (12) 
 
The weighting terms A,B  derived as the cosine and sine transforms can be considered 
as vectors in the space created by the orthogonal basis of a sine and cosine functions 
oscillating at a specific radial frequency n . Both the modulation ratio  M  and the 
phase delay    of the sample can be determined graphically when  A,B  are projected 
on a set of orthogonal axes. With two simulated lifetimes, the size of the resulting vector 
equivalent to the modulation ratio  M  and the corresponding phase delay    can be 
found with vector addition. As will be discussed in later sections, the transformation to 
this space can simplify the analysis of lifetime images and can greatly reduce the 
acquisition time necessary to characterize a fluorescent sample. 
Frequency Mixing 
 Many of the common fluorophores applied in biology have lifetimes on the order 
of nanoseconds. As a result, the intensity-modulated fluorescence emission from these 
samples will not have a significant shift in phase or incur a change in the amplitude of 
oscillation (relative to that of the exciting light) unless modulation frequencies in the 
range of megahertz are used. Experimentally, the noise which is also present at those high 
frequencies will also be acquired if fluorescence signals oscillating in intensity at such 
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high frequencies are measured directly. Furthermore, most detectors such as the cameras 
found on imaging systems, do not have the temporal resolution necessary to acquire 
images at rates in the megahertz range [49]. 
 A technique referred to as frequency mixing lowers the frequency of the repetitive 
signal from which the modulation ratio and phase delay of the sample can be determined 
[3, 5, 45, 50].  In order to apply frequency mixing, a separate radio frequency is injected 
into the gain of the detector (referred to as  G t ). In other words, the gain of the detector 
is then increased or decreased repetitively during an experiment according to the 
following equation.   
 
    ( ) 2 cos( )    o G GG t G G t    (13) 
 
The acquired signal is then the product of the function modulating the detector’s gain 
 G t  and intensity modulated fluorescence emission  S t . The terms resulting from this 
multiplication   G t S t( ) , include a term (sinusoidal function) oscillating at the 
difference frequency   G E  , a term with no time-dependence and high frequency 
terms oscillating at frequencies of  E ,  G and   G E .  
If E G  , determining the phase delay and modulation ratio of the sample only 
requires the acquisition of a series of steady-state intensity images using a process 
referred to as homodyning. In this case, all high frequency terms average to zero during 
the acquisition times common to imaging (millisecond exposure times), leaving only the 
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DC offset term and the term oscillating at the difference frequency, which consequently 
has no time dependence as shown below,  
 
 [ ] coss sLF o o s s ω ω G E G E s2
s s E s
a τG(t)• F(t) =G E a τ +2G E (ω -ω )t+φ -φ +φ
1+(ω τ )    (14) 
 
When acquiring lifetimes by homodyning on the FLIM system, a series of images are 
collected at various phase shifts applied to the detector  G  (referred to as detector 
phases) sampled evenly from 0 to2 . Alternatively, the phase offset of E(t)   can be 
varied in a similar manner for homodyne detection provided that  G remains fixed.  
 The measured phase delay and modulation ratio are commonly determined on a 
pixel-wise basis by taking the Discrete Fourier Transform (DFT) of the set of images 
collected by homodyning or by iterative least square fitting the data to a sine wave. Since 
iterative fitting and digital Fourier Transform result in the same phase delay and 
modulation ratio, (and because DFT is faster), there is no need for iterative fitting 
techniques when determining the modulation ratio and the phase delay at any of the 
component frequencies [51].  
 The DFT analysis of the fluorescence signal will produce a single measured phase 
delay   and modulation ratio  M  (see Eqs. 11 and 12). The process of relating    
and  M  to the intensities measured by homodyning begins by normalizing the function 
LF,HomoG(t)• F(t)[ ] to its corresponding steady-state intensity  SS  as shown in equation 
(15). 
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 [ ]LF,Homo ω ω G E
o o
G(t)• F(t) G E1+ Mcos φ -φ +φ
SS G E
        (15) 
 
Experimentally, LF,Homo
G(t)• F(t)
SS
   
[ ]
 is discretely sampled over a specific set of evenly 
spaced phase delays. The detector phases can be expressed as a function oscillating at a 
frequency that depends on the number of detector phases  N  sampled. If eight detector 
phases ( N = 8 ;  N could be larger or smaller, but must be at least 3) are used, then, for 
every value of  n , from n = 0  to n = N - 1  
 
0LF,Homo ω ω
G E
o on
G(t)• F(t) G E π1 Mcos φ + n-φ +φ
SS G E 4
[ ]             ,   (16) 
 
where  0G  is the phase of the intensifier modulation when n = 0 .  The average intensity 
over the repetition period is also measured at every pixel. 
The amplitude of oscillation 
   
ω ω
o o
G E M
G E
and the phase delay value  0G Eφ - φ +φ  
can be calculated by taking the digital sine and cosine transforms (Eqs. 17 and 18) using 
the measured values 
n
G(t) • F(t)
SS
   
[ ]LF,Homo  over the n values of the measurement. 
 
sin
N -1
sin,i i
n=0
πF S n
4
            (17) 
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cos
N -1
cos,i i
n=0
πF = S n
4
           (18) 
 
 0G  and  E  are known, so    can be determined. 
In heterodyne detection, the frequencies of the modulation of the detector’s gain 
and that of the intensity modulation of the excitation differ typically only by a few 
hundred hertz (for the detection of nanosecond lifetimes). This difference frequency is 
often referred to as the cross-correlation frequency.  Analog or digital filtering techniques 
can effectively determine the amplitude oscillation and phase offset of LFG(t)• F(t)[ ]  in 
order to find the phase delay and modulation ratio of the sample. Additionally, recent 
applications of heterodyne-based detection do exist that do not require direct modulation 
of the detector’s gain, relying instead on detection with digital photon counting combined 
with heterodyning in the detection circuitry [52].  
Polar Plot 
 As discussed previously, regardless of the number of lifetimes present in the 
sample or their contribution to the measured signal, the intensity-modulated fluorescent 
emission of the sample is characterized by a single modulation ratio and a single phase 
delay. In the case of imaging, measuring these values with a large set of modulation 
frequencies in order to derive specifics about the constituent lifetimes is not feasible and 
can result in the destruction of the sample (particularly when studying live samples). 
Recently, a model-free analysis called the polar plot can transform data collected in the 
frequency domain into a coordinate space from which conclusions about the fluorescent 
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species present can be graphically determined [44, 53-56]. The polar plot is generated 
from the raw data and does not require fitting or excessive corrections.  
 The polar plot transforms the phase delay and modulation ratio into a vector on 
the Cartesian plane. The derivation of the coordinate transforms of the polar plot begins 
by examining the intensity-modulated fluorescence of the sample normalized by it DC 
offset,  S t DC  . In equation (19), it is assumed that the sample contains a set of 
fluorophores each having a distinct lifetime.  
 
                                     ( ) 1 cos( )i i E i
io
ES t M t
DC E
                       (19) 
 
In equation (19), the factors  iM and  i are the modulation ratio and phase delay that 
would have been detected if each constituent fluorophore could be measured 
independently. As described previously,  ia  is the fractional contribution that each 
lifetime component has to the measured steady-state intensity, 
 
                                         i ii
i i
i
a  
 
               (20) 
 
Equivalently, the function  S t DC  can be written with a single modulation ratio and 
phase delay that result  from the emission of all the constituent fluorophores in the 
sample. 
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( ) 1 cos( )E
o
ES t M t
DC E
                                       (21) 
 
 By applying simple algebraic manipulations, equations (19) and (21) can be re-written as 
follows, 
 
           ( )( 1) cos( )o E
E S t M t
E DC
  

            (22) 
                      ( )( 1) cos( )o i i E i
i
E S t M t
E DC
  

         (23)   
 
With a simple trigonometric identity, equation (22) can be re-written in the form, 
 
 cos( ) cos( ) cos( ) sin( )sin( )E E EM t M t M t        .  (24) 
 
In this representation, the term     cos cosEM t   is in phase and the term 
    sin sinEM t  is out of phase with intensity-modulated fluorescence emission. As a 
result,  cos EM t   can be plotted as a polar coordinate on a Cartesian [x,y] plane. The 
amplitude of the vector formed by the polar coordinate is equal to the magnitude of the 
pre-factors on the in-phase and out-of-phase components of  cos EM t    
 
cos( )x M               (25) 
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sin( )y M           (26) 
 
In a similar manner, any term from the summation described in equation (23) can be 
expressed with the same trigonometric identity discussed previously,   
 
                cos( ) (cos( ) cos( ) sin( )sin( ))i i E i i i E i E iM t M t t                       (27) 
 
Therefore, a polar coordinate can be written for each of the constituent lifetimes in a 
multi-component sample. However, the polar coordinate that is measured for a sample 
with a multi-component lifetime contains contributions from the polar coordinate of each 
constituent lifetime. In this case, the resulting vector describing a sample with a multi-
component lifetime is the sum of the polar coordinates from each component lifetime 
weighted by that component’s contribution to the steady-state intensity  ia .  
 
               cos( )i i i
i
x a M                      (28) 
               sin( )i i i
i
y a M                                                          (29) 
 
 In the space of these transformations, any sample characterized by a single 
lifetime will reside on a semi-circle centered at   0.5,0 with a radius of  0.5 . Any polar 
coordinate of a sample describing a multi-component lifetime will be projected inside the 
semi-circle.  
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 The polar coordinate calculated from  M and    uniquely characterizes any 
fluorescent sample from those with a single component lifetime to those described by 
complicated distributions of lifetimes. Hence, changes between different samples or 
among different fluorescent populations in the sample can be visualized simply by 
monitoring changes in polar coordinate. Without the need for iterative fitting or intensive 
computations, calculations of distance on the polar plot can also be used to quantitatively 
calculate both intensity and species fractions of contributing fluorescent components. 
 The graphical ease of the polar plot is demonstrated in Figure 1.3, where the polar 
coordinate R
     of sample containing a mixture of two fluorophores with single 
component lifetimes is shown (Fig. 1.3A). The polar coordinates of the two constituent 
fluorophores are iR
    and jR
    (Fig. 1.3B). The locations of the polar coordinates 
representing all linear combinations of fluorescing components  i and  j is projected as 
a dotted line between the coordinates of iR
    and jR
    . The polar coordinate R
    is a 
weighted sum of iR
    and jR
    and therefore, the relative distance between R
     and 
iR
    or jR
    along the dotted line can be used to determine the corresponding intensity 
fractions. Experimentally, the modulation frequency must be selected carefully to 
sufficiently resolve and distinguish the variable contributions of fluorophores with 
different lifetimes 
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 The application of polar plot to study the lifetimes of fluorescent molecules 
(fluorescent relaxations) began in the early 1980s [44]. At that time, measuring lifetimes 
with large sets of repetitive frequencies was beginning to be used in order to examine the 
contribution of multiple distinct decay components in a fluorescent sample. The polar 
plot was described as a means to verify the relationship between the decay constant 
derived from the amplitude of oscillation and phase delay for samples with multi-
component decays. As measuring lifetimes in images became available, the 
computational ease of the polar plot shortened data acquisition times and made the 
analysis more widely accessible to people in a variety of research themes. In parallel, 
three labs introduced the polar plot for such applications naming it the AB plot [53], polar 
plot [55] and phasor plot [54]. Currently, this graphical representation of fluorescence 
lifetimes is standard in most of the software packages for the acquisition and analysis of 
lifetime measurements. 
Phase Suppression 
 As discussed previously, when detecting lifetimes by homodyning every 
fluorescent sample is represented in the detector as a cosine curve constructed over the 
set of phases injected into the detector. When multiple independent samples containing 
different effective lifetimes (and therefore phase delays) are measured with homodyne 
detection, the result is a set of cosine curves with distinct phase delays. Throughout this 
research, the temporal resolution of lifetime imaging by homodyning was not optimal for 
imaging dynamic processes taking place in live cells. In fact, our lifetime imaging system 
requires twenty four individual images in order to generate a lifetime image in the 
frequency domain.  
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 However, a technique called phase suppression which requires only two 
exposures of the sample collected a carefully chosen set of detector phases  G can 
improve the temporal resolution of a lifetime imaging system.  By subtracting  two 
intensity images collected while homodyning, the intensity of a specific fluorescent 
species in an image can be suppressed while ideally retaining the intensity of the other 
fluorophores with different phase delays in the images [3-5, 17-20, 57]. In other words, 
the results from phase suppression maps the location of different fluorescent species in an 
image based solely on the phase delay. For example, consider a fluorescent species  i  
having a characteristic phase delay  i  and separately, a fluorescent species  j  with 
another phase delay  j  as shown in Figure 1.4. Two intensity images (phase images) 
taken at two different detector phases can be collected describing species  i  such that 
there is no intensity remaining in the resulting difference image when they are subtracted 
(images highlighted in yellow in Fig. 1.4A). These two images are then considered 180o 
out of phase. Since species  j  has a different phase delay than species  i , the 
subtraction of two phase images describing species  j  collected at the same two 
detector phases used to suppress the intensity from species  i  will result in a difference 
image with a non-zero intensity (images highlighted in yellow in Fig. 1.4B). If both 
species  i  and species  j  were contained in a single sample being imaged, the 
subtraction of the two phase images taken at the detector phases highlighted in Figure 1.4 
will both eliminate all intensity from species  i  in the resulting difference image. 
Intensity from species  j  however, will be retained in the difference image.  
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 Phase suppression is advantageous for live cell imaging because the resulting 
difference images can distinguish different fluorescent species in an image with high 
contrast while requiring only two exposures of the sample. At the same time, phase 
suppression can be a physically relevant means to characterize fluorescent species in 
images because it uses the phase delay as the basis of the pixel classification. If each of 
the individual fluorescent species in the image have unique phase delays, phase 
suppression can be a very rapid and quantitative means to track different fluorophores in 
a given sample. 
Instrument for Fluorescence Lifetime Imaging  
 The lifetime imaging system used throughout this thesis is described 
schematically in Figure 1.5 [58]. The intensity from light emitted by a variety of 
continuous lasers is initially modulated by a Pockels Cell [59]. This intensity modulated 
light is made diffuse by a beam expander prior to being incident on the microscopes 
dichroic mirror. The microscope itself, operates in full-field and contains several 
objectives that can image samples with different magnifications and numerical apertures 
(for changing spatial resolution). The photons emitted by the sample are then converted 
into photo-electrons by an image intensifier located at the output port of the microscope. 
The voltage applied across the cathode of the image intensifier is repetitively modulated 
in order to detect lifetimes by homodyning. A digital phase shifter continuously changes 
the phase of the signal that is repetitively modulating the voltage on the cathode. That 
phase shifter takes input directly from a waveform generator. The same waveform 
generator also produces the signal necessary to modulate the intensity of the excitation 
light. In this configuration, both the intensity modulation of the exciting light and the 
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modulation of the cathode’s (intensifier’s) are synchronized throughout the experiment. 
A multi-channel plate (MCP) then amplifies the photo-electrons produced by the cathode. 
In this amplification stage, a significant level of noise is introduced into the image. Prior 
to being incident on the CCD camera, the photo-electrons ejected from the MCP are 
converted back in photons by means of a phosphor screen located in the intensifier. On 
this system, images are acquired between the eight phase images to correct for variations 
in the intensity of the excitation source. As a result twenty four individual images are 
acquired to make one lifetime image on this system. 
Historical Development of Frequency-Domain FLIM Systems 
The development of lifetime imaging in the frequency domain has been motivated 
by the need to probe the complex environments of living systems such as cells and 
tissues. The earliest FLIM system reported in 1959 determined effective lifetimes in the 
frequency domain by comparing the phase delay of the intensity-modulated transmitted 
light to that of the sample’s emitted fluorescence [60]. Without frequency mixing, 
specimens, including suspensions of stained tumor cells, were imaged at specific 
locations on a microscope-based imaging system. Interest in measuring the lifetimes of 
fluorophores in live cells continued throughout the 1970s with several instruments 
reported that detected lifetimes in images in the time domain [61-63]. In 1986, effective 
lifetimes were also recorded in the frequency domain at single points within images by 
taking the Fourier Transform of data collected by photon counting [64]. This system by 
Murray et. al. was one of the earliest descriptions of short pulses of light being used as an 
excitation source for FLIM in the frequency domain.  Later improvements in detectors 
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led to two-dimensional lifetime imaging in 1989 with the incorporation of an image 
dissecting tube with heterodyning in the detection system [65]. 
 In the early 1990s, FLIM systems in the frequency domain sampled more of the 
illuminated field offered by conventional microscopes. In 1991, a system was designed 
where the focused output of a pulsed laser could be moved across the field of view with a 
beam steering device [66]. Although not confocal, this system applied cross-correlation 
detection to determine the phase delay and modulation ratio of the sample at the locations 
where the focused laser was exciting the sample. Full-field FLIM systems were later 
reported in 1991 by Lakowicz et al. [4] and again in 1993 by Gadella et al. [3] Both 
systems detected the intensity-modulated emission of a microscope-based sample from 
every pixel simultaneously by homodyning using a gain-modulated intensifier and CCD 
camera.     
 Improvements in the available spatial resolution of frequency-domain FLIM 
systems have also been made throughout the 1990s and into the 2000s. Single photon [67, 
68] and two photon [69, 70] scanning confocal techniques  have made accurate optical 
sectioning and 3-dimensional imaging possible with frequency-domain FLIM. Full-field 
FLIM systems operating in the frequency domain have been recently equipped with 
spinning disk attachments in order to perform high speed confocal imaging [71, 72]. At 
this time, a variety of frequency-domain FLIM systems are commercially available and 
span many of the modalities of the previously developed systems. Alternatively, any of 
the FLIM systems that measure lifetimes in the time domain can be converted into the 
frequency domain by simply taking the Fourier Transform of the decay. However, care 
must be taken to insure that the discrete binning in time during the acquisition of the 
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fluorescence decay does not result in substantial artifacts in the phase delay and 
modulation ratio that is eventually computed [73].   
 
Common Artifacts Encountered with Lifetime Imaging 
 
Background Removal 
 
 Unwanted fluorescence (background) is common when imaging live cells with 
full-field microscopy systems. Examples include background from media in the case of 
live cell imaging, scattered light from the excitation source reaching the detector, 
fluorescence from mounting media in fixed samples and also the auto-fluorescence from 
organic compounds in biological samples. Un-modulated background from low levels of 
dark current can almost never be avoided. 
When measuring lifetimes in the frequency domain, the polar plot graphically 
relates the relative contribution in intensity of different fluorophores and is therefore, 
very useful for identifying unwanted light or extraneous fluorescence. In most cases, 
these sources of background have themselves a polar coordinate indicative of their time-
dependent fluorescence. However, complications arise when the polar coordinate of the 
sample or fluorophore of interest is not known (or could be changing) and therefore, the 
effects of background can’t be accurately determined with vector addition. In the case of 
live cell imaging with full-field microscopes for example, the contribution of background 
will vary at different positions along the cell. When cells attached to surface, the cell 
body is stretched making the edges of the cell thinner than the central portions of the cell. 
Hence, more background light from the media will enter the objective along the edge of 
the cell than in the center. Precisely knowing the geometry of every cell imaged to 
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account for this sort of variable background is not feasible or accurate. In the literature, 
simple techniques to remove background such as averaging the intensity from a region of 
interest in a section of the image that does not include the cell and subtracting that value 
from all pixels in the image, invariably will leave artifacts in the image [74].  
 Likewise, any measured phase delay and modulation ratio (even that from a 
homogenous sample such as a solution) has an associated uncertainty stemming from the 
noise in the detection system. The signal acquired from any detector counting photons 
contains Possion noise simply as a result of the stochastic nature of fluorescence 
emission. On the polar plot for example, a measurement taken on a homogenous sample 
such as a solution of fluorescent dye, appears as a symmetric distribution centered at the 
actual lifetime of the sample [58]. As the noise in the signal increases, the width of the 
distribution progressively increases. Therefore, on a pixel-wise basis, vector addition 
cannot be performed accurately to remove background either.  
 Recently, a technique has been introduced to remove background that 
incorporates the analysis of spatial frequencies using wavelets to distinguish specific 
morphological features in images [72, 75]. Analyzing spatial frequencies solves the 
problem of not knowing precisely the extent of background in the system and addresses 
the complication of having noise present in the detected signal. 
 Wavelets are sets of basis function that can decompose both images and signals 
for the purposes of image compression, noise removal and generally to analyze spatial 
frequencies.  Wavelets can be thought of in a manner similar to that of the sinusoidal 
functions applied in Fourier analysis. However, the problem with Fourier analysis is that 
it only yields the frequencies present in the signal without any spatial information. If, for 
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example, small portions (windows) of the signal are selected for Fourier analysis, 
problems exist because the frequency resolution will degrade as you select smaller 
windows along the signal to analyze.  
Wavelets are sets of basis functions that typically resemble oscillatory and very 
localized waves that can be stretched (scaled) and translated throughout an image [76-
78]. Each scaled (stretched) version of the wavelet can highlight a different set of spatial 
frequencies in the images. Therefore, the purpose of applying the wavelet basis functions 
to decompose a signal or image is to determine information about spatial frequencies 
(referred to as scales) at every position in the image. The Continuous Wavelet Transform 
(CWT), (as partially described above) that continuously shifts a wavelet basis function at 
various scales throughout an image is computationally intensive and can lead to 
redundant calculations. The Discrete Wavelet Transform (DWT) by contrast, provides an 
equivalently accurate but less computationally expensive means to decompose a signal by 
sampling the scales and positions on which the wavelet basis functions act discretely by 
powers of two.  
The ongoing research examining the MT1-MMP biosensor applies the DWT to 
images collected on the FLIM instrument for the purposes of background removal. In the 
DWT, the scaling of the wavelet in discrete steps creates a series of bandpass filters 
through which the image can be analyzed. Primarily, the presence of the low scales (high 
frequencies) in the image is determined by the scaling function in the DWT [77, 78].  
When applied to an image, the DWT converts the image using successive iterations 
through a set of low pass and bandpass filters, into a series of approximations and detail 
coefficient matrices.  
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The removal of background from the intensity images collected on the FLIM 
instrument will incorporate the approximations of the image that are given by the DWT 
into the multi-resolution analysis described by Mallat [75]. Each approximation of the 
image contains the bandpass of frequencies inherent to the analyzing wavelet that 
generated the approximation at the particular scale (resolution). If two approximations are 
taken at distinct scales (resolutions) and subtracted, the resulting difference image 
contains only the spatial frequencies in the region of frequencies between the two 
approximations. Although distinct from the process of purely re-constructing a signal 
from the entire set of approximation and detail coefficients derived from the DWT de-
composition, multi-resolution analysis can specifically distinguish in the case of live 
samples, high frequency noise generated from background factors from meaningful low 
frequency (high scale) morphological features. As shown in the later chapters, multi-
resolution analysis can substantially eliminate background when applied to FLIM [72]. 
Therefore, the optimization of removing background from the intensity images with the 
DWT and multi-resolution analysis requires both the selection of the appropriate wavelet 
and the scales to be studied.  
Photobleaching 
 
 In this section, photobleaching refers to a loss of signal that occurs during the 
collection of a lifetime image. For example, a loss of signal taking place during the 
acquisition of the eight phase images collected while detecting lifetimes by homodyning 
would correspond to photobleaching in this context. A progressive loss of signal is 
apparent when the intensities taken at each detector phase are plotted against their 
corresponding angle  G . However, the trajectories on the polar plot indicative of this 
 
 
33 
 
sort of photobleaching can vary significantly depending the phase of the exciting light’s 
intensity modulation  E  (simulation described in Figure 1.6). In some cases, the 
presence of photobleaching could be easily mistaken for simple multi-component 
lifetimes.  As will be discussed in the next chapter, a polar coordinate outside of the 
universal semi-circle is not in all cases the result of photobleaching and may even be the 
result of FRET. As such, the most effective method to detect photobleaching is to 
examine the attenuation of the individual phase images collected during the experiment 
combined with some sort of before-hand knowledge about the lifetimes of the sample 
being studied.   
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Figures 
 
 
 
Figure 1.1: MT1-MMP Enzyme: The MT1-MMP enzyme attaches to the proteins located 
throughout the ECM using the central (hemopexin) domain. The proteolysis of ECM 
proteins takes place in the catalytic domain. The chemical GM6001 used in the 
experimental sections of the thesis forms a complex with the zinc in the active site to 
inhibit the activity of MT1-MMP. The cytosolic domain of MT1-MMP mediates 
communication with internal proteins and enzymes such as Src Kinase. Based on [29]. 
 
 
 
Figure 1.2: MT1-MMP Biosensor (A) The biosensor is initially tethered to the cell’s 
membrane with trans-membrane (TM) domain of the platelet-derived growth factor 
(PDGF).  Both the donor fluorescent protein (mOrange2) and the acceptor (mCherry) are 
in close proximity such that emission from the mCherry can take place when the 
mOrange2 is excited. (B) When an active MT1-MMP enzyme cleaves the substrate of the 
biosensor, the mOrange2 and mCherry are permanently separated. No emission from the 
mCherry can be observed when mOrange2 is excited. Modified from [2].  
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Figure 1.3: Basics of the Polar Plot. (A) The polar coordinate of any fluorophore can be 
equivalently described as a vector with a length equal to the modulation ratio making an 
angle relative to the x-axis equal to the phase delay. (B) Two different fluorophores 
defined by the vectors  iR
    and jR
    contribute intensity to the measured polar 
coordinate R
    .  All possible measured combinations of the two fluorophores  i  and 
 j lie on the dotted line projected within the semi-circle.  
 
 
 
Figure 1.4: Schematic of Phase Suppression: (A) A set of images gathered using 
homodyne detection is shown with a given phase delay  i  characteristic of the sample. 
When the two intensity images which are highlighted in yellow are subtracted, there will 
be no intensity remaining in the resulting difference image from the fluorescent species 
with phase delay  i . (B) A separate set of images collected with homodyne detection is 
presented. The fluorescent species depicted in these images have a phase delay   j  such 
that  i  ≠   j . As a result, if two images are selected at the exact same detector phases 
that correspond to the highlighted images selected in (A), the subtraction of these images 
will result in a nonzero intensity in the final difference image. 
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Figure 1.5: The Fluorescence Lifetime Imaging System: Light from a continuous laser is 
intensity-modulated by a Pockels Cell (labeled intensity modulator). The fluorescence 
from the sample is also intensity-modulated. Frequency mixing is accomplished by 
injected a radio frequency (oscillating voltage) gating the voltage on the cathode of the 
detector (an intensified CCD camera). As the phase of the signal injected into the cathode 
is incrementally shifted over a full period of cosine, images are collected at each phase 
shift. From these images, the modulation ratio and phase delay can be computed on a 
pixel-wise basis.   
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Figure 1.6: Photobleaching from the perspective of the polar plot: The detection of a 
sample with a lifetime of 4ns was simulated with a modulation frequency of 40MHz. An 
incremental dampening of intensity was introduced into the phase images collected by 
homodyning (gray circles). In this simulation the phase of the exciting light’s intensity 
modulation  E  was sampled at 0,  4 and  2 . 
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Chapter 2   
 
An Apparent Discrepancy in Measurements of FRET with the Cyan 
Variant of the MT1-MMP Biosensor  
 
Abstract 
The project studying the MT1-MMP biosensor in live HT-1080 cells began with 
the Enhanced Cyan Fluorescent Protein (ECFP) and the Yellow Fluorescent Protein for 
FRET (YPet) that had been previously applied to examine the biosensor with steady-state 
fluorescence imaging.  When the biosensor was examined in live cells, it was clear that 
the definite changes in FRET detected by the steady-state methods did not translate into 
robust changes in the time-dependent fluorescence (lifetimes) measured by lifetime 
imaging. In fact, there was no difference in lifetime recorded for the ECFP regardless of 
which configuration of the biosensor was measured (intact or cleaved) in live cells. To 
make this study even more confusing, a small change in the time-dependent fluorescence 
of the acceptor (YPet) was observed in the images of live cells taken on the lifetime 
imaging system when the donor (ECFP) was excited. Despite the significant time spent 
studying the cell’s condition, applying a variety of drug treatments as well as extensive 
instrumental diagnostics, the observations about the extent of FRET taking place among 
the various methods used remained consistent. During this time, numerous questions 
about the sensitivity, relevance and accuracy of each method to detect FRET were 
continually raised. In this chapter, a critical comparison was carried out to compare the 
changes detected by various techniques for measuring FRET in order to explain this 
apparent discrepancy in the measurements. However, when these results were combined 
with theoretical calculations and models, the data from each method actually and 
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unanimously indicated that there was a likely high background of non-interacting donor 
throughout the cells analyzed.  
 
Introduction 
FRET is a unique parameter in science because quite a variety of methods and 
techniques exist simply to measure the same thing, the extent of FRET taking place in 
systems such as live cells. However, regardless of the technique applied, the extent or 
amount of FRET taking place in a given system is described by specific and definite 
physical parameters indicative of a distance-dependent and non-radiative transfer of 
energy between two oscillators. Hence, the results gathered from different types of 
measurements of FRET taken on sets of similar systems should reflect the same physical 
reality with respect to the oscillators, their concentration and their propensity to engage in 
FRET. Regardless of the type of measurement applied, it is this reality that is relevant to 
characterize the physical process of FRET taking place and that which ought to be 
quantified when any data is analyzed. Simply inventing indexes or techniques that 
conveniently exaggerate the size of changes in measurements of FRET taking place in 
systems does not side-step or make irrelevant the physical grounding required to interpret 
measurements of FRET. All measurements of FRET therefore, should be taken, analyzed 
and presented with attention paid to parameters specific to the physical process of FRET. 
Otherwise, processes such as convenient indexing or qualitative measurements will 
inherently be subject to substantial artifacts and uncertainties and will no doubt, lead to 
false conclusions.  
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In the community of scientists studying FRET-based biosensors in live cells, 
steady-state ratiometric techniques have become common because of both the ease at 
which they can be carried out and the large changes in FRET typically encountered in 
these measurements. In the simplest application, this ratiometric intensity imaging 
divides an image acquired from the donor’s fluorescent emission and an image generated 
from the emission of the acceptor while exciting the sample at the donor’s excitation 
wavelength. This ratio is mapped as a pixel-wise index indicating the extent of FRET 
taking place throughout the image. With this technique, coupling a very dim donor with a 
bright acceptor on the biosensor is ideal to create dramatic changes in intensity even 
when small changes FRET are taking place. However, the measured “FRET ratio” is 
highly dependent on the actual concentration of interacting (FRET) and non-interacting 
(No-FRET) donors and acceptors in an area of an image. It has been previously cited that 
false positives and uncertainties in the interpretation of the FRET ratio can be reduced if 
all observed biosensors are intact (each biosensor (molecule) containing a donor and 
acceptor) throughout the experiment [1].  
Recently, Fluorescence Lifetime Imaging Microscopy (FLIM) has also been 
increasingly used as a more quantitative means to determine the configuration of 
biosensors in a given pixel [2-5]. A measured lifetime relates the average amount of time 
a fluorescent molecule remains in the excited state. When fluorescent molecule is excited 
and near an acceptor, the excited state will be depleted more rapidly shortening the 
lifetime. Measured lifetimes are absolute measurements and are particularly useful when 
characterizing systems containing both interacting and non-interacting donors and 
acceptors. 
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 Although FLIM is a very direct and intensity-independent means to examine 
biosensors in images, the dynamic range of the changes in time-dependent fluorescence 
observed with FLIM are consistently smaller than that observed with steady-state 
methods such as the FRET ratio specifically when using variants of the cyan and yellow 
fluorescent proteins. Several papers have indicated that certain variants of the cyan and 
yellow fluorescent proteins simply are not suitable for FLIM while at the same time these 
pairs provide definite and robust changes in the FRET ratio when studying intracellular 
FRET-based biosensors. [6-12]. At this time, however, the reasons for these apparent 
discrepancies between measurements taken with FLIM and equivalent measurements 
taken with the FRET ratio have not been completely determined in the literature.  
In order to address the apparent discrepancies between different methods for 
detecting FRET, multiple techniques of measuring FRET in images were compared; 
steady-state measurement of FRET efficiency, the FRET ratio and measurements taken 
with FLIM on both the donor and acceptor. In addition to the measurements of FRET, 
both drug treatments and imaging with the selective excitation of the cyan and yellow 
fluorescent proteins were used in order to study regions of the cells containing different 
configurations (intact or cleaved) of the biosensors. Experimentally, changes in the 
steady-state FRET efficiency and the FRET ratio were consistently observed throughout 
the various sections of the cells analyzed. However, no change in the time-dependent 
fluorescence of the donor was detected by FLIM regardless of the region of the cell 
analyzed or the drug treatment applied. At the same time, some variation in the time-
dependent fluorescence of the acceptor was detected when exciting the donor (ECFP) 
within specific regions of the cells analyzed. The only theoretical model that accounts for 
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these experimental results implies that there is a high background of non-interacting 
donors when the ECFP-based biosensor is expressed in live cells.  
 
Materials and Methods 
FRET Efficiency: Steady-State 
Detecting the FRET Efficiency with Steady-State Measurements 
 The FRET efficiency  E  relates the amount of energy transfer taking place to 
the distance between the donor and acceptor fluorophores [13-16]. Dependencies on other 
parameters such as the quantum yield of the donor, the extinction coefficient of the 
acceptor, the wavelength range being applied, and the orientation of the donor and 
acceptor fluorophores are also contained in the equation relating the FRET efficiency to 
the separation distance between the donor and acceptor. Within a cell expressing the 
biosensor, only two distances between the donor and acceptor fluorophores exist 
describing the intact and cleaved biosensor. In any specific region of the cell, there can 
only linear combinations of these two configurations. Therefore, measurements of the 
FRET efficiency taken on live cells are not related to the distance between the donor and 
acceptor (as in the case of single molecules) unless the region of the cell being examined 
is populated by only one configuration of the biosensor. In the case where there is a 
combination of intact and cleaved biosensors in a region of an image, the FRET 
efficiency measured is simply an effective number that can be related to the relative 
stoichiometry of the biosensors.  
 As described in the following references and supplemental derivations [17-20], 
measuring the FRET efficiency in an image in steady-state requires that a series of at 
 
 
53 
 
least three images of the cell be acquired. Images of calibrating solutions and cells singly 
labeled with either the donor or acceptor alone must also be acquired to complete the 
analysis. The images of the cell of interest are collected first with emission wavelengths 
describing the donor while exciting the donor   ,D DEX EMI   , followed by an image 
generated while collecting intensity from primarily the acceptor’s wavelengths while 
exciting the donor  ,D AEX EMI    and finally an image gathering at acceptor’s emission 
while exciting only the acceptor  ,A AEX EMI   .  
 The FRET efficiency  E  can be written as follows where  1b and  2b are 
bleedthrough corrections and   is the ratio of the quantum yields of the donor and 
acceptor. 
  
      
        1 21 2
, , ,
, , , ,
D A D D A A
EX EM EX EM EX EM
D D D A D D A A
EX EM EX EM EX EM EX EM
I b I b I
E
I I b I b I
      
        
       (1) 
 
The above equation is in the precise form that is used to experimentally determine the 
FRET efficiency throughout an image. 
 The bleedthrough coefficient  1b corrects for the fluorescence emission from the 
donor that can be detected in the channel (set of emission wavelengths) specific for the 
acceptor. More specifically,  1b  is the ratio of the donor’s emission collected through the 
donor’s emission channel and separately, through the acceptor’s emission channel using a 
single excitation wavelength. In an analogous way, the coefficient  2b accounts for the 
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fluorescence emission of the acceptor that can be directly excited at the donor’s 
excitation wavelength  DEX . This directly excited emission from the acceptor could be 
misinterpreted as FRET. Experimentally, the acceptor’s fluorescence that results from 
direct excitation at the wavelength  DEX  and the intensity of the acceptor’s fluorescence 
that is emitted while being excited at   AEX  are measured and a ratio is taken to determine 
the coefficient  2b . Both of these coefficients can be determined experimentally with 
samples containing only the donor fluorophores and separately containing only the 
acceptor fluorophores.  
The ratio of the quantum yield of the donor  DonQY  and the quantum yield of the 
acceptor  AccQY  is referred to as   and can be determined experimentally using the 
same excitation and emission wavelengths as applied in the actual microscope-based 
FRET experiments. The detected fluorescence from solutions containing either only 
donor (referred to as  DDSolI ) or only acceptor fluorophores (referred to as  AASolI )  are 
measured separately on the imaging system using the same excitation sources and 
emission filters as the live cell experiments. The optical density of the donor-only 
 DDSolOD  and acceptor-only  AASolOD solutions and the optical power of the exciting light 
then normalize the measured fluorescence intensities to extract the ratio of the quantum 
yields. The optical power of the excitation sources on the imaging system needs to be 
measured with a solution of Rhodamine B in ethylene glycol  SolRhodB  often referred to 
as a quantum counter [21]. The definition of    from these measured quantities can be 
written as,  
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   (2) 
 
Specifically in the case when two different dichroic mirrors are used, care must be taken 
to account for differences in the transmission of the two mirrors in the wavelength span 
being used when determining   .  
 Several methods have been reported to find    experimentally including 
techniques based on photobleaching [22], using tandem constructs of donor and acceptor 
protein pairs of different linker lengths [23, 24], assuming a tandem construct of fixed 
linker length is expressed a 1:1 stochiometry in live cells [25], and fitting techniques 
applied to spectral data [26]. In this paper, we have combined multi-frequency lifetime 
measurements of the purified biosensor and measurements of both the cleaved and intact 
biosensor on the microscope in order to determine   .  
Simulating Spectra 
The measured FRET efficiency (or FRET ratio) can be related to normalized 
concentration of the biosensor by simulating the spectra that would result from having 
different combinations of cleaved and intact biosensor in the cell.  In order to simulate the 
spectral distribution  , Exc EmI  of the emitted intensity from a fluorophore at an 
excitation wavelength  Exc  and emission wavelength  Em , several quantities must be 
known including the excitation light’s intensity  ExcP , the extinction coefficients 
  Exc  at a specific excitation wavelength  Exc , the quantum yields  QY , the 
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concentration of the fluorophore  C , the instrument’s efficiencies to detect different 
wavelengths of light and the reference spectra of the fluorophore whose area is 
normalized to unity  REF EmS . If FRET is taking place, the FRET efficiency  E  will 
then be a factor as well to reduce the intensity of the donor’s emission and increase the 
fluorescence emitted from the acceptor. The efficiencies of the detectors are assumed to 
be uniform over the range of simulated wavelengths. In the analysis and results presented 
in this paper, correction factors are computed based on the measurement of standards and 
applied to account for the dependence on this factor.  
If the sample contains purely intact biosensor (each donor attached to an acceptor) with a 
concentration  BiosC , the equation describing the emitted intensity from the donor 
undergoing FRET can be written as, 
 
          , 1      
don REF
FRET don
Exc Em Em Exc don Exc don BiosI S P QY C E   (3)  
 
In parallel, the emitted intensity from an acceptor excited by FRET is as follows, 
 
             ,     
REF
FRET Acc
Acc Exc Em Em Exc don Exc Acc BiosI S P QY C E   (4) 
 
 In order to determine the intensities expected from various combinations of intact 
biosensors and free (non-interacting) donors and acceptors, the simulations assumed a 
single fixed concentration of the biosensor. The contribution of cleaved biosensor to this 
fixed concentration was increased from the case of having purely intact biosensor to the 
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case of having purely cleaved biosensor. The fractional contribution that each 
configuration of the biosensor (cleaved or intact) has to the fixed concentration of 
biosensor is referred to as the species fraction. Therefore, for the intact biosensor and 
separately for the cleaved biosensor, the species fraction can have values from 0 to 1.   
 The intensities from the non-interacting donors and acceptors need to be included 
along with the emission from the intact biosensor to determine the emitted intensity from 
the set of conditions simulated. With a known concentration of cleaved biosensors 
referred to as  CleaveC , the spectral contributions from the non-interacting donors and 
acceptors can be written as  
 
              ,     
don REF
NoFRET don
Exc Em Em Exc don Exc don CleaveI S P QY C   (5) 
                        ,     
REF
NoFRET Acc
Acc Exc Em Em Exc Acc Exc Acc CleaveI S P QY C   (6) 
 
The spectra of the donor (ECFP) and acceptor (YPet) can then be simulated separately as 
a function of the species fraction of the intact or cleaved biosensor. The individual 
emission spectrum from the ECFP and YPet can later be combined to find the intensities 
in the filter passes used in the live cell experiments.  
FRET Efficiency: Lifetimes 
Donor’s Lifetime 
When a fluorescent molecule becomes excited, the molecule can de-excite by a 
variety of processes including releasing a lower energy photon, inter-system crossing to a 
triplet state or even non-radiative de-excitation [13, 21, 27]. The measured lifetime of a 
fluorescent sample is equal to the inverse of the sum of all the rates associated with each 
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de-excitation pathway available to the excited molecule. In the presence of a nearby 
acceptor, the excited state of a donor fluorophore will be depleted more rapidly resulting 
in a shortened lifetime. The FRET efficiency  E  therefore, can be written in terms of 
the lifetime of the free donor  D  and the lifetime of the donor quenched by FRET 
 DA . 
        1 DA
D
E        (7) 
 
Please see Derivation 3 at the end of this chapter describing the origins of equation (7). If 
the donor fluorophore has a multi-component the lifetime, the average lifetime equal to 
the sum of the constituent lifetimes each weighted by the corresponding species fraction 
must be used in the calculation of the FRET efficiency. 
In the case of the biosensor, there are two configurations of the biosensor and 
therefore, two discrete FRET efficiencies. When examined on the polar plot, these two 
FRET efficiencies correspond to two different polar coordinates. The polar coordinate of 
any linear combinations of the intact or cleaved biosensor will lie on a straight line 
between the extrema polar coordinates indicative of the purely intact or purely cleaved 
biosensor. 
Acceptor’s Time-Dependent Fluorescence  
 FRET efficiencies can also be determined by observing the time-dependent 
fluorescence emission of the acceptor. Although the acceptor’s lifetime does not vary as a 
result of FRET, the measured phase delay and modulation ratio of the acceptor will be 
substantially changed. The measured phase delay of an acceptor undergoing FRET  AD  
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will be the sum of the phase delay of the donor undergoing FRET  DA  and the phase 
delay of the unpaired acceptor  A . In addition, the measured modulation ratio of an 
acceptor emitting as a result of FRET  ADM will be the product of the modulation ratio 
of the donor during FRET  DAM  and the modulation ratio of the directly excited 
acceptor  AM .  
    AD DA A         (8) 
    AD DA AM M M      (9) 
 
The lifetimes that can be calculated from the phase delays and modulation ratios 
in the above equations are not particularly useful. However, when the polar coordinate 
indicative of an acceptor undergoing FRET can in some cases, be projected far outside of 
the universal semi-circle. In certain cases, measuring the time–dependent emission of the 
acceptor undergoing FRET can generate changes in polar coordinate that are larger than 
those that would be recorded when collecting emission only from the donor.  
The above equations have been derived previously both by convoluting the acceptor’s 
fundamental fluorescence response over the intensity-modulated emission of a donor 
fluorophore [28]. In this approach, every infinitesimally small part of the donor’s 
fluorescence emission produces a fluorescent decay with a lifetime and spectral 
distribution which are characteristic of the acceptor. The measured phase delay and 
modulation ratio of the acceptor undergoing FRET can also be derived by examining 
measured rate of de-excitation of the acceptor in the presence of the donor with kinetic 
models [29, 30].  
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Imaging Systems 
 All steady-state images of the cells were collected on a Zeiss LSM 710 inverted 
microscope using a 63x 1.4 NA Plan-Apochromat oil immersion objective (Zeiss, 
Germany). The excitation sources used were a 405nm laser diode and the 514nm line 
from an Argon ion laser. The emission wavelengths selected for the experiment were 
458nm – 501nm and 528nm – 570nm. The samples containing solutions of purified 
biosensors and Rhodamine B were imaged using a 20x 0.8 NA Plan-Apochromat air 
objective (Zeiss, Germany) and the 63x 1.4NA oil immersion objective (Zeiss, 
Germany).  
 The lifetimes of the biosensors contained in live cells were detected with a 
custom-built full-field lifetime imaging system operating in the frequency domain [5, 31, 
32]. In this system, the intensity from a continuous 440nm laser (Crystal Laser, Reno 
NV) is modulated at a frequency of 40MHz by a Pockels cell (Conoptics, Danbury, CT). 
In order to image only the acceptor, the 488nm line of an Agon ion laser (Uniphase, CA) 
was used in parallel with the 440nm laser. The intensity-modulated emission from the 
sample was then detected by an image intensifier (Kentech, England) before being 
imaged on a CCD camera (Retiga). The dichroic mirror and emission filter selected 
wavelengths between 460nm and 500nm for imaging the donor (Omega Optical, 
Brattleboro VT). An additional dichroic mirror and filter passed wavelengths from 
500nm to 560nm in order to collect intensity primarily from the acceptor (Omega Optical 
Brattleboro VT). The live cells were imaged with a 100x 1.3NA oil immersion objective 
(Lecia, Germany). The reference for the lifetime measurements in the frequency domain 
was Fluorescein in 0.1N NaOH (lifetime = 4.3ns [31]). 
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Image Analysis: Steady-State Imaging 
 The cells imaged on the steady-state microscope were only exposed to light (40% 
of the power of the 405nm diode) for the actual imaging to avoid photobleaching. Cells 
were aligned and focused using an external Mercury Halide lamp. Three channels were 
configured for imaging which are referred to throughout the text as IDD (Excitation: 
405nm, Emission: 458nm - 501nm), IDA (Excitation: 405nm, Emission: 528nm – 
570nm) and IAA (Excitation: 514nm, Emission: 528nm – 570nm). Two consecutive sets 
of images were collected to account for bleaching specifically in the channel IDA. 
Images were also acquired without any sample present for background removal specific 
to each channel used. Following the correction for photobleaching and removal of 
background a 3x3 median filter was applied to the images analyzed. The images of the 
solutions containing the biosensors and separately the Rhodamine B were equivalently 
median filtered and underwent an analogous background removal. Errors in the measured 
steady-state FRET efficiencies and FRET ratios were computed with calculations based 
on the propagation of errors. The details of these calculations can be found in the 
supplemental derivation. 
Image Analysis: Lifetime Imaging 
 Each of the phase images used to generate a modulation and phase image of the 
lives were denoised with a custom algorithm specific for the noise characteristic of this 
intensifier and camera [31]. Background was removed with multi-resolution analysis 
applying the Sym8 wavelet [33, 34]. The intensity images presented are the average of the 
eight phase images collected while homodyning.  
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Cell Culture 
 HT-1080 cells (ATCC, Manassas VA) were cultured in DMEM supplemented by 
10% FBS. These cells were transfected with Lipofectamine 2000 (Invitrogen, Carlsbad 
CA) according the manufacturer’s instructions and then starved at 0.5% FBS for 36-48 
hours prior to imaging. The DNA plasmids transfected into the cells were the ECFP-CL 
plasmid, which was a generous gift from the Gaskins Lab and the AHLR-variant of the 
ECFP/YPet biosensor described previously [7]. For imaging, cells were grown on glass-
bottomed culture dishes (Cell E&G, Houston, TX). In order to inhibit MT1-MMP 
activity, a portion of the cells imaged were incubated with 20μM of GM6001 (Merck, 
Germany) for 12-18 hours prior to imaging.  
Fluorometer-based Measurements 
 The multi-frequency lifetime measurements were carried out using a multi-
frequency lifetime fluorometer model K2 (ISS Inc., Champaign IL). An exciting laser 
emitting a 440nm (Crystal Laser, Reno NV) was intensity modulated and emission was 
collected through a filter passing 488nm ± 10nm (Chroma, Bellows Falls VT). Quartz 
polarizers were oriented in the magic angle configuration through the fluorometer-based 
lifetime measurements. Steady-state spectra were collected on a PC1 fluorometer (ISS 
Inc., Champaign, IL). Absorbance spectra were taken on an Agilent 8453 
Spectrophotometer (Agilent, Santa Clara, CA).  
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Results 
Determining the FRET Efficiency with Time-Dependent Fluorescence 
 The FRET efficiency of the intact biosensor was calculated from multi-frequency 
lifetime measurements taken before and after the substrate of the biosensor was cleaved 
by trypsin. The polyacrylamide gel shown in Supplemental Figure 2.1 demonstrates that 
trypsin can effectively cleave the substrate of the biosensor. Prior to the addition of 
trypsin, the band indicates that proteins with masses near 50kD are present.  However, 
trypsin readily cleaved the substrate of the biosensor leaving only proteins with masses 
near 25kD in the gel. The modulation ratio and phase delay was measured on both 
configurations of the biosensor at a set of twenty modulation frequencies (Figs. 2.1A and 
2.1B). The results from iterative fitting carried out on this data set indicated that each 
configuration of the biosensor was characterized by a two component lifetime (Table 
2.1). On the intact biosensor, the lifetime distribution was dominated by a short lifetime 
component near 0.92ns resulting in an average lifetime of 0.71ns. After the substrate of 
the biosensor was cleaved, the average lifetime increased to 2.83ns with the lifetime 
distribution split between a component at 1.24ns and a component at 4.08ns. 
Consequently, the FRET efficiency of the intact biosensor was equal to 0.75.  
 The change in FRET following the cleavage of the biosensor’s substrate was also 
assessed by examining the polar coordinate of each configuration of the biosensor at a 
modulation frequency of 40MHz (Figs. 2.1C and 2.1D). As suggested by the 
measurements taken with multiple modulation frequencies, the polar coordinate of the 
ECFP move from a position near 1ns (gray circle in Fig. 2.1C)  to a position between 2ns 
and 3ns (filled black circle in Fig. 2.1C) as the substrate of the biosensor was cleaved by 
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trypsin. The sample was imaged on the homodyne FLIM instrument by placing a droplet 
of solution on a 1.5 coverglass. 
 When projected on the polar plot, changes in the measured time-dependent 
fluorescence of the acceptor can also indicate the configuration of the biosensor. In order 
to characterize the acceptor, the lifetime of a solution of purified biosensor was measured 
with an excitation wavelength of 488nm (filled black circle in Fig. 2.1D). When projected 
on the polar plot, YPet, itself, has a single component lifetime near 3.4ns. Without the 
contribution of bleedthrough and the direct excitation of the YPet, the theoretical polar 
coordinate of YPet undergoing FRET on this biosensor would be outside of the semi-
circle (open gray circle in Fig. 2.1D). The polar coordinate of YPet undergoing FRET has 
a phase delay equal to the sum of the phase delay of the donor (ECFP) undergoing FRET 
and the phase delay of the YPet (directly excited). The modulation ratio (length of the 
vector on the polar plot) describing YPet excited by FRET is also reduced in size with 
respect to the modulation ratio of the donor (ECFP) undergoing FRET.  
 However, the emission spectrum of the YPet and that of the ECFP significantly 
overlap. As a result, finding a set of emission that solely reports on the emission of YPet 
is not feasible. In addition, the absorbance spectrum of YPet extends into the blue and 
therefore, it can be directly excited by the 440nm laser. The polar coordinates 
corresponding to the phase delay and modulation ratio of the intact and cleaved biosensor 
excited at a wavelength of 440nm and detected through the filter for YPet are shown in 
Figure 2.1C. Unlike the polar coordinates describing the acceptor in Figure 2.1D, the 
locations of these polar coordinates reflect the both the overlap in emission between the 
ECFP and the direct excitation of the YPet. In short the polar coordinates shown in 
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Figure 2.1C define the trajectory measured experimentally with the samples of purified 
biosensor. 
Steady-State Spectra 
 The spectral characteristics of the ECFP/YPet variant of the MT1-MMP biosensor 
were examined with both the excitation wavelength used during the steady-state 
microscopy (405nm) and during the lifetime imaging experiments (440nm).  In Figure 
2.2, the spectra of both the intact and cleaved biosensor are presented along the individual 
contributions of ECFP and YPet computed by spectral unmixing. When excited by either 
the 405nm or 440nm wavelength, the emission spectra of the intact biosensor are 
dominated by the spectral contribution of the YPet. In these spectra (Fig. 2.2A and Fig. 
2.2C), the amplitude of ECFP’s peak is approximately one tenth of the amplitude of the 
corresponding peak from the YPet.  
 The spectrum of the ECFP however, became prominent after the substrate of the 
biosensor was cleaved by trypsin (Fig. 2.2B and Fig. 2.2D. No apparent peak from the 
YPet was observed in the emission spectrum of the cleaved biosensor at an excitation 
wavelength of 405nm (Fig. 2.2B). However, there is a small contribution from YPet 
apparent when the cleaved biosensor was excited at a wavelength of 440nm (Fig. 2.2D). 
In this case, the YPet is likely being directly excited.   
Simulations: Steady-State  
 Simulations were conducted in order to determine the measured FRET efficiency 
(steady-state) and the measured FRET ratio as a function of the species fraction of the 
intact biosensor. The previously discussed in-vitro measurements taken on the biosensor 
(and published in [6]), the reported extinction coefficients and quantum yields of the 
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ECFP [35]  and YPet proteins [36]  and reference spectra from the Tsien Lab [37] 
supplied the physical constants for the simulations. All possible combinations of intact 
and cleaved biosensors were sampled from the case where all of the biosensors were 
entirely cleaved to the case where all of the biosensors were completely intact. These 
simulations assumed an excitation wavelength of 405nm and that the fluorescence 
emission was detected through the two sets of emission wavelengths used during the 
steady-state live cell imaging (Fig. 2.3D). 
 As shown in Figure 2.3A, the FRET ratio (YPet/ECFP) for this biosensor 
increases exponentially with increasing species fraction of the intact biosensor. The rate 
of change in FRET ratio (YPet/ECFP) with respect to the species fraction of the intact 
biosensor increases dramatically with increasing species fraction. Therefore, a given 
change in the FRET ratio (YPet/ECFP) could correspond to either a large or small change 
in the actual species of the biosensor (intact or cleaved) depending on the initial species 
of the biosensor present. If the opposite FRET ratio (ECFP/YPet) is considered, the rate 
of change in the FRET ratio is also not constant with an increasing species fraction of the 
intact biosensor (Fig. 2.3B). The largest rate of change in the FRET ratio (ECFP/YPet) 
occurs when the species fraction of the intact biosensor is less than one half (Fig. 2.3B). 
Even in the case when the two configurations of the biosensors are defined as folded 
versions of a donor and acceptor tandem construct, the relationship between the species 
fraction of a particular configuration of the biosensor and the measured FRET ratio will 
still be exponential in character.  
 However for the cyan variant of the MT1-MMP biosensor, the FRET efficiency 
measured by steady-state methods, increases linearly with the increasing species fraction 
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of the intact biosensor (Fig. 2.3C). Therefore, unlike either of the FRET ratios, the rate of 
change in the measured FRET efficiency is constant with changing species fraction of the 
intact biosensor.  
Simulations: Time-Dependent 
 In parallel, the polar coordinates calculated from the phase delay and modulation 
ratio describing the biosensor were also simulated as a function of increasing species 
fraction of the intact biosensor (Fig. 2.4). In other words, the sample in this simulation 
was a solution of biosensors with a fixed concentration. Relative to that fixed 
concentration, the amount of cleaved and intact biosensors was changed from the 
condition of having purely intact biosensors to the condition of having purely cleaved 
biosensors. In order to parallel the conditions of the lifetime imaging experiments, these 
simulations assumed an excitation wavelength of 440nm and an emission filter specific 
only for the fluorescence emission of the ECFP (<500nm). As discussed previously, a 
polar coordinate of a system containing two populations of fluorophores will be sum of 
the polar coordinates of the constituent fluorophore’s polar coordinate where each is 
weighted by its specific fractional contribution to the steady-state intensity. The trajectory 
of points on the polar plot (dotted gray line in Figs. 2.4A, 2.4B and 2.4C) describing all 
linear combinations of the intact (near 1ns) and cleaved biosensor (near 2.5ns) was based 
on the previously described in-vitro measurements [6] (and was also discussed in the 
previous section of this chapter). 
 In the simulations on the polar plot, the species fraction of the intact biosensor 
was incrementally lowered and the resulting polar coordinates are shown in Figures 2.4A, 
2.4B and 2.4C. The simulations indicate that even a very small amount of cleaved 
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biosensors (species fraction of intact biosensor = 0.75) can significantly move the polar 
coordinate from the intact position (near 1ns) toward the polar coordinate of the cleaved 
biosensor (near 2.5ns) (Fig 2.4B). Therefore, even a twenty five percent reduction in the 
species fraction (normalized concentration) of the intact biosensor results in the detected 
intensity from the cleaved biosensor being greater than that of the intact biosensor. When 
the species fractions of the intact and cleaved biosensor were equal (Fig. 2.4C), only 
twenty percent of the resulting intensity was from the intact biosensor.  
 By further increasing the amount of cleaved biosensor in the simulation from a 
state where species fraction of the intact biosensor is one half to state where the species 
fraction of the intact biosensor is zero, only small changes in polar coordinate 
(approximately 4o in phase delay or 0.06 in Cartesian distance) remain that can be used to 
quantify these changes in the configuration of the biosensor. However, despite the small 
change in polar coordinate between the condition of having a species fraction of the intact 
biosensor at one half and that of having purely cleaved biosensor, the simulated FRET 
ratio (YPet/ECFP) would change from 1.73 to 0.37. In parallel, the simulated FRET ratio 
(ECFP/YPet) would change from 0.58 to 2.7. Hence, if the species fraction (normalized 
concentration) of the intact biosensor changes from one half to zero, there is only a small 
change in the time-dependent fluorescence emission detected by FLIM but at the same 
time, there can be more than a four-fold change in the FRET ratio.  
Steady-State Measurements of FRET 
Measurements of solutions 
 A solution of intact biosensors was measured using the 20x Plan-Apochromat air 
objective. This solution of intact biosensor has a known FRET efficiency and FRET ratio 
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and therefore, can be used to find the corrections necessary for accurate measurements on 
live cells. The 20x air objective had a large excitation volume and hence provided much 
better signal-to-noise ratio for measuring the fluorescence from quenched donor (ECFP) 
in this solution sample than the 63x Plan-Apochromat oil immersion objective. The 
wavelength-dependent transmission of this objective was compared to that of the 63x oil 
immersion objective using a sample of cleaved biosensor. No significant differences were 
noted. The wavelengths selected for these experiments are shown along with the emission 
spectra of ECFP and YPet in Figure 2.3D. The collected intensities (IDD, IDA and IAA) 
describing the intact biosensor (Table 2.2), do indicate that the fluorescence emission of 
the donor (ECFP) was quenched. The calculated FRET ratio (ECFP/YPet) from the 
measurements taken on the microscope was 0.2 ± 0.05.  
 A separate measurement of the cleaved biosensor and separately a solution of 
Rhodamine B with the 20x air objective resulted in a value of    equal to 0.84 ± 0.23. 
By cleaving the biosensor with trypsin, the emission of the non-interacting (no FRET) 
YPet and ECFP could be measured. The fluorescence emission of each protein could be 
independently measured by cleaving the biosensor because the absorbance of the YPet 
protein is negligible at an excitation wavelength of 405nm as is the absorbance of ECFP 
at an excitation wavelength of 514nm. When combined with the previous intensity 
measurements taken on the FRET standard, this value of    yielded a value for the 
steady-state FRET efficiency of the solution of intact biosensors equal to 0.79 ± 0.0427. 
The factor   was also determined by measuring solutions of cleaved biosensor and 
separately solutions of Rhodamine B with the same 63x Plan-Apochromat oil immersion 
objective used to image the live cells. Measurements of four sets of solutions were made 
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independently. The average value and standard deviation of   determined from this set 
of measurements was 0.86 ± 0.29.  
Correction Factors for Live Cell Imaging 
 The measurements of solutions on the steady-state microscope were then applied 
to determine correction factors accounting for transmission efficiencies of the 
microscope’s dichroics and emission optics. Comparisons were made to equivalent 
samples of solutions measured on both a time-resolved and a corrected steady-state 
fluorometer (Figs. 2.1 and 2.2). The FRET efficiency of the intact ECFP/YPet version of 
the MT1-MMP has been previously determined using multi-frequency lifetime 
measurements as 0.75. Using a fully corrected steady-state fluorometer, we have 
determined the FRET ratio (ECFP/YPet) of the intact MT1-MMP biosensor excited at 
405nm to be 0.17.   
 Correcting for the FRET ratio can be done simply by comparing the FRET ratios 
collected from the microscope and fluorometer in order to determine a correction factor. 
Correcting the microscope’s measurement of FRET Efficiency primarily stems from 
using two different dichroic mirrors to measure the sample of Rhodamine B at excitation 
wavelengths of 405nm and separately 514nm when determining   . All other 
wavelength-dependent artifacts are considered in the bleedthrough coefficients applied 
when calculating the FRET efficiency. Therefore, the factor    was corrected by 
simulating the FRET efficiency as a function of    (Supp. Fig. 2.2). Intensity values 
measured from the FRET standard on the steady-state microscope were entered into this 
simulation to compute the FRET efficiency at each value of   . A reduced value of  
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equal to 0.66 corresponding to the known FRET efficiency of 0.75 was the corrected 
value used in this study.  
Live Cells: Steady-State Imaging 
Bleedthrough Coefficients  
HT-1080 cells transfected with DNA encoding ECFP only were imaged on the steady-
state microscope through the filters described in Figure 2.3D. In order to find the 
coefficient  1b , ten cells were imaged. The cells in each image (IDD and IDA) were 
segmented and the intensities from each image were averaged separately to calculate  1b
. An example of one of the HT-1080 cells examined is shown in Supplemental Figures 
2.3A and 2.3B. The emitted fluorescence was distributed uniformly throughout the cells 
transfected with the ECFP-only plasmid. The resulting values and corresponding 
uncertainties for  1b  are shown in Table 2.3. In order to asses the quality of ECFP’s 
expression, spectral images of several HT-1080 cells were also collected (Supp. Fig. 
2.3C). Intensities from these spectral images are plotted at their corresponding set of 
wavelengths and are compared to the know reference spectrum of ECFP in Supplemental 
Figure 2.3D. When compared to the reference emission spectrum of ECFP, both the 
position of the emission maximum and the overall shape of the spectrum measured in the 
live cells indicated that the ECFP was properly expressed.   
 The bleedthrough coefficient  2b  which is the ratio of YPet’s fluorescence 
directly excited at 405nm and the fluorescence directly excited at 514nm was assumed to 
be zero.  
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HT-1080 Cells 
A series of HT-1080 cells transfected with the ECFP/YPet MT1-MMP biosensor 
were examined in order to determine the FRET efficiency and FRET ratio with steady-
state imaging (Fig. 2.5). As mentioned previously, HT-1080 cells endogenously express 
MT1-MMP. Consequently, these cells will contain a mixture of intact and cleaved 
biosensors.  
In the first cell examined shown in Figures 2.5A, 2.5B and 2.5C, images were 
collected with all three excitation and emission filter settings (IDD, IDA and IAA). By 
comparing the image collected only from the donor’s fluorescence (IDD) and that from 
only the acceptor’s fluorescence (IAA), there is a definite region along the perimeter of 
the cell where there is no staining (fluorescence) from the acceptor (YPet) indicating that 
the biosensor is likely cleaved. In the central portion of the cell, both the donor and the 
acceptor are present.  
Regions of interest were selected in both the periphery and center of the cell for 
analysis (white boxes in Fig. 2.5A). On a pixel-wise basis, the FRET ratio and FRET 
efficiency were calculated in each region and the resulting distributions are shown as 
histograms in Figures 2.5D and 2.5F. Graphically, the distributions from each region of 
interest describing the FRET efficiency and separately the FRET ratio have definite peaks 
and do indicate that there is a low FRET state along the perimeter of the cell (regions 3 
and 4) and a higher FRET state in the cell’s center (regions 1 and 2).  
The average intensities from each region collected through the donor’s channels 
IDD and IDA were also used to quantitatively determine the FRET efficiency and FRET 
ratio (Table 2.4). The calculation of the uncertainty in the FRET efficiency and FRET 
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ratio is described in derivation 2. The low FRET efficiency (0.02 in region 3 and 0.03 in 
region 4) and high FRET ratio (2.17 in region 3 and 2.07 in region 4) indicate that the 
majority of the biosensors are cleaved. However, in the central part of the cell where 
some of the biosensor is expected to be intact, the FRET efficiencies (0.178 in region 1 
and 0.177 in region 2) are lower than the FRET efficiency of the intact biosensor 
measured in vitro. The FRET ratio calculated in the central part of the cell (1.24 in region 
1 and 1.24 in region 2) is also higher than the FRET ratio describing the purely intact 
biosensor in vitro. 
In order to look for higher extents of FRET in the cells, the FRET efficiency and 
FRET ratio were also examined globally in a pixel-wise manner (color images in Figs. 
2.5E and 2.5G). However, as indicated in the color renderings, the values for the FRET 
efficiency and FRET ratio throughout the cell do not show that a higher FRET state 
exists. Furthermore, the FRET efficiencies and FRET ratios examined in the entire set of 
cells (data not shown) analyzed did also indicate that the maximum FRET efficiency 
detected was near 0.3.  
 In the course of the steady-state measurements, the spectral characteristics of 
various regions of the transfected HT-1080 cells were also studied to see if the recorded 
spectra reflect these low FRET measurements (Supp. Figs. 2.4 and 2.5). In both of the 
presented cases, regions of interest were selected in regions along the edge of the cell 
(regions 1 and 3) and in the center of the cell near the nucleus (region 2). As before, these 
regions were selected to highlight areas of the cell containing cleaved biosensor and 
separately, the intact biosensor. An excitation wavelength of 405nm was used in this 
experiment. 
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 In the regions along the perimeter of the cell (Supp. Figs. 2.4B, 2.4D, 2.5B and 
2.5D), the dominant feature each of the spectra was the emission spectrum of the ECFP. 
There were no deviations in the intensity near 530nm (YPet’s) emission peak indicating 
FRET. Furthermore, in these regions along the edge of the cell (Supp. Figs. 2.4B, 2.4D, 
2.5B and 2.5D, both the relative peak intensity and the shape of the reference emission 
spectrum of ECFP overlapped well with the data collected from the cell’s images. 
However, the emission spectrum collected in the center of the cell (Supp. Figs. 2.4C and 
2.5C) did indicate a deviation in intensity from the spectrum of pure ECFP near the 
emission peak of the YPet (~530nm). In these plots, the measured spectrum is 
accompanied by a simulated spectrum containing a mixture of intact and cleaved 
biosensor as a reference (gray line). In both cases (Supp. Figs. 2.4C and 2.5C), the 
measured and reference spectra matched the data well and reflects qualitatively the low 
amount of FRET detected with the steady-state FRET efficiency and FRET ratio.   
HT-1080 Cells Treated with Inhibitor  
A set of HT-1080 cells containing the ECFP/YPet version of the MT1-MMP 
biosensor were pre-incubated with the MMP inhibitor GM6001 prior to imaging (Fig. 
2.6). The incubation with GM6001 will therefore, prevent the biosensor from being 
cleaved leaving it intact in the cell. 
  Intensity images of the GM6001-treated cells were also acquired through the 
channels IDD, IDA and IAA (Figs. 2.6A, 2.6B and 2.6C). In these cells, the staining 
pattern from the images collected with only the donor’s fluorescence (IDD) matched (co-
localized) well with the images collected using only the acceptor’s fluorescence (IAA). 
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There was no discernable edge or peripheral region in this cell that lacked staining by the 
acceptor YPet.  
A set of regions (white boxes in Fig. 2.6A) were selected to analyze the FRET 
efficiency and FRET ratio. The corresponding distributions of the FRET efficiencies 
(Fig. 2.6D) and FRET ratios (Fig. 2.6F) determined in a pixel-wise manner were fairly 
uniform in both shape and position of the peak throughout the four regions selected 
within the cell. As before, the average intensities from the four regions of interest were 
used to compute the FRET efficiency and FRET ratio (Table 2.5). The calculated FRET 
efficiencies spanned the range from 0.21 to 0.27 while the calculated FRET ratios ranged 
from 1.13 to 0.92. Although these FRET efficiencies are higher (and the FRET ratios are 
lower) than those found in the cell not treated with GM6001, they do not parallel the in-
vitro measurements and therefore possibly indicate that the majority of the biosensors are 
cleaved in these cells. 
In order to look for areas in the cells with higher amounts of FRET, the FRET 
efficiency and FRET ratio was mapped on a pixel-wise basis throughout the intensity 
image of the cell (Figs. 2.6E and 2.6G). In these images, there were no discernible 
regions that indicated higher FRET efficiencies (lower FRET ratios) than those analyzed 
in the previously described analysis.  
 HT-1080 cells transfected with the ECFP/YPet variant of the MT1-MMP and pre-
treated with the GM6001 inhibitor were also imaged on a spectral imaging system with a 
405nm excitation wavelength (Supp. Fig. 2.6). The purpose of these experiments was to 
confirm the observations noted in the previous steady-state measurements of low FRET 
specifically under the conditions when the biosensor was intact (MMP inhibitor 
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treatment). Individual images were collected from a wavelength of 429nm to 625nm with 
steps of approximately 9.8nm. The intensities analyzed from the three regions of interest 
(white boxes in Supp. Fig. 2.6A) are plotted versus wavelength in Supplemental Figures 
2.6B 2.6C and 2.6D. Even without applying linear unmixing, the dominant feature 
occupying most of the intensity in the plotted spectra is the emission spectrum of the 
ECFP (peak at 480nm). Only a small peak from YPet’s emission spectrum is visible as 
well near 530nm. Even though the regions selected in this analysis spanned the majority 
of the cell’s body, no significant differences were apparent in the relative amplitudes of 
ECFP’s and YPet’s emission peaks or in the overall shape in the recorded spectra in the 
various regions. Furthermore, the relative amplitudes of ECFP’s emission peak and 
YPet’s emission peak do not resemble those in the previously measured or simulated 
emission spectrum of the purely intact biosensor.   
Live Cells: Lifetime Imaging Using the Donor (ECFP) 
HT-1080 Cells 
Images of the HT-1080 cells were collected on the homodyne FLIM instrument at 
a modulation frequency of 40MHz. A 440nm and separately a 488nm laser line were 
used to excite each sample. The fluorescence emission was collected through the filter 
pass specific to each laser line shown in Figure 2.7C. The 440nm laser and the 
corresponding filter observed emission from the donor ECFP while exciting primarily the 
donor (ECFP) while the 488nm laser and filter selectively excited and collected the 
emitted fluorescence from the acceptor YPet. 
 In the cell images shown in Figure 2.7, there are areas on the periphery of the cell 
clearly visible in the channel specific for ECFP (Fig. 2.7A) which are not apparent in the 
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image collected with the 488nm laser (Fig. 2.7B). However, the staining in the central 
regions of the cell was similar when collected using the 440nm and 488nm lasers with 
their corresponding filters. Therefore, in these peripheral regions of this cell, there is a 
lack of YPet which does indicate that the biosensor is likely cleaved.  
 The phase delay and modulation ratio were gathered from four regions of interest 
in the cell (white boxes in Fig. 2.7A) which included areas in the center (regions 2 and 3) 
as well as areas along the perimeter of the cell lacking YPet (regions 1 and 4). The polar 
coordinates describing the pixels in these regions are shown in the scatter plots in Figure 
2.7D. Despite the differences in staining of the ECFP and YPet in the various regions of 
the cell, the polar coordinates gathered from all of the four regions were all projected at a 
position just above 2ns. Even in the central regions of the cell, the polar coordinates did 
not indicate a strongly quenched lifetime of the donor (ECFP) corresponding to the intact 
biosensor.  The wide distribution of points on the polar plot associated with each region 
of interest is the result of noise in the detection system [31]. Consequently, the center of 
each distribution shown in the polar plots (Fig. 2.7D) is indicative of the fluorescent 
species in that region. The extrema points specifically in the larger distributions of polar 
coordinates taken from the areas of the cell with low signal are not representative of 
unique fluorescent species but likely a part of a larger distribution. 
 In addition to examining specific regions within the cell, the two intensity images 
of the cells were also segmented (red borders in Figs 2.7A and 2.7B) to examine the 
entire edge and center of the cell on the polar plot. The edge is defined as the area 
between the boundary plotted as a red line in Figure 2.7A and the boundary plotted in 
Figure 2.7B. The center is simply the area contained in the boundary plotted in Figure 
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2.7B. The mean polar coordinates of the edge and central sections of the cell along with 
standard deviations in both the x- and y-dimensions are presented on the polar plot in 
Figure 2.7E. The polar coordinate describing the edge shows a likely contribution from 
residual background in this area of low signal but this polar coordinate does not differ 
significantly from the polar coordinate calculated from the pixels in the center of the cell. 
The polar coordinate of the background resides in the lower left corner of the polar plot 
representing un-modulated signals entering the detector. 
HT-1080 Cells Treated with Inhibitor  
The polar coordinate of the intact biosensor was further examined by pre-
incubating the HT-1080 cells with GM6001 to prevent the cleavage of the biosensor. 
Imaging was also carried out with the lasers and filters described in Figure 2.7C in order 
to examine to the emission from the donor (ECFP) at an excitation wavelength of 440nm 
and separately the emission from the acceptor (YPet) by directly exciting the sample with 
a 488nm laser. The images gathered from the ECFP’s emission (Fig. 2.8A) and YPet’s 
emission (Fig. 2.8B) show a high degree of co-localization. In other words, the features in 
Figure 2.8A such as the nucleus, bright region around the nucleus and the edge of the cell 
are clearly visible in the images shown in both Figures 2.8A and 2.8B.  
In this analysis, pixels from various regions of interest in the cell (white boxes in 
Fig. 2.8A) were projected as polar coordinates on the scatter plots shown in Figure 2.8C. 
In all cases, the polar coordinates collected from the cell remained in a position just 
above 2ns. None of the polar coordinates indicated a strongly quenched lifetime of the 
donor (ECFP) as detected for the intact biosensor in the in-vitro measurements but 
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instead, closely paralleled the positions of the polar coordinates describing the untreated 
HT-1080 cell.  
Live Cells: Lifetime Imaging using the Acceptor (YPet) 
HT-1080 Cells  
 HT-1080 cells transfected with the ECFP/YPet-variant of the MT1-MMP 
biosensor were imaged in order to examine the acceptor’s time-dependent fluorescence 
on the homodyne lifetime imaging system (Fig. 2.9). Each cell was imaged with three 
separate excitation sources and emission filter combinations specific for either the donor, 
the acceptor while being excited at the donor’s excitation wavelength (440nm) or the 
acceptor being directly excited (488nm) (Figs. 2.9A, 2.9B and 2.9C).  
 Without an MMP inhibitor present, the initial set of cells examined contained a 
mixture of intact and cleaved biosensors. In the first cell imaged, the average intensity 
image of the cell (gathered from the eight phase images), using the excitation source 
(440nm) and emission filter specific for ECFP is shown in Figure 2.9A. The intensity 
image collected with the same excitation laser but through a filter for YPet contains the 
same morphological features of the cell shown in Figure 2.9A. For example, the bright 
region surrounding the nucleus as well as the dimmer edge (peripheral regions) are 
consistent in the images of the cells presented in Figure 2.9A and Figure 2.9B. However, 
when the cell was imaged by selectively exciting the YPet, the edges of the cell (near 
regions of interest #2 and #4 in Fig. 2.9B) were not visible in the resulting intensity 
image (Fig. 2.9C). The polar coordinates from the pixels in the ROIs shown in Figure 
2.9B were taken from the images acquired with the 440nm exciting laser and the filter 
specific for YPet and projected on the polar plot (Fig. 2.9D). In regions #2 and #4 located 
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at the bottom of the cell lacking staining from YPet, the polar coordinates moved toward 
shorter lifetimes (near 2ns) indicating that the biosensor was possibly cleaved. As 
discussed previously, this position on the polar plot also corresponds to the location of 
non-interacting ECFP measured in a solution of purified biosensor. In the regions 
containing intensity from both the ECFP and YPet, the polar coordinates remained longer 
lifetimes (near 3ns) possibly indicating that the biosensor was possibly intact. 
 Image segmentation was applied to the images of the HT-1080 cells collected in 
this acceptor-based FLIM experiment in order to study the entire edge and center of the 
cell. As before, the center of the cell is simply the area contained within the boundary 
depicted in Figure 2.9C. The edge of the cell is essentially the area of the cell lacking 
staining from YPet and is therefore, defined as the part of the cell located between the red 
boundaries drawn in Figures 2.9B and 2.9C. In general, the average polar coordinate 
calculated from the center of the cell was closer to longer lifetimes (near 3ns) than the 
average polar coordinate computed from the pixels along the edge of cell (Fig. 2.9E). 
Given the low signal along the edge of the cell, the average polar coordinate calculated 
from the pixels along the edge of the cell appears to be being slightly pulled toward the 
area on the polar plot indicative of un-modulated background. However, the separation in 
polar coordinate between the edge and center of the cell (between approximately 2ns and 
3ns) are consistent with the analysis of the specific regions throughout the cells.  
HT-1080 Cells Treated with Inhibitor  
 HT-1080 cells were also pre-treated with the MMP inhibitor GM6001 and imaged 
with emphasis on the polar coordinates of the YPet. The intensity images were collected 
with the three excitation laser and filters used previously. These are labeled as ECFP 
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(Fig. 2.10A), YPet undergoing FRET (Fig. 2.10B) and YPet directly excited (Fig. 2.10C). 
Although the intensities vary in each of the three images, the primary features of the cell 
such as the nucleus, edge and bright region surrounding the nucleus were apparent in 
each of the images. In other words, there was apparent staining by both ECFP and YPet 
throughout the entirety of the cell itself. The polar coordinates from the pixels within the 
four regions of interest shown in Figure 2.10B are projected on the scatter plots in Figure 
2.10D. Regardless of whether the region was selected near the edge or center of the cell, 
the polar coordinates consistently remained near 3ns on the polar plot.   
 
Discussion 
 The presented measurements taken on the MT1-MMP biosensor transfected into 
HT-1080 cells using the FRET ratio, steady-state FRET efficiency and FLIM verified 
that changes in FRET detected by the steady-state methods did not correspond to 
significant changes in the measured time-dependent fluorescence of the donor ECFP.   
Throughout, the images of the HT-1080 cells collected with FLIM, there was very 
minimal quenching of the donor’s (ECFP’s) lifetime with nearly all polar coordinates 
remaining in a region of the polar plot slightly above 2ns. However, some variation in the 
polar coordinate of the acceptor (YPet) was recorded spanning an area on the polar plot 
between 3ns and 2ns. In parallel, the measured steady-state FRET efficiency in the cell 
images had a range of nearly zero to maximum of approximately 0.3 throughout the 
different organelles of the cells examined. Despite the small variations in the time-
dependent fluorescence of the donor measured by FLIM, the FRET ratio (ECFP/YPet) 
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still had the largest change in value ranging from nearly one to two when different 
regions of the cells were compared. 
The presented simulations imply that the results gathered from the different 
methods for detecting FRET may be indicative of a high background of non-interacting 
donor (ECFP) in the cells analyzed. In the simulation examining the measured FRET 
ratio (ECFP/YPet) as function of the species fraction (normalized concentration) of the 
intact biosensor, the largest changes in FRET ratio are observed when the species fraction 
is less than 0.4. In this range of species fraction of the intact biosensor (0 to 0.4), the 
simulated changes in the measured steady-state FRET efficiency would be on the order of 
0.3 to 0.5. At the same time, further simulations predict that there would be no detectable 
change in the polar coordinate of the donor if the species fraction of the intact biosensor 
was changed from zero to 0.4. Although a precise comparison between the measurements 
taken on live cells and the data collected in vitro cannot be done without extensive 
analysis of the expression of the biosensor and environmental perturbations on the 
protein’s photophysics, the most likely explanation of the experimental observations is 
that there is a high background of non-interacting ECFP. In other words, the 
measurements examining the biosensor in the live HT-1080 cells strongly imply that the 
biosensor is expressed in a manner closely paralleling its expression for the in-vitro 
analysis, but that a large majority of the donors are not undergoing FRET in the live HT-
1080 cells.  
 Other interpretations of data such as the possibility that the FRET efficiency of 
the intact biosensor is smaller in the live HT-1080 cells than in the bacterial cells used to 
extract the biosensor in-vitro are simply not supported by the measurements. Examples of 
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such variable expressions between the solution of biosensors examined in vitro and those 
examined in live cell HT-1080 cells would include a different mutual orientation of the 
donor and acceptor. If the intact biosensor itself, had a smaller FRET efficiency when 
expressed in the live HT-1080 cells when compared to the solution of biosensors studied 
from the in-vitro purification, two populations of polar coordinates would be clearly 
observed from the lifetime images of the live cells indicative of the measured steady-state 
FRET efficiency which spanned values from zero to 0.3. In this case, a change in the 
lifetime of the ECFP as a result of FRET would be  on the order of 0.5ns to 0.8ns 
(assuming the lifetime of ECFP is near 2ns) and easily resolvable on the lifetime imaging 
system. However, in the presented data, the position of the polar coordinates examined 
from regions of the cell with no staining by YPet were not clearly distinguishable from 
the polar coordinate examined in areas of the cells stained by both YPet and ECFP. The 
lifetime of pure ECFP has been previously shown to vary as a function of both ion 
concentration and pH [38]. Therefore, it is expected that lifetime of the pure ECFP as 
indicated by the in-vitro measurements or by values taken from the literature, may not 
perfectly match the polar coordinate in the measured HT-1080 cells. However, the lack of 
variation in the polar coordinates likely describing the intact and cleaved biosensor 
suggests that there is a high background of non-interacting ECFP. 
The fluorescence emission of several variants of the cyan and yellow fluorescent 
proteins can be perturbed by factors in their local environment. For example, certain 
ranges of intracellular pH have been previously shown to diminish the absorbance of the 
yellow fluorescent proteins, making them poor acceptors for FRET in cells [39]. In a 
recent paper, it was reported that even the normal levels of ATP in a cell can significantly 
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reduce the amount of FRET taking place between the yellow and cyan fluorescent 
proteins expressed as a tandem protein [40]. The ATP-dependent effects however were 
shown to be specific to ECFP and were not apparent in parallel studies of the cyan variant 
Cerulean. It is also quite possible that the maturation times of the ECFP and YPet may be 
different and therefore contribute to a background of unpaired ECFP. 
However, even with environmental perturbations, definite changes in the polar 
coordinate were observed when the YPet’s emission was imaged with FLIM while 
exciting the donor ECFP. In these experiments, polar coordinates moved between two 
pools of lifetimes on the polar plot (between 2ns and 3ns), which were possibly indicative 
of the cleaved and intact biosensor. Although the trajectory of the polar coordinates 
recorded during the live cell experiments paralleled the trend observed during the in-vitro 
experiments, there was a definite bias in the live cell experiments toward the polar 
coordinate of the non-interacting ECFP. Throughout the regions analyzed during the 
experiments examining the acceptor with FLIM, none of the polar coordinates were in the 
range of 3ns to 4ns that were predicted in the in-vitro measurements. At this time, there is 
no reported environmental perturbation that has been shown to vary the lifetime of YPet 
by more than one nanosecond. Despite the apparent change in polar coordinate observed 
in these experiments, the variation in polar coordinate may simply arise from the 
presence or lack of YPet in the regions analyzed. YPet itself, can be directly excited at 
440nm and contribute intensity comparable to that from ECFP in the wavelength range 
used to observe YPet in this chapter. As a result, even in the case where there is no FRET 
taking place, the change in emission from non-(or weakly) interacting ECFP to that of 
directly excited YPet and non-(or weakly) interacting ECFP would lead to a change in 
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polar coordinate similar to that observed in the live cell experiments. The results 
presented studying YPet’s emission with FLIM therefore, also imply a low state of 
FRET. If the polar coordinates were observed in areas on the polar plot near longer 
lifetimes (>3ns), there would be evidence for significant energy transfer taking place.  
 
Conclusions 
In general, several photophysical characteristics of the fluorescent proteins 
selected for ratiometric biosensors may not suitable for detection with FLIM and analysis 
on the polar plot. The design of many popular ratiometric biosensors has been centered 
on having extremely bright and well absorbing acceptors paired with very dim donors. As 
a result of energy transfer, the donors are highly quenched making them much more 
difficult to detect. On the polar plot, the polar coordinate generated by multiple 
fluorescing species in the same portion of the cell is the sum of the polar coordinates of 
the constituent fluorescent species, each weighted by their respective contribution to the 
measured intensity. Consequently, if there is a substantial difference in intensity between 
the donor’s emission on the intact and separately on the cleaved biosensor, even small 
amounts of the cleaved biosensor can strongly obscure the polar coordinate with a high 
background of unpaired donor. 
Regardless of the type of measurement applied to study the biosensor in cells, the 
measurements and proposed models possibly suggest that the true physical dynamic 
range of this biosensor is small and therefore, making conclusions about the 
configuration of this biosensor in cells remains difficult. The exponential relationship 
between the measured FRET ratio and the species fraction of the intact biosensor can also 
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lead to false positives if large changes in FRET ratio such as those observed in the 
chapter, are interpreted as comparable changes in the actual species of the biosensor 
present. However, at the same time, the measurements taken on biosensors expressed in 
the live cells with FLIM readily indicated that there is likely a high background on non-
interacting donor simply with a graphical inspection of the data on the polar plot. When 
analyzed on the polar plot, the data collected with FLIM have the unique advantage that 
the species of the biosensor can be extracted directly from the measured data without the 
need for extensive modeling, fitting or corrections. 
Newly developed fluorescent proteins including those which absorb and emit light 
at longer wavelengths (>550nm) can improve the reliability in the detection of the 
configuration of intracellular FRET-based biosensors in live cells [41, 42]. Already, the 
mOrange2/mCherry variant of the MT1-MMP biosensor has been shown to accurately 
report the sub-cellular activity of the MT1-MMP enzyme with high contrast in live HT-
1080 cells [43].  
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Derivation 1: Calculation of the FRET Efficiency from Steady-State 
Measurements 
 The equations relating measured various steady-state intensities to the FRET 
efficiency can be derived analytically by first considering the emission from the donors 
and acceptors in the image without FRET referred to as  DI and  AI . In other words, 
the intensities  DI and  AI , are that which would have been emitted by the actual 
concentration of donors and acceptors in an area of the image as if they were all non-
interacting.  
 Next, it is assumed that you have a solution containing a uniform volume of 
molecules (donors conjugated to acceptors) undergoing FRET. Each of the spectra 
discussed previously in the derivation of FRET efficiency with steady-state 
measurements can then be written in terms of  DI and  AI . 
       , 1D DEX EM DI I E        A1.1 
                                       1 2 1, 1D AEX EM D A DI I E b I b I E             A1.2 
      ,A AEX EM AI I       A1.3 
The FRET efficiency  E  can then be solved for simply in terms of the measured 
intensities and correction factors defined previously.  
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In the simulations examining the FRET efficiency  E  as a function of the species of the 
intact biosensor, the concentration of cleaved biosensor was increased relative to the 
concentration of intact biosensors by adding terms to the above equations accounting for 
non-interacting (No FRET) constituents. 
 
Derivation 2: Calculations of Uncertainty for Steady-State 
Measurements of the FRET Efficiency and FRET Ratio 
 When the FRET efficiency from the steady-state measurements and corrections 
were calculated, the uncertainty in the FRET efficiency was based solely on the 
uncertainty in the intensity measurements referred to as  IDD  and  IDA . The 
bleedthrough coefficients (  1b  and  2b ) and the ratio of the quantum yields of the 
donor and acceptor   were assumed to be fixed. A propagation of errors calculation 
then determined the uncertainty in the FRET efficiency  E  shown below, 
   
2 2
              
E EE IDD IDA
IDD IDA
   A2.1 
In equation A2.1, the terms    
E
IDD
and    
E
IDA
are the partial derivatives of the FRET 
efficiency with respect to the intensities collected from the channels  IDD  and  IDA . 
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 Determining the FRET ratio in the cell images required only one correction 
accounting for differences in the wavelength sensitivity of the detection system. 
Therefore, in order to find the uncertainty in the FRET ratio (referred to as  R ), the 
wavelength-dependent correction was assumed fixed and only the uncertainty in the 
measured intensities  IDD  and  IDA contributed in the propagation of error calculation 
shown below, 
   
2 2
              
R RR IDD IDA
IDD IDA
   A2.4 
In this case, the derivatives of the FRET ratio with respect to the measured intensities 
 IDD  and  IDA take the following form, 
     1 
R
IDD IDA
      A2.5 
      2
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R IDD
IDA IDA
    A2.6 
 
Derivation 3: The Mathematics Relating the FRET Efficiency to 
Measured Lifetimes of the Donor 
 The excited state of a donor is depleted more rapidly in the presence of an 
acceptor. The depletion of the excited state of a fluorescent molecule can be modeled as a 
first order kinetic process where the system as equilibrated to as a quasi-state before 
returning to the ground state energy. In other words, once the excited molecule has 
reached the lowest vibrational level in the excited state, the pathway by which it returns 
to the ground state is random. However, each pathway has an associated rate constant 
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(referred to as  k ) indicating its average frequency of occurrence. While, undergoing 
FRET, the lifetime of the donor therefore shortens as a result of a new de-excitation 
pathway opened by the presence of the acceptor. In short, the lifetime of the donor 
undergoing FRET  DA  and the lifetime of donor without an acceptor  D  can be 
related to FRET efficiency  E  by the following equation. 
     1 DA
D
E        A3.1 
In order to derive equation (A3.1), the FRET efficiency has to be related to the various 
rates of the deactivation as shown, 
     T
T i
i T
kE
k k

       A3.2 
In this representation, the FRET efficiency compares the rate of energy transfer to the 
rates of all available de-excitation pathways in the system and is therefore, analogous to 
the quantum yield of energy transfer. In order to use equation (A3.2) to derive equation 
(A3.1), the lifetimes of the donor  DA  and  D  can also be written in terms of the rates 
of the de-excitation pathways present in the system. 
     1

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i T
k k
    A3.3 
         1

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i T
k
     A3.4 
With simple algebra, the FRET efficiency can then be expressed in the form of equation 
A3.1.  
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Tables 
Table 2.1: Fitting results from multi-frequency lifetime measurements taken on the 
purified biosensor 
 
 a1 τ1 (ns) a2 τ2 (ns) ‹τ› (ns) 
ECFP- 
FRET  0.92 0.42 0.08 3.99 0.71 
ECFP 0.44 1.24 0.56 4.08 2.83 
 
Supp. Table 2.2: Measurement of the FRET standard on the steady-state microscope 
  Intensity 
IDD 298.4 ± 61.1 
IDA 1460.3 ± 186.4 
IAA 1367.6 ± 158.1 
 
Table 2.3: Bleedthrough Coefficient (b1) 
  b1 
Cell 1 0.3721 
Cell 2 0.3448 
Cell 3 0.3848 
Cell 4 0.3401 
Cell 5 0.3522 
Cell 6 0.3468 
Cell 7 0.3406 
Cell 8 0.3608 
Cell 9 0.3579 
Cell 10 0.3505 
    
Mean 0.35506 
Std. 
Dev. 
0.014341
87 
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Table 2.4 Analysis of the steady-state FRET efficiency and FRET ratio in the regions of 
interest in an HT-1080 cell transfected with the MT1-MMP biosensor 
 
 
Avg. 
FRET 
Eff.  
Uncert. in 
FRET 
Efficiency 
Avg. 
FRET 
Ratio 
Uncert. in 
FRET 
Ratio 
ROI 1  0.1784 0.1049 1.238 0.5034
ROI 2 0.1769 0.1218 1.244 0.5883
ROI 3 0.0231 0.2376 2.169 2.4753
ROI 4 0.0346 0.1688 2.071 1.6414
 
Table 2.5: The steady-state FRET efficiency and FRET ratio calculated in each of the 
regions of interest selected in an HT-1080 cell transfected with the MT1-MMP biosensor 
and treated with the MMP inhibitor GM6001. 
 
 
Avg. 
FRET 
Eff. 
Uncert. 
In FRET 
Efficiency 
Avg. 
FRET 
Ratio 
Uncert. 
In FRET 
Ratio  
ROI 1 0.2057 0.3393 1.1326 1.4584
ROI 2 0.2363 0.1065 1.0275 0.4076
ROI 3 0.2563 0.1191 0.9649 0.424
ROI 4 0.2729 0.2193 0.9162 0.7362
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Figures 
 
Figure 2.1: Measurements of the time-dependent fluorescence of purified biosensor: (A) 
The modulation ratio (black squares) and phase delay (gray circles) were collected from a 
sample of purified biosensor at a set of modulation frequencies sampled from 10MHz to 
100MHz. The lines connecting the individual data points represent the results of iterative 
fitting required to extract information about the individual lifetime components in the 
sample (B) Following cleavage by trypsin, the phase delay (gray circles) and modulation 
ratio (black squares) were measured at the same modulation frequencies applied in (A). 
The rates of de-modulation and the shifts in phase delay observed as a function of 
frequency indicate a longer lifetime than the sample measured in (A). (C) The trajectories 
of the phase delay and modulation ratio of the MT1-MMP biosensor are presented before 
and after cleavage, visualized through the channels specific for ECFP and YPet as 
indicated. (D) The phase delay and modulation ratio of YPet on the MT1-MMP biosensor 
before (measured) and after (simulated assuming that only the fluorescence of the 
acceptor excited by FRET is observed – see text)) cleavage, detected through the YPet 
channel are projected on the polar plot.  
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Figure 2.2: Steady-state emission spectra of a purified solution of MT1-MMP biosensors: 
(A) The fluorescence emission of the intact biosensor was recorded at an excitation 
wavelength of 405nm. The contributions of both ECFP and YPet were identified with 
spectral unmixing. (B) The emitted fluorescence from the cleaved biosensor excited at 
405nm consists only of intensity from ECFP. (C) This emission spectrum of the intact 
MT1-MMP biosensor was collected at an excitation wavelength of 440nm which was 
also used in the lifetime imaging experiments. (D) With an excitation wavelength of 
440nm, emission from the directly excited acceptor (YPet) is clearly visible following the 
spectral unmixing.  
 
 
95 
 
 
Figure 2.3: Simulations of the FRET ratio and FRET efficiency: (A) The FRET ratio 
(YPet/ECFP) was simulated using the emission wavelengths shown in (D) as a function 
of the normalized concentration of the intact biosensor. (B) The results of the simulation 
determining the FRET ratio (ECFP/YPet) for a large set of normalized concentrations of 
the intact biosensor are plotted. (C) The steady-state FRET efficiency was calculated also 
as a function of the normalized concentration of the intact biosensor (black line). The 
simulated points were fitted to a straight line (dashed gray line). (D) The two sets of 
emission wavelengths (gray areas in plot) used both in these simulations and later in the 
steady-state measurements taken on live cells are shown along with the normalized 
emission spectra of ECFP and YPet.  
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Figure 2.4: Time–dependent simulations of the biosensor in-vitro: (A-C) At a modulation 
frequency of 40MHz, three polar plots were simulated with a filter specific for ECFP’s 
emission at three species fractions of the intact biosensor (1.0 (A), 0.75 (B) and 0.5 (C)). 
The simulated point plotted as a black cross is shown along with a dotted gray line that 
indicates the set of locations on the polar plot where all linear combinations of the intact 
and cleaved biosensors exist. (D-F)  The emission spectra of the biosensor corresponding 
to the species fractions of the intact biosensor of 1.0 (D), 0.75 (E) and 0.5 (F) are shown. 
When the spectra in (E) and (F) are compared, there is a significant change in the FRET 
ratio that corresponds to a very slight change in polar coordinate as shown on the 
corresponding plot plots. (G-I) Tables are presented indicating the normalized 
concentration of the intact biosensor (species fraction) and the fractional contribution to 
the steady-state intensity for each state of the biosensor examined in these simulations.  
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Figure 2.5: Steady-state FRET measurement of an HT-1080 cell transfected with the 
MT1-MMP biosensor: (A) An intensity image collected through the channel IDD (Exc. 
405nm, Em. {458nm – 501nm}) of an HT-1080 cell transfected with the MT1-MMP 
biosensor is shown. (B) An intensity image of the same cell from (A) is displayed having 
been imaged with the channel IDA (Exc. 405nm, Em. {528nm – 570nm}). (C) This 
intensity image of the HT-1080 cell was collected while exciting only the YPet in the cell 
through the channel IAA (Exc. 514nm, Em. {528nm – 570nm}). There is a definite area 
of the cell on the right edge where there is no YPet present indicating that the biosensor is 
cleaved. (D). On a pixel-wise basis, the FRET efficiency in the four regions of interest 
shown in (A) are plotted in this histogram. (E) A color rendering displaying the steady-
state FRET efficiency computed at each pixel of the cell’s image is shown. (F) This 
histogram displayed the values of the FRET ratio (ECFP/YPet) determined at each pixel 
within the four regions of interest in (A). (G) This image displays the FRET ratio 
(ECFP/YPet) determined throughout the entire image of the cell.  
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Figure 2.6: Steady-state measurement of FRET taken on transfected HT-1080 cells pre-
treated with the MMP inhibitor GM6001. (A) This steady-state intensity image of an HT-
1080 cell transfected with the MT1-MMP biosensor and pre-treated with the MMP 
inhibitor GM6001 was collected through the channel IDD (Exc. 405nm, Em. {458nm – 
501nm}). (B) An intensity of the same cell in (A) is presented collected using the channel 
IDA (Exc. 405nm, Em. {528nm – 570nm})  (C) This intensity image of the HT-1080 cell 
was generated with only the fluorescence emission of the YPet by imaging the cell with 
the channel IAA (Exc. 514nm, Em. {528nm – 570nm}). (D) In every pixel of the four 
regions of interest highlighted in (A), the steady-state FRET efficiency was computed 
and the resulting values are presented in the histogram. (E) The steady-state FRET 
efficiency determined in a pixel-wise manner is mapped in color throughout the cell’s 
image. (F) In each of the pixels in the regions of interest shown in (A), the FRET ratio 
(ECFP/YPet) was calculated and is plotted as a histogram. (G) A color mapping of the 
FRET ratio (ECFP/YPet) is shown 
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Figure 2.7: Images collected with FLIM of HT-1080 cells transfected with the MT1-
MMP biosensor. (A) This intensity image was collected at an excitation wavelength of 
440nm through the filter shown in (C) specific for ECFP. (B) This image of the HT-1080 
was collected with the fluorescence of YPet by exciting the sample with a 488nm laser. 
The images shown in (A) and (B) represent the average intensity of the eight phase 
images collected to generate the FLIM image. (C) The two sets of emission wavelengths 
(gray shading) used to image the cell with the 440nm and 488nm laser are presented with 
the normalized emission spectra of ECFP and YPet. (D) The polar coordinates of the 
pixels within the regions of interest highlighted in (A) are projected on the presented 
polar plots. (E) The average polar coordinate of the central portion of the cell (area 
highlighted in red in (B)) and the edge of the cell (difference in area between the two 
areas highlighted in red in (A) and (B)) are plotted with their corresponding standard 
deviations in x and y.  
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Figure 2.8: HT-1080 cell transfected with the MT1-MMP biosensor, treated with 
GM6001 and imaged with FLIM: (A) An intensity image of the HT-1080 cell is shown 
having been excited by the 440nm laser and imaged through a filter specific for ECFP’s 
fluorescence. (B) The same cell from (A) was imaged while being excited with a 488nm 
laser through the emission filter specific for YPet shown in the darker gray area in Fig. 
5C. (C) The polar coordinates from each pixel within the regions of interest highlighted 
in (A) are projected on the polar plots #1-4. 
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Figure 2.9: Time-dependent fluorescence of the acceptor detected in a live HT-1080 cell 
transfected with the MT1-MMP biosensor: (A) This intensity image was collected with 
the emission of the ECFP by averaging the eight phase images collected during the FLIM 
experiment. (B) By exciting with the 440nm laser and collecting the fluorescence through 
a filter near the emission peak of YPet, this intensity image likely contains contributions 
from ECFP’s emission, emission from directly excited YPet and the sensitized emission 
of YPet. (C) The spatial distribution of YPet is indicated in this intensity image which 
was collected by exciting the cell with a 488nm laser. (D) The pixels from the four 
regions on interests in (B) are projected as polar coordinates on these scatter plots. (E) 
The average polar coordinate calculated from the pixels in the center and edge of the cell 
are shown on this plot along with the corresponding uncertainties in x and y. The center 
of the cell is the area within the red boundary plotted in (C). The edge of the cell is 
defined as the area located between the red boundaries plotted in (B) and (C).  
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Figure 2.10: A live HT-1080 cell transfected with the MT1-MMP biosensor, pre-treated 
with the MMP inhibitor GM6001 and imaged with FLIM using the fluorescence of the 
acceptor: (A) The emitted fluorescence of the ECFP was collected after averaging the 
eight phase images acquired during the acquisition of the lifetime image. (B) This image 
was taken by exciting the sample at 440nm and recording the fluorescence near the 
emission peak of YPet. (C) By exciting and collecting fluorescence only from the YPet, 
this image indicates that there is good co-localization between the YPet and ECFP in this 
cell. (D) The polar coordinates corresponding to the pixels in the regions of interest 
highlight in (B) are projected on these polar plots.  
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Supplemental Figure 2.1: Polyacrylamide gel: Both the ECFP/YPet and 
mOrange2/mCherry variant of the MT1-MMP biosensor were analyzed before and after 
the biosensor’s substrate was cleaved by trypsin. In both cases, the mass of the biosensor 
were reduced by approximately a factor of one half following the addition of trypsin. The 
initial masses of the intact biosensor were however both near 60kD with no unpaired 
constituents apparent in the gel.  
 
 
104 
 
 
Supplemental Figure 2.2: Correcting the measured   : The measured intensities from 
the FRET standard (solution) were used to plot the FRET efficiency as a function of   . 
By knowing the actual FRET efficiency of the sample, a corrected value of   can be 
determined. 
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Supplemental Figure 2.3: Determining the bleedthrough coefficient  1b : (A) A steady-
state intensity image of an HT-1080 cell transfected with a ECFP-only plasmid was 
collected through the channel IDD (Exc. 405nm, Em. {458nm – 501nm}). Unlike the 
staining of the MT1-MMP biosensor, the staining from this plasmid does not reveal any 
apparent organelles in the cell. (B) An intensity image of the same HT-1080 cell from (A) 
is shown having been imaged through the channel IDA (Exc. 405nm, Em. {528nm – 
570nm}). (C) This intensity image of the HT-1080 cell was taken from a set of spectral 
images examining the transfection of the ECFP-only plasmid with an excitation 
wavelength of 405nm. (D) The intensities and corresponding standard deviations 
collected from the region of interest highlighted in (C) are plotted as a function of 
wavelength (dark black line). The reference spectrum of pure ECFP (Tsien Lab [37]) is 
also shown (dashed gray line).  
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Supplemental Figure 2.4: Steady-state spectra collected from an HT-1080 cell transfected 
with the MT1-MMP biosensor (1): (A) An intensity image taken with an excitation 
wavelength of 405nm and an emission wavelength of 517nm ±9.8nm is displayed with 
three regions of interest highlighted. (B) The intensities from the first region of interest 
are plotted as a function of wavelength. A reference spectrum of pure ECFP is plotted in 
light gray. (C) In region #2 located near the nucleus of the cell, the emission spectrum 
plotted as a dashed black line contained a contribution from YPet near 530nm. The 
emission spectrum derived from a simulated combination of cleaved and intact 
biosensors is presented in light gray. (D) The emission spectrum from region #3 is plotted 
as a dotted black line accompanied by a reference spectrum of pure ECFP (gray line).  
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Supplemental Figure 2.5: Spectral imaging of an HT-1080 cell transfected with the MT1-
MMP biosensor (2): (A) This intensity image describing an HT-1080 cell transfected 
with the MT1-MMP biosensor was collected with a 405nm exciting laser and a bandpass 
of emission wavelengths equal to 517nm ± 9.8nm. (B) In region #1, the recorded 
spectrum (black line) closely followed the intensity profile of the pure ECFP (gray line). 
(C) Some fluorescence from YPet is apparent near 530nm in the emission spectrum from 
region #2 (dashed black line). As a reference, a simulated spectrum corresponding to a 
combination of cleaved and intact biosensor is presented (gray line). (D) The emission 
spectrum taken from region #3 (dotted black line) matched the reference spectrum of 
pure ECFP (gray line) very closely.  
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Supplemental Figure 2.6: Spectral measurements of HT-1080 cells pre-treated with 
GM6001: (A) An intensity image an HT-1080 cell imaged with a spectral detector at an 
emission wavelength of 517nm ± 9.8nm is displayed with several regions of interest 
shown in white. (B-D) The average intensities and corresponding standard deviations 
(error bars) from each of the regions #1-3 shown in (A) are plotted as a function of 
wavelength. The first emission peak from the emission spectrum of ECFP is 
approximately at 478nm and the emission peak from YPet is at 530nm. 
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Chapter 3 
The Long Wavelength Variant of the MT1-MMP Biosensor 
Abstract 
 In this chapter, the MT1-MMP biosensor was modified to contain the mOrange2 
and mCherry fluorescent proteins. These fluorescent proteins are monomeric variants of 
the red fluorescent protein found in the luminescent choral Discosoma sp. The change in 
the FRET ratio (amplitude of the donor’s emitted intensity divided by the emission of the 
acceptor) between the intact and cleaved configuration of the biosensor is significantly 
smaller than the corresponding change observed with the cyan and yellow fluorescent 
proteins discussed in the previous chapter. The apparent difference in FRET is primarily 
the result of the low quantum yield of the mCherry which is nearly one third of the 
quantum yield of YPet. However, only the extinction coefficient of the acceptor and the 
set of wavelengths that it can absorb principally dictate the FRET efficiency with respect 
to the acceptor. Experimentally, the lifetime measured on the intact biosensor and 
separately on the cleaved biosensor with the mOrange2 and mCherry proteins translated 
into two polar coordinates, sufficiently separated for classifying the biosensor’s 
configuration in images. As a result, with these fluorescent proteins which absorb and 
emit at wavelengths longer than 550nm, the activity of MT1-MMP was observed with 
lifetime imaging in live cancer cells undergoing dynamics in matrices of collagen-I. As 
stated previously, the matrices of collagen-I were intended to simulate the extra-cellular 
matrix (ECM) that metastatic cancer cells initially confront after leaving a tumor. The 
presented results indicate that MT1-MMP’s role in the formation of protrusions that 
emerge from the cell’s body to explore the local environment is quite complex. In some 
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cases, MT1-MMP is not required in the formation of protrusions while in other cases, the 
activation of MT1-MMP is not precisely correlated with the extension of protrusive 
structures from the cell. The protrusions formed during these experiments in matrices of 
collagen are the ideal places from which to study how metastatic cancer cells examine 
and translate information about the local environment into cues directing their behavior. 
 
Introduction 
When applied to study the MT1-MMP biosensor in live cells with FLIM, the 
contrast provided by the cyan and yellow fluorescent proteins was too poor to accurately 
monitor the activity of MT1-MMP [1]. Even though the steady-state techniques were able 
to resolve different extents of FRET in live cells, the susceptibility of the cyan and yellow 
proteins to environmental perturbations that can significantly change the FRET efficiency 
make them a completely unreliable system to study the activity of MT1-MMP [2-5].  
The incorporation of the mOrange2 and mCherry fluorescent proteins into the 
MT1-MMP biosensor improved the contrast and the reliability in the detection of the 
biosensor in live cells [6-8]. Unlike the previous study of the MT1-MMP biosensor 
containing the ECFP/YPet fluorescent proteins with FLIM, both configurations of the 
biosensor were clearly resolvable in the same cell. The locations on the polar plot 
indicative of each configuration of the biosensor were stable, far apart and not 
substantially perturbed by changes in local environment. Furthermore, configurational 
changes in the mOrange2/mCherry MT1-MMP biosensor could be accurately followed in 
time following the removal of the MMP inhibitor GM6001.  
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The newly developed long wavelength fluorescent proteins which can be excited 
and emit light at wavelengths greater than 550nm, offer advantages for live cell imaging.  
For example, longer wavelengths mean that images of cells can be collected without the 
contribution of auto-fluorescence typically encountered with the cyan and yellow 
fluorescent proteins. In addition, live cells and tissues are also not as readily damaged by 
these longer excitation wavelengths. From the perspective of FRET, the overlap integral 
that partly determines efficiency of energy transfer has a dependency on the wavelength 
range being applied. This increase in overlap inherent to the longer wavelengths results 
typically, in higher Förster distances [9-13]. Hence, longer wavelengths intrinsically can 
improve the sensitivity in the detection of the biosensor by providing larger changes in 
FRET efficiency at greater separation distances between the donor and acceptor. 
 With the mOrange2/mCherry MT1-MMP biosensor, considerable work was 
undertaken to improve the temporal resolution of the FLIM system. Ultimately, the goal 
of these efforts was to more carefully visualize the configurational changes in the 
biosensor following the removal of MMP inhibitors. As discussed previously, lifetime 
images can be acquired at high speed (near video rates) but only with sufficient signal-to-
noise, which is not often available when studying live cells. Furthermore, regardless of 
the brightness of the sample or the sensitivity of the imaging system, the temporal 
resolution of FLIM is also degraded because multiple exposures of the sample are 
necessary to generate a single lifetime image. On our FLIM system for example, more 
than twenty individual image acquisitions are required to generate a single lifetime image 
[14-16]. With laser excitation, only a few lifetime images can be acquired of the 
transfected HT-1080 cells before the cell’s health rapidly degrades. As a result, a variant 
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of FLIM called phase suppression was incorporated into both the instrument control as 
well as in the image analysis software during this work. Phase suppression lowered the 
time necessary to acquire a lifetime-resolved image to less than one tenth of that of the 
original FLIM system [14, 17-22]. When combined with the optimized analysis of spatial 
frequencies in the images with wavelets, the results in this chapter present the most 
quantitative approach to visualizing the activity of MT1-MMP in live cells. In addition, 
quantitative analysis is also presented demonstrating equivalence between the 
identification of the configuration of the biosensor derived from the polar plot and that 
derived from phase suppression. 
In this chapter, the condition of the live cells was optimized so that the kinetics of 
the biosensor could be monitored for more than an hour following the removal of MMP 
inhibitors. Factors such as the osmotic stress endured by the cells during the removal of 
inhibitors, level of nutrients contained in the media during all stages of the culture and 
precise environmental controls were all optimized during the course of this research.  In 
the initial proof-of-concept experiments performed on glass surfaces, the activation of the 
MT1-MMP biosensor was present around the entire perimeter of the HT-1080 cells 
without a bias for specific extensions or protrusions. However, in order to simulate the 
conditions encountered in vivo when a metastatic cancer cell is moving through the extra-
cellular matrix in tissues, live HT-1080 were also cultured and imaged within 3-
dimensional matrices of collagen-I. When compared to the cells imaged on glass 
surfaces, far more extensive morphological changes in the cells were observed in the 3D 
matrix following the removal of GM6001. In addition, the cleavage of the biosensor was 
specifically observed and followed at protrusive structures formed around the cell’s 
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perimeter. However, the presented data also confirms that the correlation between the 
activation of MT1-MMP and the formation of protrusions along the edge of the cells 
cultured in collagen is complicated.  
 
Materials/Methods 
FLIM System 
 The excitation light from a 532 nm laser (World Star Tech, Toronto, Canada) was 
intensity modulated by a Pockels Cell (Conoptics Inc., Danbury, CT).  The modulation 
frequency for the lifetime measurements was 40 MHz. All samples were imaged on a 
Leica DMIRB microscope (Leica, Germany). The emission was collected through a 
dichroic and emission filter combination passing 560 nm-640 nm (Omega Optical, 
Brattleboro, VT). The detection system consisted of an intensifier (Kentech, England) 
modulated at high frequency and CCD camera (QImaging, Surrey, BC) positioned at the 
output port of the microscope. The CCD camera collected images by performing a 2x2 
binning resulting in images of 678x518 pixels. The live cells were imaged using a 
100x/1.3NA oil immersion objective (Leica, Germany). All in-vitro measurements on the 
FLIM system were performed with a 40x/0.75NA air objective (Leica, Germany). The 
lifetime reference for all lifetime measurements was 1 μM Rhodamine 6G (Aldrich, 
Milwaukee, WI) in water (lifetime = 4.11ns [23]) .  
Cell Culture 
HT-1080 cells (ATCC, Manassas, VA) were cultured in Dulbecco’s Modified 
Eagles Medium (DMEM) (Invitrogen, Carlsbad, CA) and transfected with Lipofectamine 
2000 (Invitrogen, Carlsbad, CA). The AHLR-variant of the mOrange/mCherry MT1-
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MMP biosensor [24] was contained in the pDisplay plasmid (Invitrogen, Carlsbad, CA). 
Following transfection, the cells were starved in 0.5% Fetal Bovine Serum (Atlanta 
Biologicals, Lawrenceville, GA) for 36-54 hours prior to imaging. The cells were 
incubated with 20 μM GM6001 (Merck, Germany) for 12-18 hours prior to imaging. 
During imaging, the GM6001 was washed out 5-6 times using CO2 independent media 
(Invitrogen, Carlsbad, CA). 
Protein Purification and Characterization 
The mOrange2/mCherry MT1-MMP biosensor was purified by Nickel chelation 
after being expressed with an N-terminal His6 tag in Escherichia coli [25]. Steady-state 
spectra were collected on a PC1 fluorometer (ISS Inc., Champaign, IL) in a solution at 
approximately 1 μM of the purified biosensor. The excitation wavelength was 532 nm 
and the emission was collected at 1nm increments from 555 nm to 750 nm. The recorded 
spectra were corrected for lamp fluctuations, background, the volume of trypsin 
(Invitrogen, Carlsbad, CA) added to cleave the biosensor and for emission-side 
corrections. Magic angle polarizer conditions were applied. The spectra were de-
composed with linear spectral unmixing [26] with reference spectra provided by Roger 
Tsien’s Lab. Lifetime measurements were carried with a solution of 1 μM of purified 
biosensor placed on a glass-bottomed Petri dish (Cell E&G, Houston, TX). Lifetime data 
was collected both before and after the biosensor was cleaved by trypsin using the filters 
described previously as well as with an additional 570 nm (±10 nm) bandpass filter 
(Omega Optical, Brattleboro, VT).  
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Collagen Matrix 
 The collagen matrices were prepared following the procedure modified from the 
protocols in [27, 28]. Initially, a solution containing 25µl of 0.1M PBS (pH = 7.1) and 
102µl of 0.025M NaOH was mixed with 125µl of Collagen-I (BD Biosciences San Jose, 
CA). This solution was then sterilized by being subjected to UV illumination in a cell 
culture hood for 6 minutes. A suspension of HT-1080 cells transfected with the 
mOrange2/mCherry MT1-MMP biosensor and suspended in 5% FBS DMEM media was 
then added to the collagen solution prior to plating on a glass bottomed dish. The matrix 
containing the cells was then incubated for 5 minutes at 37C. Following the incubation, 
approximately 150 µl of 5% FBS DMEM containing 20mM GM6001 was added over the 
attached matrix. The cells were then imaged 12-18 hours after being plated within the 
collagen matrix.  
LSM 710 
 Images of the collagen matrix were collected with second harmonic generation 
(SHG) on an LSM 710 (Zeiss, Germany). The excitation source used was a multi-photon 
Titanium Sapphire laser (Spectra Physics) emitting 70fs pulses at a wavelength of 
780nm. A quarter-wave plate was inserted into the excitation path to circularly polarize 
the exciting light prior to being incident on the sample. The HT-1080 cells transfected 
with the biosensor were imaged with a 63x/1.4NA Apochromat objective (Zeiss, 
Germany). The resulting backwards SHG signal was collected through a dichroic mirror 
passing wavelengths less than 760nm to the non de-scanned detector on the system. In 
parallel, steady-state fluorescence images were collected by exciting the sample with a 
561nm laser and detecting the emitted fluorescence between 581nm and 701nm.  
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Fractional Intensity Mapping 
Many images of the HT-1080 cells in this chapter are presented with a color code. 
The color in each pixel was determined by the positions of each pixel on the polar plot 
relative to the centers of the intact and cleaved biosensors. More specifically, the color of 
each pixel depends on the contribution of each configuration (intact or cleaved) of 
biosensor to the steady-state intensity measured in that pixel. The configuration which 
contributes the largest fractional contribution to the total measured steady-state intensity 
determines the color in the pixel (red = intact biosensor, green = cleaved biosensor). 
However, the steady-state intensities of both configurations of the biosensor are similar 
because our emission filter accepts emission from both the donor and acceptor. 
Therefore, the fractional intensities are also estimates of the normalized concentration of 
each configuration of the biosensor (species fraction). With this analysis, spatial features 
of the biosensor’s activity were observed and validated by analysis directly on the polar 
plot.  
The fractional contributions to the steady-state intensity of the cleaved and intact 
biosensor at each pixel are determined from the polar plot coordinates according to the 
following matrix calculation.  
 
 meas mOr2 Bios mOr2
meas mOr2 Bios Bios
x x x α
y y y α
               
   (1) 
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In Eq. 1, the terms      mOr2 mOr2 Biosx , y , x  and  Biosy  are the coordinates of the cleaved 
(mOrange2) and intact biosensor (Bios) on the polar plot.  The corresponding measured 
data points  are  Measx and  Measy . The calculated contributions of each configuration 
(cleaved = mOrange2, intact = Bios) of the biosensor to the measured steady-state 
intensity at a pixel are  mOr2α  and  Biosα . 
 The polar coordinates of the two configurations of the MT1-MMP biosensor (
     mOr2 mOr2 Biosx , y , x  and  Biosy ) were determined by measuring a series of HT-1080 
cells transfected with the biosensor. The positions on the polar plot assigned to each 
configuration of the biosensor were computed from bivariate Gaussian fits applied to the 
FLIM data from live cells Before representing the distribution of FLIM data on the polar 
plot by two dimensional Gaussian functions, the pixels belonging only to the cells were 
selected segmented after the suppression of background and noise by wavelets. The 
threshold was adjusted so that the majority of the cell body from each image was selected 
for the set of cells examined during this analysis. Following the segmentation, the pixels 
were binned to form a 3-dimensional histogram on the polar plot. 
The data from the HT-1080 cells, which were not treated with the GM6001 inhibitor, 
were fitted with a double Gaussian bivariate fit (Supp. Fig. 3.1 and Table 3.1). The centers of 
the two Gaussian functions representing the cleaved and intact biosensor were found and are 
shown with their respective uncertainties in Table 3.1.   
A single bivariate Gaussian fit applied to the images of live cells containing the 
MT1-MMP biosensor but pre-treated with the GM6001 inhibitor. GM6001 prevents the 
cleavage of the biosensor. After nine cells were analyzed, the fitting of these polar 
coordinates resulted in a single Gaussian distribution centered at a polar coordinate of 
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[0.764±0.0774,0.380±0.0566]. The above polar coordinates derived from the control HT-
1080 cells (not pre-treated with GM6001) were used to represent the positions of the two 
configurations of the biosensor on the polar plot applied in this chapter. 
 
Results  
 In-vitro Measurements of the mOrange2/mCherry MT1-MMP Biosensor 
 The MT1-MMP biosensor containing the mOrange2 and mCherry fluorescent 
proteins was examined in vitro with both steady-state and time-resolved fluorescence 
measurements. The solutions of biosensors measured in this section were expressed, 
extracted and purified from competent bacterial cells. Trypsin was used to cleave the 
biosensor for this characterization. The ability of trypsin to cleave the substrate of the 
biosensor can be seen clearly in the polyacrylamide gel (Fig. 3.1D). Only the cleaved 
components with masses between 25kD and 37kD remain in the center band. The left-
most band contained proteins with masses between 50kD and 75kD (intact biosensor).  
 The time-resolved fluorescence of the biosensor was measured on the homodyne 
FLIM instrument at a modulation frequency of 40MHz while exciting the sample with a 
532nm laser. Three fluorescent species (mOrange2, mCherry undergoing FRET and 
directly excited mCherry) were detected through a dichroic and emission filter 
combination passing 560nm to 640nm to the detector (Fig. 3.1C). When both 
configurations of the biosensor were measured (intact and cleaved) through this 
dichroic/filter combination, the polar coordinate of the biosensor upon cleavage moved 
toward longer lifetimes (Fig. 3.1A). The movement of the polar coordinate after cleavage 
toward longer lifetimes (Fig. 3.1A) suggests a loss of FRET.  
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In order to measure the mOrange2 protein in both the intact and cleaved 
biosensor, a bandpass filter passing only the emission of mOrange2 (570 nm ± 10 nm) 
was inserted before the detector. In both configurations of the biosensor, the mOrange2 
had a multi-component lifetime distribution (Fig. 3.1B). However, the cleavage of the 
biosensor resulted in the polar coordinate for mOrange2 emission moving from near 2ns 
toward a region on the polar plot between 3ns and 4ns (Fig. 3.1B). This movement of the 
polar coordinate to a region of longer lifetimes after the cleavage of the biosensor also 
confirms the presence of FRET prior to the cleavage.  
Steady-state measurements were performed at an excitation wavelength of 532nm 
to monitor changes in mOrange2’s and mCherry’s emission spectra before and after 
cleavage of the biosensor’s substrate. In these experiments, a solution of purified 
biosensor was measured in a fluorometer both before and after the substrate of the 
biosensor was cleaved by trypsin. Spectral unmixing was applied using reference spectra 
from Roger Tsien’s Lab  to isolate the spectral contributions from mOrange2 and 
mCherry (Fig. 3.2). There was a clear increase in the fluorescence emission from 
mOrange2 following the cleavage of the biosensor (Figs. 3.2A and 3.2B). In parallel, the 
emission from mCherry decreased indicating the absence of FRET in the system (Figs 
3.2A and 3.2B). The change in the spectrum of mCherry is only discernable after spectral 
unmixing because of bleed-through from mOrange2’s emission. Although the variation in 
the FRET ratio (the donor’s emitted intensity divided by the acceptor’s emitted intensity) 
is small when compared to the difference in FRET ratio between the two configurations 
of the ECFP/YPet variant of the MT1-MMP biosensor, there is a significant change in the 
amount of energy transfer validated by both time-resolved and in-vitro measurements. 
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Background and Noise Removal 
 Images of the HT-1080 cells transfected with the mOrange2/mCherry biosensor 
contain significant noise from the intensified CCD camera and unwanted background 
light being emitted mainly from the cell’s media. In most cases, the intensity of the 
unwanted (background) fluorescence is un-modulated with a very small phase delay. 
Throughout an image (frame) of a cell, the contribution of intensity from the background 
is not constant. For example, when a cell attaches and spreads on a slide, the edges of the 
cell are physically thinner than the central portions of the cell. Therefore, when using 
full-field microscopy, more background fluorescence will enter the image along the edge 
than in the center of the cell. Previous techniques that simply average the intensity in a 
region of interest not containing the cell and subtract that value from the image will not 
provide an accurate means to remove background. Likewise, the use of simple median 
filters or Gaussian mean filters to remove noise can degrade the spatial resolution in 
images. During this project, images were decomposed with basis functions called 
wavelets in order to reduce the unwanted fluorescence and noise in images [15, 29-31]. 
By analyzing the images according to spatial frequencies, uneven background and signal-
dependent noise can be substantially reduced without losing spatial resolution (Please see 
introductory chapter on wavelets for detailed discussion). 
 An example of the variable background encountered in experiments using live 
cells is presented in Figure 3.3. The lifetime measurements taken in vitro indicate that the 
polar coordinates of the two configurations of the MT1-MMP biosensor are near the 
semi-circle (Fig. 3.1). Three regions of interest are examined spanning both the edge and 
interior parts of the cell (colored boxes in Figure 3.3A). The polar coordinates projected 
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from the pixels in the red region (edge of cell) are being pulled into the semi-circle 
(towards the origin) and likely contain an intensity contribution from background (Fig. 
3.3C). The polar coordinates generated from the yellow region are located inside the 
semi-circle as well further indicating that intensity from the background may be present 
(Fig. 3.3D). However, in the central portion of the cell (green region of interest), the 
resulting polar coordinates are approximately at the semi-circle (Fig. 3.3E). Unlike the 
regions sampled near the edge of the cell, the relative contribution from background in 
the central portions of the cell is difficult to distinguish simply by looking at the polar 
plot. This could likely be the result of the increased thickness of the cell which also 
contributes to the increased signal measured in this region. In other words, there are more 
fluorophores in the center of the cell being imaged by the objective in the axial direction 
than along the thinner edges. 
 In all of the regions of interest, the removal of noise decreased the size of the 
distribution of polar coordinates (middle panel in Figs. 3.3C, 3.3D and 3.3E). However, 
the locations of the polar coordinates from each of the distributions still remained at 
positions indicative of the before-mentioned contributions from background. Following 
the removal of background, each of the distributions moved toward the semi-circle along 
a line connecting the original center of the distribution and the polar coordinate of the 
background. For example, the polar coordinates colored in red, moved toward 3ns on the 
polar plot after the background was removed from the image. If a line is drawn 
connecting the center of distribution of polar coordinates in red before the background 
was removed and the center of the same distribution after the background was removed, 
the line would pass through the area on the polar plot indicative of un-modulated 
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background. As expected, the relative contribution of the background was the most 
significant near the edge of the cell. The center of the distribution of polar coordinates 
located in the central region of the cell remained constant before and after the background 
was removed.   
Spatial Features of the MT1-MMP Biosensor in HT-1080 Cells 
 HT-1080 cells transfected with MT1-MMP biosensor were imaged with FLIM, 
using the emission filter shown in Figure 3.1C and a 532nm laser for excitation. In order 
to examine the intact biosensor, the HT-1080 cell in Fig. 3.4 was imaged after incubation 
with the GM6001 inhibitor for 12-18 hours. The measured polar coordinates in the 
regions of interest selected within the cell (white squares in Fig. 3.4A and the polar plots 
in Fig. 3.4E) remained near 2 ns, indicating that the biosensor was mostly intact. 
Likewise, the fractional intensities, depicted by the color-coding in Figs. 3.4B, 3.4C and 
3.4D, indicated that the biosensors within the cell were intact (red shading – intact 
biosensor, green shading – cleaved biosensor).  
When cells were not incubated with the GM6001 inhibitor, the locations of the 
polar coordinates (Figs. 3.5A and 3.5E) and the mapping of fractional intensities (Fig 
3.5B-3.5D) indicated that both configurations of the biosensor were present in the cell. 
Pixels from the regions of interest in Figure 3.5A are projected on the polar plots in 
Figure 3.5E; two separate lifetime pools near 2 ns and 3 ns are observed. The fractional 
intensities within the HT-1080 cells not treated with the GM6001 inhibitor (Fig. 3.5B-
3.5D) showed that the intact biosensor was contained primarily in the brighter region near 
the nucleus (red shading in Fig. 3.5B and Fig. 3.5D), while the cleaved biosensor 
appeared mostly around the cell’s periphery (green shading in Fig. 3.5C and Fig. 3.5D).  
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Phase Suppression Applied to Study Live Cells 
Capillary 
 Experiments were carried out to test the resolution of phase suppression with two 
capillaries containing separately a solution of Rhodamine B (lifetime = 1.7ns) and a 
solution of Rhodamine 6G (lifetime = 4.11ns) (Fig. 3.6). The concentration of each 
solution was adjusted so that both capillaries could be simultaneously imaged with the 
same excitation source, gain settings of the detector, objective and emission filters. In this 
experiment, two detector phases were chosen to suppress the intensity from the capillary 
of Rhodamine B and two different detector phases were selected to remove the intensity 
emitted from the capillary of Rhodamine 6G. In the resulting difference images (Figs. 
3.6B and 3.6C), the intensity from each capillary is highlighted in the frame of the image 
with high contrast. Spatial features of the capillary such as the indentation on the top edge 
of the capillary can also be seen in the difference images (Figs. 3.6B and 3.6C). 
Single Cells 
 Initially, experiments were carried out to determine how well phase suppression 
could resolve the two configurations of the biosensor on an image of an HT-1080 cell 
transfected with the mOrange2/mCherry MT1-MMP biosensor (Fig. 3.7). This cell was 
not treated with MMP inhibitors and therefore, contained a mixture of intact and cleaved 
biosensors. The mapping of the fractional intensities indicated that the cleaved biosensor 
(green) was present along the periphery of the cell and the intact biosensor (red) remained 
in the central portion of the cell (Figs. 3.7B, 3.7C and 3.7D). Two detector phases were 
chosen to suppress the intensity from the cleaved biosensor and separately two detector 
phases were chosen to suppress the intensity from the intact biosensor. The two selected 
 
 
130 
 
phase images were subtracted so that positive intensities remained in areas of the image 
containing fluorescent species that were not suppressed. In other words, if the intact 
biosensor was suppressed, then the cleaved biosensor would appear as a positive value in 
the difference image. Any negative values in areas of the difference images where 
intensity from a specific fluorescent species was being suppressed, were due to noise or 
precision of the phase setting. Only positive values are shown in the phase suppression 
images (Figs. 3.7E-3.7G) and throughout the images presented in this chapter. As a 
result, the intensities remaining in the difference images indicate the regions of the cell 
where the fluorescence emission is dominated by either the intact (Fig. 3.7F) or cleaved 
biosensor (Fig. 3.7E). 
 During these experiments, the HT-1080 cells transfected with the biosensor were 
excited with a 532nm laser and imaged with the homodyne FLIM system. As shown, the 
regions highlighted by the fractional intensity mapping indicative of each configuration 
of the biosensor (derived from the polar plot) match the corresponding intensities 
highlighted by the phase suppression. For example, the green regions in the fractional 
intensity mapping (Figs. 3.7B) match the intensities in the difference images from the 
cleaved biosensor (Fig. 3.7E). Therefore, phase suppression can indicate the 
configuration of the biosensor as well in this case but with only two exposures of the 
sample.  
Improving Temporal Resolution: HT-1080 Cells Cultured on Glass Surfaces 
 Experiments were conducted to evaluate the temporal resolution of phase 
suppression for monitoring the kinetics of the mOrange2/mCherry MT1-MMP biosensor 
in live HT-1080 cells. In the previous analysis of single cells, large changes in the 
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configuration of the biosensor were observed because the MT1-MMP enzyme was 
allowed to cleave the biosensor for more than 12 hours at 37C prior to imaging. 
However, in order to visualize and follow the activation of the MT1-MMP biosensor 
dynamically, the MMP inhibitor GM6001 can be washed out from the media of a cell 
pre-treated with the inhibitor. In these experiments the MT1-MMP enzyme would be 
activated and its activity could be followed at smaller intervals of time with phase 
suppression. Imaging cells for extended periods required improvements in both the 
conditions of the cell as well as the environmental conditions on the stage of the 
microscope. 
The initial experiments observed the activation of the MT1-MMP both before and 
thirty minutes after the removal of the GM6001 inhibitor from the cell’s media (Figs. 3.8 
and 3.9). Rhodamine 6G was used to determine accurately the phase setting of the 
instrument prior to the measurements being taken on cells. Four phase angles were 
selected for the phase suppression in order to suppress the intensity from mOrange2 
(cleaved biosensor) and separately to suppress the intensity from the intact biosensor. 
Full-field homodyne FLIM images were taken in parallel with the images gathered for 
the phase suppression. During these experiments, images were acquired prior to the 
washout of GM6001 (Fig. 3.8) as well as at a time approximately thirty minutes 
following the washout (Fig. 3.9).  
 As shown by red shading in Fig. 3.8D, prior to the washout of the GM6001 
inhibitor, the intact biosensor’s fractional intensity was dominant in the majority of the 
cell body. Some intensity from the cleaved biosensor appeared along the cell’s edge 
(green shading in Fig 3.8C). When the pixels from the regions of interest in Fig. 3.8E 
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were projected on the polar plots in Fig. 3.8F, the polar coordinates at locations within 
the cell body were close to 2 ns. Near the bottom of the cell (region 3 in Figs. 3.8E and 
3.8F), the polar coordinates corresponded to lifetimes above 2 ns. When phase 
suppression was applied to suppress the intensity from the intact biosensor (Fig. 3.8A) 
very little intensity remained in the cell body with only a few low intensity features 
appearing along the cell’s edge. However, when the intensity from the mOrange2 
(cleaved biosensor) was suppressed (Fig. 3.8B) the intensity remaining in the difference 
image (indicative of the intact biosensor) was shown to be distributed throughout the 
majority of the cell’s interior body. 
 Following the washout of GM6001, the fractional intensity around the edge of the 
cell was dominated by mOrange2 (cleaved biosensor) (green shading in Fig. 3.9C). The 
difference image shown in Fig. 3.9A, where the intact biosensor’s intensity was 
suppressed, paralleled the trends indicated by the polar plot analysis using fractional 
intensities. Thus, when the intensity from the intact biosensor was suppressed, intensity 
in the difference image, representing free mOrange2 (cleaved biosensor), was found 
predominantly at the cell’s edge (Fig. 3.9A). This latter intensity, corresponding to free 
mOrange2, matched well to the green regions in Fig. 3.9C where the fractional intensity 
from the cleaved biosensor was dominant. The intensity from the intact biosensor 
remained primarily within the central portion of the cell body (Figs. 3.9B and 3.9D). In 
addition, when projected on the polar plot, the pixels from the regions of interest 1 and 3 
are located closer to 3 ns while region 2 remained closer to 2 ns (Fig 3.9E and 3.9F).  
 However, the study of the biosensor required images to be acquired at much finer 
steps in time in order to observe biologically relevant phenomena. In Figure 3.10, an HT-
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1080 cell transfected with the MT1-MMP biosensor was imaged at 15 minutes intervals 
for a period of one hour following the removal of the GM6001 from the media. In this 
example and in the following data sets presented, changes in the culture protocol related 
to the FBS content and media required a change in the polar coordinates calculated for 
the intact and cleaved biosensor. Therefore, these new polar coordinate centers were 
calculated as [0.6265,0.4197] and [0.7399,0.4035]. Intensity images of the cell 
representing the average of the four images collected for phase suppression are shown at 
the indicated time intervals in Figure 3.10A. As shown in these images, the formation of 
a protrusion along the lower left side of the cell occurred concurrently with the retraction 
of the cell’s bottom edge. Two sets of detector phases were chosen to suppress the 
intensity from the intact biosensor and separately, to suppress the intensity from the 
cleaved biosensor. The difference images that result from the subtraction from each set of 
detector phases chosen are shown in the Figures 3.10B and 3.10C. In other words, the 
intensities shown in Figure 3.10C are the result of the cleaved biosensor and the 
intensities in Figure 3.10B correspond to emission from the intact biosensor. Following 
the removal of the MMP inhibitor GM6001, intensity from the cleaved biosensor 
emerged along the protrusion primarily near the top and also near the bottom left side of 
the cell. The intensity from the intact biosensor remained in the center of the cell 
throughout the imaging session. 
 By further improving the environmental conditions on the microscope’s stage and 
during the cell’s culture, the activity of the MT1-MMP biosensor could be monitored 
with even finer temporal resolution (Figs. 3.11 and 3.12). In these experiments, the HT-
1080 cells were cultured on glass slides and pre-incubated with the MT1-MMP inhibitor 
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GM6001. As a result, the polar coordinates sampled in the various regions of interest at 
the beginning of each experiment were located near 2ns on the polar plot suggesting that 
the biosensor was initially intact (Figs. 3.11A, 3.11B, 3.12A and 3.12B). After the 
inhibitor was removed (washed out from) the media, the cells attached to glass underwent 
limited morphological changes (Figs. 3.11E and 3.12E). For example, the most noticeable 
change in the morphology of the cells indicated by the average intensities was a small 
protrusion which formed along the bottom of the second cell (intensity images in Fig. 
3.12E). In both sets of intensity images, the features in the cells indicated by the staining 
of the biosensor such as the nucleus, the bright area adjacent to the nucleus and the 
dimmer edges remained consistent throughout the experiment. However, at a time of 
forty five minutes following the removal of the MMP inhibitor GM6001, the polar 
coordinates in regions 1 and 3 in Figures 3.11C and 3.11D moved closer to 3ns which 
suggested that the biosensor was cleaved at those locations. Likewise, in the second 
example, the polar coordinates in regions 1, 3 and 4 in Figures 3.12C and 3.12D were 
also located near 3ns implying the presence of the cleaved biosensor at a time of hour 
after the inhibitor was removed from the media.  
 In order to asses the configuration of the biosensor in the difference images 
produced during the imaging with phase suppression, a color coding has been applied to 
these images. In Figures 3.11F and 3.12F for example, areas colored in green indicate the 
locations in the cell where the intensity from the difference image (product of the 
subtraction of two phase images) indicative of the cleaved biosensor is greater than the 
corresponding intensity in the separate difference image that highlights intensity from 
intact biosensor. Therefore, the green color in the images indicates the presence of the 
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cleaved biosensor and in a similar manner, areas in the images colored red correspond to 
locations in the cell containing the intact biosensor. This method of rendering images 
produced by phase suppression in color was also applied in the next section which 
examined the HT-1080 cells transfected with the MT1-MMP biosensor in matrices of 
collagen-I.  
 Therefore, the images rendered in Figures 3.11F and 3.12F monitor the state of 
the biosensor’s configuration throughout the entire cell cultured on a glass surface simply 
using phase suppression. As time progressed after the MMP inhibitor (GM6001) was 
removed, the active MT1-MMP enzymes cleaved the biosensor throughout the underside 
of the cell. Intensity in the difference images generated by the phase suppression emerged 
from the cleaved biosensor while the intensity from the intact biosensor concurrently 
decreased (Figs. 3.11F and 3.2F). In both of the cells shown (Figs. 3.11 and 3.12), the 
cleavage of the biosensor began along the edge of the cell and then gradually proceeded 
inward toward the center of the cell.  However, the intensity from the intact biosensor 
was present consistently in the bright area adjacent to the nucleus even at the final time 
point sampled. In the majority of cases sampled during this study (data not shown), the 
cleavage of the biosensor took place around the entire perimeter of the HT-1080 cells 
cultured on glass. The change in configuration of the biosensor was not biased 
significantly toward protrusions or extensions of the cell’s membrane.  
HT-1080 Cells in 3D Matrices of Collagen-I 
  Live HT-1080 cells were cultured and imaged within 3-dimensional matrices of 
collagen-I. The matrix of collagen was intended to simulate the environment encountered 
by a metastasizing cancer cell as it leaves the primary tumor and negotiates through the 
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extra-cellular matrix (ECM) (in order to enter a part of the vasculature and invade distant 
tissues). In the preparation of the collagen matrix, maintaining the cell’s vital condition in 
the collagen and positioning the cells in the matrix within the working distance of the 
objectives used were the primary obstacles in these experiments. Likewise, the HT-1080 
themselves will exert a pulling force on the collagen once attached. If the density of cells 
in the matrix is too high, the pulling forces exerted by all the cells can both shrink and 
detach the matrix of collagen in a process referred to as matrix contraction. As lengthy 
testing demonstrated, the attachment of the collagen to the glass surface is a very 
sensitive process. Specifically, the time that the collagen spends in the incubator after it 
has been initially applied to culture dish needs to be carefully monitored. Variations in 
the procedure described to prepare the matrix on order of tens of seconds can also result 
in a premature detachment of the matrix. 
 In order to characterize the HT-1080 cells in the 3D matrix, steady-state 
fluorescence images of the cells were collected in parallel with images of the collagen-I 
(Fig. 3.13). The steady-state intensity images were generated first before the two-photon 
laser passed over the field of view to instigate the scatter (second harmonic generation 
(SHG)) necessary to image the collagen. The backwards SHG signal detected here may 
not be indicative of all the collagen present but the images of the collagen do indicate that 
the cells are successfully incorporated into the matrix. In order to prevent the cells from 
disrupting the collagen, the cells were treated with the MMP inhibitor GM6001 (20mM) 
immediately following their incorporation into the collagen matrix (approximately 12-18 
hours prior to imaging). A definite hole is present (dark area) in the images of the 
collagen-I mirroring the location of the cells shown in the corresponding steady-state 
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intensity images. None of the proteins such as actin or the microtubules in the cell’s 
cytoskeleton have non-centrosymmetry or the long coherence length which instigate 
strong SHG signals. In the SHG images of the collagen-I, the density of the collagen-I is 
highest near the edge of the cell and slightly decreases throughout the region imaged. The 
fiber length, pore sizes between the fibers and overall density also vary though between 
the cells sampled.  
 The spatiotemporal activation of the MT1-MMP enzyme was monitored within 
the HT-1080 cells transfected with the MT1-MMP biosensor and cultured in the 3-
dimensional collagen matrices (Figs. 3.14-3.18). As before, the cells were pre-incubated 
with the MMP inhibitor GM6001 prior to imaging and the MT1-MMP enzyme was 
activated by removing (washing away) the inhibitor from the cell’s media.  
 The results from three experiments in which a configurational change in the 
biosensor was observed following the removal of GM6001 from the cell’s media are 
shown in Figures 3.14, 3.15 and 3.16. In the first example (Fig. 3.14), immediately 
following the incubation with GM6001, the coordinates selected from regions of interest 
(white boxes in Fig. 3.14A), were projected near 2ns on the polar plot (Fig. 3.14B) 
indicating that the biosensor was intact. Likewise, the majority of the intensity shown in 
the difference images (generated by phase suppression) was from the intact biosensor 
prior to the removal of the MMP inhibitor GM6001 (“Before” image in Fig. 3.14F). In 
this experiment, the morphological changes as evaluated by the fluorescent staining of 
the biosensor (intensity images in Fig. 3.14E), taking place after the removal of GM6001 
were much more significant when compared to the previous experiments conducted on 
the glass surfaces. An expansion of the cell occurred along the top edge of the cell while 
 
 
138 
 
at the same time, the extension along the cell’s bottom edge that was initially present, 
retracted during the imaging period. On the top of the cell, the membrane appeared to 
expand in a fan-like shape into the matrix of collagen. As shown by the color renderings 
of the difference images generated by phase suppression, both events were accompanied 
by a configurational change in the biosensor (going from intact to cleaved) specific to 
those locations (increase in green shading in Fig. 3.14F). As the top fan-like shaped 
protrusion became larger, the population of the cleaved biosensors in this area increased 
incrementally. In the two regions of interest in the top fan-like protrusion (regions 1 and 4 
in Fig. 3.14C), the polar coordinates moved closer to 3ns suggesting also that the 
biosensor was cleaved in those areas. As the central portion of the cell contracted from an 
elliptical to a circular morphology during the period of imaging, the polar coordinates 
from these regions (regions 3 and 4) as well as the colored renderings of the difference 
images (Fig. 3.14F) indicated that the biosensor was intact in these areas (center of cell).  
 A second example of an experiment conducted to examine the activation of MT1-
MMP in transfected HT-1080 cells cultured in a 3D matrix of collagen-I is presented in 
Figure 3.15.  Unlike the previous example, following the removal of the GM6001 
inhibitor, the cell’s morphology as estimated by the images of average intensity in Fig. 
3.15E, changed with multiple protrusions extending and retracting throughout the 
imaging session. However, at a time of approximately ten minutes after the inhibitor was 
removed, one prominent protrusion emerged along the top left of the cell. At the leading 
edges of this protrusion, the configuration of the biosensor progressively changed from 
intact to cleaved indicating the MT1-MMP enzyme was active. The change in the 
configuration of the biosensor was verified on the polar plot (region 4 in Fig. 3.15D) as 
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well as by the colored rendering of the difference images (Fig. 3.15F). For example, the 
polar coordinates corresponding to the edge of the protrusions (region 4 in Fig. 3.15D) 
were located near 3ns and therefore corresponded to the cleaved biosensor. On the lower 
right portion of the cell, a protrusion formed extending into the collagen matrix and later 
retracted prior to the end of the imaging period (Fig. 3.15E). The extension occurred 
immediately after the inhibitor GM6001 was removed and continued until a time of forty 
minutes following the removal of GM6001 when retraction began. In this area, intensity 
from the cleaved biosensor was most abundant between a time of thirty minutes and 
thirty five minutes after the removal of the MMP inhibitor. Upon retraction, the intensity 
from the intact biosensor became more dominant. After one hour following the removal 
of the MMP inhibitor, the pixels near this protrusion (region 2 in Fig. 3.15C) were 
projected near the position of the intact biosensor (near 2ns) on the polar plot in Figure 
3.15D. In the colored (red/green) images rendered from the phase suppression (Fig. 
3.15F), a few spurious green pixels appeared possibly indicating the presence of the 
cleaved biosensor. However, these pixels were likely the result of noise in the detected 
signal. Only those green pixels (intensity from the cleaved biosensor in the difference 
images) in Figure 3.15F concentrated in specific regions of the cell can be quantitatively 
attributed to the presence of the cleaved biosensor.  
 In the final example (Fig. 3.16), an HT-1080 cell undergoing both morphological 
changes corresponding to configurational changes in the biosensor is presented. In this 
case, the overall morphology of the cell remained constant with two protrusions emerging 
along the left side of the cell during imaging (see intensity images in Fig. 3.16E). 
However, in this cell the activation of the MT1-MMP visualized by an increase in 
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intensity from the cleaved biosensor (green shading in Fig. 3.16F) occurred with a delay 
as a protrusion emerged along the top of the cell. As before, the pre-treatment of the cells 
with GM6001 prevented the biosensor from being cleaved (red shading from Fig. 3.16F 
in “Before” image and polar plots in Fig. 3.16B). After the MMP inhibitor GM6001 was 
removed, a protrusion formed and retracted in the top left corner of the cell during 
imaging. This protrusion began to form approximately ten minutes after the inhibitor was 
removed and was very prominent in the intensity image of the cell twenty minutes after 
the inhibitor was removed. However, intensity from the cleaved biosensor did not 
become apparent until thirty minutes after the inhibitor was removed. Intensity from the 
cleaved biosensor became most prominent midway through the imaging experiment 
along this protrusion (near the times of thirty five minutes and forty minutes after the 
removal of the inhibitor). The increase in intensity from the intact biosensor occurred 
concurrently with the retraction of the protrusion. During the experiment, a protrusion 
(near region 1 in Fig. 3.16C) grew out from the bottom left side of the cell beginning 
approximately fifty minutes after the GM6001 was washed out. In this case however, the 
activation of the enzyme occurred as the protrusion grew. Finer time resolution would be 
able to more carefully correlate the growth of protrusions and the activity of MT1-MMP.  
On the polar plot, the movement of the polar coordinates in region 1 shown in Figure 
3.16C toward a position near 3ns likely also suggests that the MT1-MMP is active and 
cleaving the biosensor. 
 In some cases, morphological changes including the formation of protrusions and 
extensions of the cell’s membrane occurred without a concurrent change in the 
configuration of the biosensor (Fig. 3.17). The transfected HT-1080 cell described in 
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Figure 3.17 was cultured in a 3-dimensional collagen matrix and pre-treated with the 
MMP inhibitor GM6001. As before, two detector phases were chosen to suppress the 
intensity from the intact biosensor and separately, two detector phases were selected to 
suppress the intensity from the cleaved biosensor. The difference images generated from 
these phase images therefore, follow the intensities from the intact and cleaved biosensor 
in the images (Fig. 3.17F). In the series of intensity images collected during the imaging 
of the first cell for example, protrusions (extensions) emerged along the top and bottom 
of the cell (Fig. 3.17E). However, at no time following the removal of GM6001 was there 
any substantial intensity from the cleaved biosensor in the difference images generated 
with phase suppression along this protrusion or anywhere in the cell (Fig. 3.17F). During 
the imaging period, a few green pixels possibly indicative of the cleaved biosensor 
appeared randomly. These pixels were likely the result of noise. When the pixels from the 
four regions of interest were analyzed on the polar plot (Figs. 3.17C and 3.17D), no 
configurational change in the biosensor was observed at a time of nearly an hour 
following the removal of the GM6001 inhibitor from the cell’s media. All polar 
coordinates including those at the protrusions (regions 1 and 4 in Fig. 3.17C) were 
located near 2ns indicating that the biosensor was intact.  
 In Figure 3.18, a second example further demonstrates that morphological 
changes taking place within the HT-1080 cells following the removal of MMP inhibitors 
may not require the activity of MT1-MMP. Before the MMP inhibitor (GM6001) was 
removed, the polar coordinates from the pixels located in four regions of interest 
highlighted in Figure 3.18A, were all near 2ns on the polar plot (Fig. 3.18B). As time 
progressed following the removal of GM6001, the average intensity images indicated that 
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a definite protrusion formed along the lower left side of the cell (Fig. 3.18E) while at the 
same time, the topmost area of the cell (near region 2 in Fig. 3.18A) underwent an 
expansion toward the top of the image’s frame. At a time one hour after the inhibitor 
GM6001 was washed out of the cell’s media, the polar coordinates from pixels sampled 
throughout the cell were projected on the polar plot (Figs. 3.18C and 3.18D). In each 
region of interest, all polar coordinates remained near 2ns which likely corresponds to the 
intact biosensor. Even in the regions sampled directly along the protrusion (regions 1 and 
2 in Fig. 3.18C), the polar coordinates still indicate that the biosensor is likely intact. In 
the region 1 specifically along the protrusion, some of the pixels were near 3ns possibly 
indicating that the biosensor was cleaved. However, the signal levels in this region was 
low and as a result, the data were noisy (please refer to section on the noise of the 
instrument for more specific explanations). In this case, the average polar coordinate 
(near 2ns) represents the fluorescent species in that area.  Difference images were also 
generated from the individual phase images selected to suppress the intensity from the 
intact and separately the cleaved biosensor. In time, there were no definite regions in the 
cell containing intensity from the cleaved biosensor (Fig. 3.18F). The intensity from the 
difference image contained contributions dominantly from the intact biosensor.  
 
Discussion 
 In this chapter, the activity of the MT1-MMP enzyme was examined throughout 
live HT-1080 cells containing the mOrange2/mCherry MT1-MMP biosensor. On the 
polar plot, the polar coordinates corresponding to the intact and cleaved biosensor were 
sufficiently distinct so that the configuration of the biosensor could be classified on a 
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pixel-wise basis. Although the analysis conducted on the polar plot was based on the 
relative intensity emitted by each configuration of the biosensor, the set of emission 
wavelengths detected by the intensified CCD was selected to make the integrated 
intensities of both configurations of the biosensor approximately equal. Hence, the 
calculations carried out on the polar plot not only assigned a classification of the 
biosensor’s configuration based on intensity but also, based on the actual normalized 
concentration of the biosensor present. With the incorporation of phase suppression into 
the lifetime imaging system, the kinetics of MT1-MMP’s activation could be monitored 
for more than an hour following the removal of MMP inhibitors without the effects of 
photo-damage killing the cell. The equivalence between the intensities highlighted by 
phase suppression and the configuration of the biosensor derived from calculations on the 
polar plot was shown in multiple sets of experimental data. As such, the intensities in the 
difference images generated from phase suppression also provided an estimation of the 
normalized concentration of each configuration of the biosensor present.  
 With the data and analysis presented, new patterns of MT1-MMP’s activity in 
matrices of collagen have been observed specifically near protrusions. In contrast, when 
cells have been studied in two-dimensional settings both in the literature [32] and in this 
chapter, the activity of MT1-MMP is spread throughout the entire perimeter of the cell 
without a specific bias for protrusions. The HT-1080 cells cultured in collagen also 
underwent more substantial morphological changes than the HT-1080 cells examined on 
glass surfaces. These protrusions observed along the perimeters of the cells cultured in 
collagen, are ideal locations from which to investigate how the cancer cells examine and 
essentially collect information from their local environment. These protrusions observed 
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consisted both of small point-like extensions as well as large fan-shaped expansions 
spreading from the main cell body. In some of the presented cases, the activity of MT1-
MMP was accompanied by the formation of protrusions while in another example, MT1-
MMP’s activity was delayed relative to the development of protrusions. A portion of the 
presented data even implied that the activity of MT1-MMP may not be necessary for a 
cell to extend protrusive structures.  
 Although these results confirm that MT1-MMP’s role regulating the invasive 
character of cancer cells is likely quite complex, the presented data motivates more 
questions than conclusions about the activity MT1-MMP. A detailed investigation of the 
cell’s local environment would be necessary to understand fundamentally the reason why 
MT1-MMP is active only in certain protrusions as the cell undergoes morphological 
changes. One possible explanation for the selective activity of MT1-MMP may be related 
to the density of collagen located in the cell’s local environment. In the case of migration 
for example, the MT1-MMP-dependent migration has already been shown to depend on 
the density of collagen in the areas immediately surrounding the cell [33-36]. As shown 
in the images of the collagen-I collected with SHG in this chapter, the density of the 
collagen and the pore sizes formed between the collagen fibers can vary even in different 
locations within the same culture dish. The concurrent imaging of the collagen fibers 
along with the fluorescence emitted by the biosensor would be crucial in order to 
understand MT1-MMP’s role as the cell interacts with collagen matrix. Also, studying 
the proteolytic damage to the collagen matrix following the activity of MT1-MMP-
dependent and MT1-MMP–independent protrusions would reveal very useful information 
to characterize these interactions. In addition, the incorporation of transmitted light 
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microscopy would also be useful to look for features in the cell’s local environment that 
would be undetectable by imaging with fluorescence.  
 In future studies, this project will require improved spatial resolution in both the 
lateral and axial directions. Visualizing collagen with fluorescently labels such as 
Fluorescein is also necessary because the 2-photon lasers capable of imaging collagen 
with SHG would readily kill live cells (specifically when the collagen is not well-
ordered). In addition, the HT-1080 cells cultured in the collagen matrix likely do not 
position themselves precisely parallel to the plane observed by the microscope’s 
objective. In most cases, specific portions of the cell such as features along the edge of 
the cells (or even the protrusions observed here) likely span multiple planes in the axial 
dimension. Currently, two modalities of high resolution fluorescence imaging (spinning 
disk confocal [29] and light sheet illumination [37]) exist which are conducive for live 
cell imaging. New advances in light sheet illumination may also allow for cells to be 
imaged individually in live tissues. Furthermore, an overall modulation frequency of 
60MHz instead of the 40MHz used in this chapter would provide an approximately 
twenty percent improvement in the resolution of the two configurations of the biosensor 
on the polar plot when compared to the resolution obtained in this chapter. Noise could 
be substantially reduced with newer equipment such as laser diodes whose intensity can 
be directly modulated and modern intensifiers. Unlike a collimated laser passing through 
a Pockels cell, directly modulating the intensity of light emitted by a laser diode lowers 
the noise in the acquired lifetime images because of the increase in the modulation depth 
(AC/DC ratio) of the emitted light. Newer phosphor screens as well as more sensitive 
 
 
146 
 
cathodes on image intensifiers can also reduce noise so that smaller changes in lifetime 
can be robustly quantified. 
 Finally, one aspect of imaging biosensors in live cells that has been largely 
overlooked in the literature is the necessity to monitor the position of a biosensor in the 
cell after it has adopted a different configuration. For example, if the MT1-MMP 
biosensor studied here is changing configuration in some specific region of the cell, how 
can a newly cleaved biosensor be distinguished from a biosensor that was previously 
cleaved and just moved within the cell. Being able to track a cleaved biosensor after its 
interaction with the MT1-MMP enzyme or at the very least, being able to establish where 
the biosensor was initially activated is absolutely necessary to understand the biology 
conveyed by the activation patterns. Recently traditional tools in data analysis such as 
auto-correlation are starting to be applied to study and monitor biosensors after being 
initially activated in live cells [38, 39]. With both improved temporal and spatial 
resolution, these sorts of statistical tools will no doubt, clarify and more accurately 
characterize the activation patterns of the MT1-MMP biosensor observed in this chapter. 
 
PhaseDelayImaging Software 
 The research presented in this chapter required new software principally to 
acquire images at continuously variable phase shifts (phase of radio frequency injected 
into the detector’s gain). This software coordinated the functions of the Uniblitz shutter, 
CCD camera and phase shifter (Lorsch) specific to the values entered into the user 
interface (Supp. Fig. 3.2). In short, the Uniblitz shutter and digital phase shifter can be 
controlled by appropriately timed TTL pulses emitted from the local PCI card (National 
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Instruments).  The digital phase shifter can be continuously varied with a precision of 
within ±0.7o. In the software’s control window (Supp. Fig. 3.2), the box labeled “Actual 
Phase” indicates the true phase shift outputted by the phase shifter once the user requests 
a specific phase in the “Desired Phase” box. The camera is operated with functions from 
the QCam API package. The exposure time and binning can be varied depending on the 
needs of the experiment. Following the acquisition of an image, the windows-based 
SaveFileDialog directs the user to declare a filename and location to save the image to. 
These images are stored as binary images with a frame size of 678x518 pixels. Many 
commercial software packages including MatLab, Autoquant and MetaMorph can open 
the image for further image processing.  
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Figures  
 
 
 
Figure 3.1: Time-resolved in-vitro measurements: (A) The polar coordinates of the MT1-
MMP biosensor were measured before and after the biosensor was cleaved by trypsin. 
Measurements were taken at a modulation frequency of 40MHz through the emission 
filter shown in (C). (B) The phase delay and modulation ratio of the mOrange2 was also 
measured on both configurations of the biosensor at an emission wavelength of 570nm ± 
10nm. When measured and plotted on the polar plot at a modulation frequency of 
40MHz, there is a definite movement of the polar coordinate toward longer lifetimes after 
cleavage of the biosensor. (C) The normalized emission spectra of mOrange2 and 
mCherry are displayed along with the filter pass of the emission filter used in (A) (and 
used for the live cell measurements) highlighted. (D)  Separate protein solutions of the 
intact biosensor and the biosensor cleaved by trypsin were examined in the 
electrophoresis gel. The leftmost lane contains the intact biosensor and the center lane 
contains the cleaved biosensor. The far right lane is the indicator lane displaying the 
reference masses.  
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Figure 3.2: Steady-state measurements taken on the MT1-MMP biosensor: (A) The 
emission spectrum of the intact MT1-MMP biosensor was measured with an excitation 
wavelength of 532nm. Linear spectral unmixing was applied to resolve the contributions 
of the mOrange2 and mCherry separately. (B) The emission spectrum of the cleaved 
biosensor was also measured at an excitation wavelength of 532nm. After the biosensor 
was cleaved, there is a definite loss in emission from the mCherry and an increase in 
fluorescence emission from the mOrange2 relative to (A) indicating a loss of FRET.  
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Figure 3.3: Analyzing measurements of live cells with wavelets: (A) An intensity image 
of an HT1080 cell not treated with the GM6001 inhibitor is shown with the regions of 
interest for (C), (D) and (E) highlighted. (B) Intensity images of the HT1080 cell not 
treated with the GM6001 inhibitor describing the morphology of the cell is displayed 
following the denoising (center image) and the multi-resolution background removal (far 
right image). (C) The pixels from the red region of interest shown in (A) are projected on 
the polar plot during the denoising and background removal steps. Near the edge of the 
cell, there is considerable background likely from the media that the cells are immersed 
in. (D) The pixels from the yellow region of interest near the nucleus of the cell in (A) are 
plotted on the polar plot. This region still has very detectable background despite being 
taken from a region with higher intensity on the cell. (E) The pixels of the green region of 
higher intensity in (A) are displayed on the polar plot. Interestingly, after the background 
removal, there appears to be a second lifetime pool here near 2ns as compared to the 
region in (C) which was near 3ns   
 
 
151 
 
 
 
Figure 3.4: HT-1080 cell treated with the GM6001 inhibitor: (A) An intensity image of 
an HT-1080 cell taken during a FLIM experiment while homodyning is presented with 
four regions of interest highlighted in white. (B) An IMD (intensity-masked display) 
image is shown where the red shading indicates where the fractional intensity of the 
intact biosensor is dominant relative to the cleaved biosensor. (C) In this IMD image, the 
areas in the cell where the fractional intensity from the cleaved biosensor is dominant are 
shown in green. (D) When both (B) and (C) are combined, the resulting cell image shows 
that most of the collected intensity is being emitted from the intact biosensor as indicated 
by the red shading. (E) The pixels from the regions in interest in (A) are projected on the 
polar plot in these scatter plots. The plots indicate that there is likely a single lifetime 
pool near 2ns representing the intact biosensor.  
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Figure 3.5: HT-1080 cell not treated with the GM6001 inhibitor: (A) An intensity image 
of an HT-1080 is shown with regions of interests (1-4) highlighted. (B) Red shading is 
presented indicating where the fractional intensity from the intact biosensor is most 
prevalent. (C) Highlighted in green are the areas in the cell where the fractional intensity 
of the cleaved biosensor is dominant in the image. As shown, these areas reside mostly 
on the edge of the cell. (D) Images (B) and (C) were then combined to form an image 
where the dominant fractional intensities of both configurations of the biosensor are 
highlighted together. (E) These scatter plots are projections of the pixels from the regions 
of interest in (A).  Two lifetime pools near 2ns (regions 1 and 3) and 3ns (regions 2 and 
4) are clearly visible.  
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Figure 3.6: Simple example of phase suppression: (A) A lifetime image derived from the 
measured phase delays describes two micro-cuvettes containing Rhodamine B (top 
capillary) and Rhodamine 6G (bottom capillary). (B) Two detector phases were selected 
to suppress the intensity from the bottom capillary. The resulting difference image only 
contains intensities from the top capillary. (C) This difference image was generated by 
subtracting two images gathered at two separate detector phases (different from those 
applied in (B)) in order to suppress intensity from the top capillary. 
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Figure 3.7: Analyzing a single HT-1080 cell with phase suppression: (A) This intensity 
image of an HT-1080 cell transfected with the MT1-MMP biosensor is the average of the 
eight phase images collected for a lifetime image. (B) The areas in the image where the 
majority of the intensity (based on a calculation from the polar plot), is being emitted 
from the cleaved biosensor are highlighted in green. (C) The areas in red specify the 
locations in the image where the intensity emitted from the intact biosensor is in the 
majority based on a calculation from the polar plot. (D) The images from (B) and (C) are 
combined to show the localization by intensity of both the intact and cleaved biosensor in 
the cell. (E) This difference image is the result of a subtraction of two images acquired at 
a set of detector phases selected to suppress the intensity from the intact biosensor. (F) 
The intensities in this image are the result of applying phase suppression to remove the 
intensity from the cleaved biosensor. (G) A three-dimensional rendering of the results 
from phase suppression shown in (E) and (F) is presented.   
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Figure 3.8: Phase suppression applied to study an HT1080 cell before the GM6001 
inhibitor was washed out: (A) Phase suppression was applied to suppress the intensity 
from the intact biosensor in the image, leaving only intensity from the mOrange2 
(cleaved biosensor). (B) A set of detector phase angles was also selected to suppress the 
intensity from the mOrange2 (cleaved biosensor). In this image, the result of that 
suppression strategy shows that the intact biosensor’s fluorescence is being emitted from 
a majority of the cell’s body. (C) A color coding masked by the intensity image in (E) has 
been applied to the image. The green shading in the various pixels indicates where in the 
cell the fractional intensity of the mOrange2 (cleaved biosensor) dominates the average 
intensity measured. (D) The pixels in which the fractional intensity is majority from the 
intact biosensor are colored in red. This image has been masked by the intensity image in 
(E). There is a similarity to the pixels shown here to the intensities highlighted in (B). (E) 
An intensity image of the cell is shown with three regions of interest indicated. (F) The 
pixels from each of the regions of interest in (E) are projected on the polar plot.  
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Figure 3.9: Analysis of an HT1080 cell with phase suppression thirty minutes after the 
GM6001 inhibitor was washed out: (A) Two detector phases were chosen and images 
were subsequently acquired to suppress the intensity from the intact biosensor. As shown, 
intensity remained from the mOrange2 (cleaved biosensor) primarily along the edge of 
the cell. (B) Phase suppression was also used to suppress the intensity of mOrange2 
(cleaved biosensor). When performed, the intensity from the intact biosensor was found 
predominantly in the interior of the cell away from the edge. (C) Overlaid on the intensity 
image in (E) is a color coding describing the locations where the majority of the average 
intensity measured in the pixel comes from mOrange2 (cleaved biosensor). (D) Colored 
in red are the pixels in which the majority of the fractional intensity is from the intact 
biosensor. (E) An intensity image of the cell following the washout of GM6001 is shown 
along with three regions of interest indicated. (F). Three polar plots are shown in which 
the pixels from the regions of interest in (E) are displayed.  
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Figure 3.10: Improving the temporal resolution of phase suppression: (A) The intensity 
images show the morphological changes taking place before and at several time points 
after the inhibitor GM6001 was removed. (B) Two detector phases were selected to 
suppress the intensity from the cleaved biosensor. The resulting difference images 
indicate that the intensity from the intact biosensor remained primarily in the central 
portions of the cell throughout the experiment. (C) These difference images show that the 
intensity from the cleaved biosensor emerged along the perimeter of the cell and was 
specifically concentrated in the protrusion that formed along the lower left corner of the 
cell.  
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Figure 3.11: Time-lapsed imaging of HT-1080 cells on glass with phase suppression for 
forty five minutes: (A) This intensity image is the average of the eight phase images 
collected with the homodyne FLIM system before the MMP inhibitor GM6001 was 
removed. (B) The pixels from the four regions of interest in (A) are projected on the 
corresponding polar plots. Most of the polar coordinates are near 2ns likely indicating 
that the biosensor is intact. (C) The intensity image presented shows that the overall 
morphology of the cell did not significantly change forty five minutes after the GM6001 
was removed from the cell’s media. (D) The polar coordinates from the pixels in regions 
1, 2 and 3 moved to a position closer to 3ns which implies that the biosensors in these 
areas are cleaved forty five minutes after the GM6001 was removed. (E) A set of average 
intensity images taken throughout the experiment with phase suppression are presented. 
(F) The results from the phase suppression are color-coded in order to describe the areas 
in the image where the intensity in the difference images are majority from the intact 
biosensor (red) or from the cleaved biosensor (green).  
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Figure 3.12: Time-lapsed imaging of HT-1080 cells on glass with phase suppression for a 
period of one hour: (A) Following the pre-treatment with GM6001, the intensity image of 
this HT-1080 cell clearly shows the nucleus and several extensions along the edge of the 
cell. (B) The polar coordinates corresponding to the pixels contained within the four 
regions of interest in (A) are projected near 2ns on the polar plot suggesting that the 
biosensor is initially intact. (C) As indicated by this intensity image, some morphological 
changes in the cell took place along the edge near the bottom and top of cell during the 
one hour experiment. Like (A), this intensity image is the average of the eight phase 
images acquired during the lifetime imaging experiment (D) In regions 1, 3 and 4, the 
polar coordinates from these pixels moved closer to the position associated with the 
cleaved biosensor (near 3ns) on the presented scatter plots. (E) By averaging the four 
intensity images acquired during the phase suppression experiment, these images 
describe the changes in the staining of biosensor at the times sampled. (F) The difference 
images highlighting the intensities from the cleaved biosensor and separately, the intact 
biosensor were combined with color code to spatially map the areas in the cell where the 
intact biosensor’s intensity is in the majority (red) or where the cleaved biosensor’s 
intensity is in the majority (green). 
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Figure 3.13: Steady-state imaging of transfected HT-1080 cells in a 3D matrix of 
collagen-I: (A-D) Images of four HT-1080 cells are presented. Images of the collagen-I 
collected with backwards second harmonic generation (SHG) were acquired in parallel 
with steady-state fluorescence images of the HT-1080 cells. In order to prevent the 
degradation of the collagen fibers, these cells were pre-treated with the MMP inhibitor 
GM6001. 
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Figure 3.14: Activation of MT1-MMP in a live HT-1080 cell cultured in a 3-dimensional 
collagen matrix (1): (A) This intensity image was acquired after the HT-1080 cell was 
pre-treated with the MMP inhibitor for 12-18 hours prior to imaging. (B) The polar 
coordinates from the pixels in the four regions of interest in (A) are near the location of 
the intact biosensor (near 2ns) on the polar plot. (C) At a time of one hour after the 
removal of the MMP inhibitor GM6001, the morphology of the cell distinctly changed as 
shown in this intensity image generated by averaging the eight phase images acquired 
during lifetime imaging. (D) The polar coordinates near the left edge of the cell (regions 
1 and 4 in (C)) moved to a position near 3ns one hour after the MMP inhibitor was 
removed likely indicating that the biosensor was cleaved. (E) Each intensity image shown 
is the average of the four intensity images acquired during phase suppression. (E) In these 
color-coded results from imaging with phase suppression (red – majority of intensity 
from intact biosensor, green – majority of intensity from cleaved biosensor), the cleaved 
biosensor emerged along the protrusions at the bottom and at the top left portions of the 
cell. 
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Figure 3.15: Activation of MT1-MMP in a live HT-1080 cell cultured in a 3-dimensional 
collagen matrix (2): (A) After being pre-treated with the MMP inhibitor, the average of 
the eight phase images acquired during the lifetime imaging was computed and shows the 
staining of the biosensor’s plasmid, pDisplay. (B)  When the pixels from the regions 
indicated in (A) are projected on the polar plot, the locations of the coordinates indicate 
that the biosensor is intact (near 2ns). (C) The fluorescent staining of the biosensor 
changed during the experiment, with new protrusions formed along the top and right side 
of the cell as shown in this intensity image. (D) At a time of one hour after the removal of 
the MMP inhibitor GM6001, the polar coordinates from the pixels in region 4 specifically 
moved toward longer lifetimes, suggesting the presence of the cleaved biosensor. (E) By 
averaging the four intensity images acquired for analysis with phase suppression, the 
presented intensity images show the change in overall morphology of the cell in time. (F) 
The intensities from the difference images containing the intensity from the cleaved and 
separately, from the intact biosensor, were combined and colored to show where the 
intensity from intact biosensor was dominant (red shading) and where the intensity from 
the cleaved biosensor was in the majority (green shading).  
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Figure 3.16: Activation of MT1-MMP in a live HT-1080 cell cultured in a 3-dimensional 
collagen matrix (3): (A) An HT-1080 cell transfected with the mOrange2/mCherry MT1-
MMP biosensor was imaged with the homodyne FLIM system after being incubated with 
the MMP inhibitor GM6001 for 12-18 hours. (B) The polar coordinates corresponding to 
the four regions in (A) are projected on these scatter plots. Most of the polar coordinates 
are near 2ns suggesting that the biosensor is intact. (C) This intensity image is the 
average of the eight phase images acquired by the homodyne FLIM system one hour after 
the MMP inhibitor was removed. (D) Specifically in region 1 from (C), the polar 
coordinates indicative of this portion of the cell moved toward 3ns (cleaved biosensor) 
while the polar coordinates from the other regions (2-4) remained near 2ns (intact 
biosensor). (E) The staining of the MT1-MMP biosensor was monitored in time by 
averaging the four phase images collected during the experiment with phase suppression. 
(F) At the various time points sampled, the presented images are colored to show the 
areas in the combined difference images (combining the difference image containing 
intensity from the intact biosensor and separately the difference images containing 
intensity from the cleaved biosensor) where the majority of the intensity is from the intact 
biosensor (red) or from the cleaved biosensor (green).  
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Figure 3.17: Lack of MT1-MMP’s activation following the removal of inhibitors in live 
HT-1080 cells cultured in a 3-dimensional collagen matrix (1): (A) Before the MMP 
inhibitor GM6001 was removed, the intensity of the HT-1080 cell studied here showed 
that the cell was well spread (not rounded). (B) Throughout the cell, the polar coordinates 
corresponding to the pixels from the regions of interested highlighted in (A) were all 
projected near the location of the intact biosensor (near 2ns) on the polar plot. (C) One 
hour after the removal of the MMP inhibitor GM6001, some extensions were observed 
along the top and bottom of the cell as assessed by this intensity image. (D) Even without 
the presence of the inhibitors, the polar coordinates from the four regions studied within 
the cell remained near 2ns indicating that the biosensors were intact. (E) The staining of 
the cell by the biosensor was monitored in time by averaging the four intensity images 
collected during the imaging with phase suppression. (F) Intensities from the difference 
images indicative of the cleaved and intact biosensor are presented. Areas in the cell 
dominated in intensity emitted from the intact biosensor are colored in red and separately, 
locations in the cell containing intensity mostly from the cleaved biosensor are colored in 
green.  
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Figure 3.18: Lack of MT1-MMP’s activation following the removal of inhibitors in live 
HT-1080 cells cultured in a 3-dimensional collagen matrix (2): (A) An intensity image 
shows an HT-1080 pre-treated with MMP inhibitors and cultured in a 3-dimensional 
collagen matrix. The average of the eight phase images collected during lifetime imaging 
were used to generate this image. (B) The polar coordinates calculated from pixels in 
regions selected throughout the cell suggest that the biosensor is likely intact before the 
inhibitor was washed away. (C) Approximately one hour after the MMP inhibitor was 
removed, this intensity image indicates that the morphology of the cell did change during 
the experiment. (D) Even along the bottom of the cell where some extension was noted, 
all polar coordinates in the regions analyzed within this cell’s image remained near 2ns at 
a time one hour after the inhibitor was removed. (E) The average intensity emitted by the 
biosensor was tracked in time by averaging the four phase images acquired when 
applying phase suppression to study the cells. (F) The difference images calculated 
during the examination of the cells with phase suppression are presented with a color-
coding highlighting areas within the cells dominated in intensity by either the intact 
biosensor (red) or the cleaved biosensor (green).  
 
 
166 
 
 
 
Supplemental Figure 3.1: Gaussian Fitting Applied to the Polar Plot: (A) The two 
Gaussians functions derived from the 3D histograms of polar coordinates of the HT-1080 
cells transfected with the MT1-MMP biosensor (No GM6001) are plotted separately on 
the polar plot. The smaller distribution corresponds to the intact biosensor occurring 
mostly at regions of high intensity within the cells while the larger distribution 
corresponds to the cleaved biosensor. The inset in the top left corner displays a 2D 
projection of the 3D distribution. (B)  The sum of the two Gaussians computed by fitting 
the histograms on the polar plot (left-most panel) is compared to the data (center panel). 
The difference between the actual measured polar coordinates inside the HT-1080 cells 
displayed as a 3D histogram and the Gaussian fits is shown in the panel on the far-right.  
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Supplemental Figure 3.2: PhaseDelayImaging Software: (A) This dialog box accepts the 
user’s desired phase as input (B) The exposure time of the camera can be continuously 
changed by a simple input from the user. (C) The actual phase outputted by the digital 
phase shifter is presented in this box. The precision of the phase shifter is ±0.7o. (D) The 
binning of the individual wells on the CCD chip can also be adjusted easily by the user 
depending on the needs of the experiment. (E) With the parameters from A-D inputted, 
this push button sends the commands to control the various components of the instrument 
and acquires an image. Following the acquisition of the image, the windows-based dialog 
appears to specify a filename and directory to save the image. 
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Tables 
 
#cells 
x1 
center 
y1 
center 
x1 
std. 
dev. 
y1  
std. 
dev. 
x2 
center
y2 
center 
x2  
std. 
dev. 
y2  
std. 
dev. R2 
5 0.679 0.4565 0.111 0.0897 0.3948 0.2626 0.2337 0.2639 0.964
6 0.672 0.4421 0.118 0.1028 0.8293 0.3625 0.04082 0.03304 0.928
7 0.671 0.4352 0.113 0.0938 0.8201 0.368 0.04275 0.03359 0.92
8 0.671 0.4312 0.113 0.0952 0.8156 0.3701 0.04479 0.03244 0.923
9 0.674 0.4356 0.105 0.0848 0.8147 0.3702 0.04436 0.03253 0.912
10 0.675 0.4272 0.105 0.0871 0.8132 0.3674 0.04475 0.03215 0.918
 
Table 3.1: Gaussian fitting on the polar plot applied to HT-1080 cells not treated with 
GM6001:  The polar coordinates determined using the modulation ratios and phase 
delays taken from the pixels within the HT-1080 cells containing the MT1-MMP 
biosensor were binned in a 3-dimensional histogram on the polar plot. The results from 
fitting the data with two Gaussian functions are indicated as a function of the number of 
cells examined. The centers of the fitted distributions, the corresponding standard 
deviations and fit parameters are shown. 
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Chapter 4 
 
Educational Research 
 
Abstract 
 
 In collaboration with Prof. Robert Clegg, a portion of my graduate studies have 
been dedicated to developing new experiments and resources for advanced 
undergraduates and graduate students working through the Physics 552 (Optical 
Spectroscopy) course. Over the span of four offerings of the course, we had the 
opportunity to continually evaluate the response of students to the laboratories in the 
course and also make changes necessary to facilitate their understanding of various 
topics. The underlying theme of this work was two-fold: (1) Design simple experiments 
that would convey the fundamentals of lifetime imaging. (2) Develop experiments to 
introduce the students to advanced topics with research-grade fluorescence instruments 
such as spectral unmixing, phosphorescence and time-resolved anisotropy. In this 
chapter, I have provided the labs that I developed and wrote. My colleague Kai Wen 
Teng contributed to the experimental section in the lab that examines phosphorescence. 
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Phosphorescence Lab 
 
Introduction 
 
 In this lab, you will be examining the photophysical characteristics of the dye 
Acridine Orange by combining many of the concepts and procedures that you have 
learned throughout the course. In addition, we will look at ways to measure the 
phosphorescence of Acridine Orange and examine applications of how both its 
fluorescence and phosphorescence emission can be used to study complex biological 
systems.    
 
Background 
 
 Acridine Orange itself is a weak base and therefore, can easily enter and stain 
living mammalian cells. The staining of Acridine Orange is specifically targeted for 
intracellular structures containing DNA such as nucleoli. Although, Acridine Orange is 
well established as an effective DNA intercalator, evidence also suggests that Acridine 
Orange can weakly bind to the exterior of the DNA helix by weak electrostatic 
interactions. As an intercalator, Acridine Orange has been shown to both stack and form 
clusters when bound to DNA.  
 The benefit of using Acridine Orange as a stain is that the fluorescence and 
phosphorescence emission can provide information about the types of structures that the 
dye is bound to as well as indications about its local environment. In solution, Acridine 
Orange can be mainly characterized by green fluorescence with a lifetime near 1.7ns-
1.9ns. When Acridine Orange forms dimers or higher order aggregates (on DNA for 
example), a strong red fluorescence can be observed. The lifetime of the red fluorescence 
of Acridine Orange has been reported to be between 5ns and 20ns depending on the 
extent of aggregation. Interestingly, in the absence of oxygen, red phosphorescence 
emission (>590nm) has also been observed both in vitro and in live cells with lifetimes 
on the order of milliseconds. Thus far, the phosphorescence has only been observed in 
areas of the cell primarily characterized by green fluorescence.  
Despite the uncertainty that still remains about the staining of Acridine Orange in live 
samples, an understanding of the phosphorescence emission can potentially allow for 
extremely high contrast imaging of specific cellular features (especially when combined 
with fluorescence imaging).   
 Thus far, the majority of the course has been spent examining energy transitions 
between the singlet states in our molecules to measure fluorescence spectra and lifetimes. 
In any molecule that we studied previously and also in the Acridine Orange that we are 
currently measuring, the energy levels that an electron can occupy can be characterized 
(for the most part!) by several basic properties including the electronic energy, 
vibrational energy, rotational energy and spin. In short, the difference in the transitions 
between the singlet states that we have been studying and those with triplet states that 
lead to phosphorescence emission stems from the different spin configurations in the 
singlet and triplet states. All singlet states in this hypothetical molecule contain electrons 
with opposite spins whereas triplet states contain electrons with parallel spins.  
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  Phosphorescence emission typically requires the transition from an excited singlet 
state to the triplet state by a pathway called intersystem crossing. This sort of transition is 
very often the result of a transition between two vibrational energy levels (having the 
same energy – isoenergetic) from electronic states of different multiplicities. This is 
technically a forbidden transition. However, a process called spin-orbit coupling makes 
this transition possible by essentially flipping the spin of the electron. Spin-orbit coupling 
requires an interaction of the orbital angular momentum of the outer electrons with the 
spin of the excited electron to facilitate the spin flip.(There is also a nice intuitive analogy 
on the bottom of page 30 in Valeur discussing spin-orbit coupling).  
 In order to observe the phosphorescence emission of Acridine Orange, all oxygen 
in solution must be removed by an oxygen scavenging agent. In this lab, we will be using 
the enzyme Glucose Oxidase for oxygen removal. Oxygen quenches the emitted 
phosphorescence by non-radiative energy transfer from the excited triplet state (Please 
see Lakowicz for examples). Therefore, lots of oxygen in solution (or in your cell) will 
significantly reduce the intensity of the phosphorescence emission and shorten the 
lifetime of your phosphorescence decay. When studying Acridine Orange, the intensity 
from the phosphorescent emission can be greatly increased also by cooling the sample 
particularly to liquid nitrogen temperatures (77K). Low temperatures significantly inhibit 
the diffusion of oxygen in solution, which then leads to an increase in the phosphorescent 
emission as a result of limited oxygen quenching.  
 In this lab, we will be using the Prof. Clegg’s steady-state fluorometer combined 
with an attachment to measure steady-state phosphorescence (Figure 4.1). The 
phosphorescence attachment consists of two primary components: (1) the internal 
rotating cylinder (2) the outer holder which mounts to the fluorometer. The outer holder 
(2) has windows which resemble slits cut into it for the excitation light to enter and the 
emission to leave at 90o relative to the excitation through either the left or right emission 
channel. The windows cut into (2) remain fixed throughout the experiment. The internal 
cylinder (1) has only two windows cut into it which are 180o apart.  
 This phosphorescence attachment functions to see the light emitted from the 
sample at some time after the excitation light has been incident on it. This is 
accomplished by the fast rotation of the internal cylinder (1). As this cylinder turns, one 
window will allow for the brief excitation of the sample. As this window continues to 
rotate after the excitation event, it will pass between the sample and the detector. If the 
time between the excitation and the moment when the window passes between the 
sample and detector are on the approximate order of the phosphorescence lifetime of the 
sample, the detector will observe photons from phosphorescence. Although only a single 
window was discussed here from component (1), the same logic would follow also for 
the second window. This particular attachment allows one to continuously adjust the 
speed of rotation so that a wide range of phosphorescence lifetimes can be measured.   
 A definite advantage of this measurement is that all light from the excitation 
channel can be completely blocked which eliminates the need for any emission filter to 
detect the phosphorescence emission. 
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Experiments 
 
Recording Fluorescence Spectrum 
 
Acridine Orange Spectrum 
 
1. Pipet the following into a 1 mL cuvette: 
-     530 uL of PBS (Phosphate buffered saline) 
-     14 uL of Acridine Orange stock. (5.7 OD) 
 
2. Take an emission spectrum of the sample using the user-defined setting  
        Acridine Orange. 
 
 Acridine Orange on DNA Spectrum 
 
1. Pipet the following into a 1 mL cuvette: 
- 500 uL of PBS. 
- 30 uL of DNA stock (100 OD) 
- 14 uL of Acridine Orange stock. 
 
2. Take an emission spectrum of the sample using the user-defined setting 
Acridine Orange DNA. 
 
3. Do not discard the content of the cuvette  
 
Intensity Measurements with Phosphorescence Attachment 
 
First we must remove the sample holder from the PC1 fluorometer, and replace it 
with the SLM phosphorescence attachment. Your TA will assist you with this 
procedure. 
 
 Acridine Orange on DNA Intensity Measurement (Control) 
  
1. Place your 1mL cuvette containing the Acridine Orange and DNA sample into 
the center of the phosphorescence attachment 
 
2. Begin measuring intensity vs. time using the user-defined method 
Phosphorescence Intensity.  
 
-Please also have your TA increase the slit sizes on both monochromators, 
remove polarizers and place a filter in the emission channel. (Removing the 
polarizers increases the signal/noise and the emission filter prevents 
reflections from reaching detector). 
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-Please also turn the lights off and cover the sample chamber with a dark 
cloth. 
 
3. After 30 seconds of measurements, activate the phosphorescence attachment. 
Record the intensity for 30 seconds with the phosphorescence attachment on. 
Repeat step 3. That is, you should have 120 seconds of data where 0-30sec 
phosphorescence attachment is off, 30-60sec phosphorescence attachment is 
on, 60-90sec phosphorescence attachment is off and 90-120sec 
phosphorescence attachment is on.  
 
Acridine Orange on DNA Phosphorescence Spectrum 
 
1. Pipet the following into a clean 1 mL cuvette:  
- 443 uL of PBS. 
- 30 uL of DNA stock. 
- 14 uL of Acridine Orange stock. 
- 2 uL of catalase (the eppendorf labeled with c). 
- 6 uL of glucose oxidase (labeled with g). 
 
 
The enzymes for oxygen scavenging are now added; as soon as the substrates 
(dextrose) are added into the cuvette the deoxygenating reaction will begin. 
Prepare a stopper for the 1 mL cuvette and a strip of parafilm to quickly seal 
the cuvette as soon as we add dextrose in the next step. 
 
            2.  Add 49 uL of dextrose and quickly seal the cuvette with stopper and wrap the       
                 stopper around with a parafilm. 
 
            3.  Place the cuvette into the sample holder of the SLM phosphorescence  
                 attachment. Activate the phosphorescence attachment and turn the speed to 10. 
 
4.  Please select the user-defined method Phosphorescence Spectrum.   
     Cover the sample holder with a dark cloth, turn off the lights in the room and   
     hit start.  
 
            5. The oxygen scavenging agent takes some time to get rid of the oxygen. You         
    will take another spectrum after 15 minutes. Please also take one last  
    spectrum.  
 
 Acridine Orange on DNA Phosphorescence Intensity Measurement 
 
1.    Please select the user-defined method Phosphorescence Intensity 
 
2. We will first inspect the phosphorescence intensity by turning the 
phosphorescence attachment on and off while running at the maximum speed. 
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Start the recording of the intensity with the phosphorescence attachment off, 
then turn the phosphorescence attachment on after 30 seconds. Repeat this 
procedure for a total of 120 seconds, that is a total of 4 on/off intervals. 
 
3. Next, we will inspect the phosphorescence intensity as a function of spinning 
frequency. Select user-defined method Phosphorescence and Frequency. 
Activate the phosphorescence attachment, turn to maximum speed and begin 
data acquisition. 
 
4. Starting with the maximum spinning frequency of 2 gradually decrease the 
spinning frequency by 0.2 every 30 seconds. (See table in appendix for actual 
spinning frequencies).  
 
 
Demonstrating the Principle of Our Phosphorescence Detection 
 
This experiment should be done in small groups while the spectra are being    
recorded from the previous experiments. In this experiment, there is a setup built  
behind the fluorometer that will demonstrate the principle of how we are detecting  
phosphorescence and the benefits of imaging with phosphorescence. 
 
 Setting up the System 
 
1. Please take note of and make a sketch of the setup prior to beginning. 
 
2. Please position both the ruby and the sample of rhodamine so that they can be 
imaged simultaneously by the camera through the opening in the chopper. 
 
3. Connect the ‘Sync” output located on the chopper’s control box to the input of 
the frequency counter. Adjust the larger control dial located on the chopper’s 
control box to achieve a chopping frequency of 100Hz. 
 
4. Please re-connect the ‘Sync’ output from the chopper to the trigger input on 
the oscilloscope 
 
Data Acquisition 
 
1. Take note of the traces on the oscilloscope and identify the waveform driving 
the LED’s intensity modulation and the waveform corresponding to the 
shuttering of the camera by the chopper. 
 
2. Set of the phase of the frequency generator to 0o. Please acquire and save an 
image of the sample on the desktop of the computer. 
 
3. Repeat step (2) using phases of 45 o, 90 o, 135 o and 180o. Monitor the traces 
on the oscilloscope as you change the phase of the function generator.  
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Questions 
 
1. Correct your phosphorescence spectrum for unwanted background:  
 
 First, determine the equation for the straight line extending from the 
 beginning to the end of your spectrum.  
 
 Subtract the background from spectrum. Your response to (1) should  
  include the phosphorescence spectrum before the background subtraction  
  and separately after the background subtraction 
 
2. What causes the green peak that you see in your phosphorescence spectrum? If 
you measure the lifetime using the intensity from the green peak, will that 
measured lifetime be the same as the lifetime you would measure using the 
intensity from the red peak? Why? 
 
3. We had asked the class to measure the intensity of the sample as a function of the 
spinning frequency of the phosphorescence attachment. This sort of experiment 
can allow you to measure the lifetime of your sample.  
 
In the appendix of Prof. Clegg’s 1991 article (indicated on website and in (1)), he 
has the following equation describing the intensity measured by a detector using a 
phosphorescence device similar to the one applied in this lab.  
 
 
  
 
Please refer to Figure (1) in the reference (1) for a graphical definition of 
many of the variables shown above. (Please note that we have made a 
correction that does not appear in the paper.) 
 
.     Please describe briefly why the intensity that you measured during this   
       experiment increased as well increased the spinning rate of the      
       phosphorescence attachment. 
 
      Please plot the average intensity that you measured as a function of   
       frequency.  
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There will be an excel file provided containing 11 intensity measurements   
 taken at each speed of the phosphorescence attachment. Take the average of             
 each of the 11 sets of intensities.. 
 
At the end of your calculations, you should have 11 intensity values and 11 
frequencies. Please plot these (frequency on x-axis and average intensity on y-
axis).  
 
PLEASE JUST SUBMIT A PLOT FOR QUESITON #3. NO FITTING IS 
REQUIRED. BELOW ARE THE RESULTS OF THE TAs ONLY IF YOU 
ARE INTERESTED.  
  
 
4. Present a simple schematic of the setup. In this experiment, what was the function 
of the frequency generator? 
 
5. Please present the images acquired during the experiment. Along with the images,  
 please sketch and label the corresponding scope traces for the driving voltage of 
 the LED and the shuttering of the camera. (In other words, each image should be 
 accompanied by a drawing of the two traces (camera shutter and LED) that were 
 observed on the scope during the experiment).  
 
 
Table 4.1: Frequency Table for Phosphorescence Attachment 
 
Dial Frequency (Hz) 
0 27 
0.2 34 
0.4 41 
0.6 47 
0.8 53 
1 59 
1.2 64 
1.4 70 
1.6 75 
1.8 80 
2 85 
 
 
Reference 
 
[1] Marriott et al., “ Time-resolved imaging microscopy. Phosphorescence and delayed 
luminescence imaging” Biophysical Journal Vol. 60 No. 6, pp 1374-1387, 1991 
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Lab: Anisotropy Decay (New Part Added to Anisotropy Lab) 
 
Introduction 
 
 The polarized fluorescence emission of a fluorophore can relate detailed 
information about the rotational characteristics of a sample. In the previous section, we 
examined the steady-state anisotropy of a series of fluorescein both as a function of 
quenching (shortening of lifetime) and as a function of viscosity in the local environment. 
In both cases, an analysis based on the Perrin plot was able to yield rotational correlation 
times, viscosities and even lifetimes. Measuring the time-dependent anisotropy 
(anisotropy decay) is also a direct way to determine the lifetime, fundamental anisotropy 
and the rotational correlation time of a fluorophore in a specific sample. Measuring the 
anisotropy decay involves only a single sample and does not require a series of samples 
to extract physical information. However, as done in this lab, we will need to measure the 
time-dependent fluorescence of our sample at many modulation frequencies and hence it 
will be time consuming. 
 
Background 
 
 In this experiment, you will be exciting the sample with vertically polarized light. 
The emission will be collected in the left emission channel which is perpendicular to the 
excitation channel. The emission polarizer will be rotated so that you can detect the 
fluorescent emission that is polarized both perpendicular   I t  and parallel   I t
relative to the excitation’s polarization. If the sample is excited by a very short pulse of 
vertically polarized exciting light, the anisotropy decay is simply the time course of the 
anisotropy  r t  shown below,  
        2
I t I t
r t
I t I t


   
With this definition, the separately decaying intensities that are polarized perpendicular 
and parallel to the polarization of the exciting light can be written as, 
       
1 2
1
I t r t
I t
r t


   
 
       
1
1 2
I t r t
I t
r t


   
In the cases studied today, the function  r t will decay as an exponential. Cases when the 
decay may be non-exponential include when quenching is taking place for example. 
However, the pre-exponential factor and the decay constant describe the fundamental 
anisotropy  or , lifetime    and rotational correlation time    as shown, 
  tor t r e   
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If there are multiple fluorescent components in the sample being directly excited, the 
function  r t can be written as a sum where each component has a fundamental 
anisotropy and rotational correlation time each weighted in the sum by the corresponding 
fractional contribution to the steady-state intensity. 
 In the frequency domain, the sample will be excited with an intensity-modulated 
and polarized excitation light source. The goal in this experiment is related to the 
intensity-modulated polarized components of the sample’s fluorescence emission to the 
physical parameters describing the fluorophore. The analysis stems from the convolution 
of the two polarized components of the fluorescence emission with the waveform of the 
exciting light. Therefore, each polarized component of the emission can be described as a 
sinusoidal function oscillating at the same frequency that the intensity of the exciting 
light is being modulated at. Likewise, there will be a phase delay and amplitude of 
oscillation associated with both polarized components of the emission. Unlike measuring 
lifetimes in the frequency domain, the phase delay and amplitude of oscillation detected 
for each polarized component is not compared to that of a known reference fluorophore. 
Instead, the differences in the measured phases    and the ratio of the amplitudes of 
oscillation   taken from the two polarized components of the emission are calculated. 
As a result, all instrumental corrections for the phase delay and amplitude of oscillation 
cancel and no reference is needed.  
 In order to quantitatively relate   and   to physical constants describing the 
sample, the amplitude of oscillating and phase delay need to be defined using Fourier 
analysis. At a specific frequency, the oscillating polarized components of the 
fluorescence emission can be expressed as a sum of sinusoidal functions each weighted 
by the corresponding sine and cosine transforms. The entire intensity-modulated 
fluorescence emission can be re-constructed if all frequencies of oscillation are 
considered. The sine and cosine transforms essentially indicating how much each 
frequency of oscillating contributes to the overall signal can be defined for a polarization 
(p) as follows, 
   
0
cosp p E
t
N I t t dt


   
 
   
0
sinp p E
t
D I t t dt


 
 
 
The evaluation of these integrals is quite complicated and can be found in the 
accompanying reference to the lab. However, with a trigonometric identity, the amplitude 
of oscillation  PM and phase delay  P describing the polarized fluorescence emission 
at a polarization (p) are, 
1tan PP
P
N
D
        
2 2
P P PM N D   
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The difference in phase delay and the ratio of the amplitudes of oscillation measured 
from the two polarized components of the fluorescence emission are functionally 
dependent on the lifetime, fundamental anisotropy, frequency of oscillation and the 
rotational correlation time. They can be written as,  
 
1tan
D N N D
N N D D
    
  
      
 
 
1
2 2 2
2 2
N D
N D
 
 
        
 
When all of the sine and cosine transforms are evaluated, the terms   and    become 
complicated functions with dependencies on the modulation frequency  E , the 
rotational correlation time   , the lifetime   of the sample and the sample’s 
fundamental anisotropy  or . Therefore, with iterative fitting of measurements of  
and    taken at multiple modulation frequencies, all the physical constants of the 
sample can be defined. A more concise description of the derivation provided here can be 
found in (1).  
 
Experiment 
 
1. Mount the 448nm laser diode behind the SLM’s sample chamber. Please be 
 careful and see your TA for assistance. 
 
2. Align the diode so that there is plenty of light reaching the sample chamber to 
excite the sample. Insert the 448nm bandpass filter (small round filter) into the 
filter holder in the excitation channel. 
 
3. Please prepare a solution of Fluorescein in a mixture of 50/50 water/glycerol in 
 one of the large 4.5ml cuvettes and place it in the sample holder. 
 
4. Please find the experiment located within the user-defined menu call “Fluor Anis 
 Decay” and load it. 
 
5. Please run the experiment and coordinate amongst your colleagues to operate the 
shutters and polarizer when instructed by the software. The data acquisition is 
automated here. 
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6. Before the experiment has concluded, please record the G-factor _____ 
 
Questions 
 
1. Why do we not need use a reference (sample with known lifetime) to detect the 
anisotropy decay? We had to use a reference in the previous measurements in the 
frequency domain.  
 
2. The software reported a lifetime of Fluorescein following the fitting. Does this value 
make sense? Why would the lifetime of fluorescein change in different solutions 
 
3. Why are measurements at multiple frequencies necessary? Why did we not just extract 
the rotational correlation times, lifetime and fundamental anisotropy from a measurement 
at a single frequency? 
Reference 
 
[1] Lakowicz, J.R. et al., “Review of Fluorescence Anisotropy Decay Analysis by 
Frequency-Domain Fluorescence Spectroscopy” Journal of Fluorescence Vol. 3 No. 2, pp 
103 – 115, 1993 
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Lab: Spectral Unmixing with Lifetimes (New Part Added to 
 Quantitative Fluorescence Lab) 
 
Introduction 
 
 For many experiments, it is necessary to visualize the dynamics of different 
fluorophores in a sample. However, the absorbance and emission spectra of many of the 
common fluorophores overlap and as a result, finding unique sets of excitation and 
emission wavelengths to distinguish each fluorophore may be difficult. Linear spectral 
unmixing is a technique that can follow changes in the emission of distinct fluorophores 
even if their spectra overlap. Computationally, the contributions of each fluorophore to 
the measured intensity can be determined using measured intensities taken at small 
wavelength intervals across the entire spectrum. When combined with concurrent 
measurements of the lifetime in the frequency domain, spectral unmixing can reveal 
detailed information about contributions of intensity from component fluorophores at 
various concentrations. In this lab, you will measure a sample containing Fluorescein and 
Rhodamine B in order to learn how to acquire a data set necessary for spectral analysis 
and how to unmix spectrum to extract component spectra.  In parallel, the measured 
phase delay and modulation ratio will be projected on the polar plot in order to evaluate 
the spectral unmixing. 
Background 
 The purpose of spectral unmixing is to determine the contribution of different 
fluorophores to a measured intensity. In other words, if the measured intensity is 
 Meas EmI   at an emission wavelength  Em , the unmixing will reveal how much of that 
intensity is result of different fluorophores with overlapping spectra 
      1 2 3, , ,...Em Em EmF F F   . As shown below, the contributions of the different 
fluorophores to the measured intensity are described by the coefficients  ia . 
 
 
 
In this lab, we will be measuring emission spectra for the unmixing calculations. 
Each spectrum can be considered as a single column matrix. As such, we will be using a 
matrix-based calculation to unmix our measured spectra. Please see the references for this 
lab for examples of iterative fitting algorithms that can also be used to unmix spectra. 
With a measured emission spectrum  MeasS  and a set of known spectra of the individual 
fluorescing components  REFS , the spectral unmixing determines the abundance vector 
 a which satisfies the following relationship, 
 
    Meas REFS S a  
 
The abundance vector relates how much each individual spectrum in the reference matrix 
contributes to the measured spectrum. During the analysis in this lab, you will multiply 
both sides of the above equation by the inverse of the reference matrix in order to 
       1 1 2 2 3 3 ...Meas Em Em Em EmI a F a F a F        
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determine the abundance vector (1).  In the case of this lab where there are two 
fluorophores.  
To begin the analysis, spectra need to be acquired of the component fluorophores 
in the mixture (referred to as reference spectra,  REFS ). The matrix  REFS  is shown 
below as a function of emission wavelengths  1 2 3, , , ...   . 
 
 
   
 
 
 
 
1 1
2 2
3 3
. .
. .
. .
FL RhB
FL RhB
FL RhB
REF
S S
S S
S SS
 
 
 
             
 
In order to accurately unmix the measured spectrum  MeasS , the reference spectra  REFS
must be collected under conditions similar to those of the sample (solvent, temperature, 
detector…). The abundance vector calculated for each spectral component of the 
reference matrix will therefore, be given with respect to the reference spectrum.  
 The reference matrix is not square and hence its inversion is not straight-forward. 
We will be finding a pseudo-inverse with singlular value decomposition (SVD). When 
the reference matrix  is decomposed by SVD, three matrices referred to as  u , 
 s  and  v are calculated. The pseudo-inverse of the reference matrix can then be 
calculated as, 
  †1 †1* *REFS v us      
 
Please remember that the matrix containing the singular values (s) has many zeros as 
elements when you go through the above calculation. Therefore, the abundance matrix 
can be then be as follows 
 
     1REF Measa S S  
Experiment 
 
   Sample Preparation 
 
1. Prepare a sample of pure Fluorescein in water using the provided stock (See TA 
for amounts to add). The solution should be prepared in the corning tube labeled 
“Fluorescein Student”. 
 REFS
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2. Prepare a sample of pure Rhodamine B n water using the provided stock. (See TA 
for amounts to add) The solution should be prepared in the corning tube labeled 
“Rhodamine Student” 
Measuring Lifetimes 
 
1. Load 1.5ml of the newly prepared solution of Fluorescein to one of the 4.5ml 
 cuvettes. Place this sample in the position on the sample turret marked ‘s’ 
2. Load 1.5ml of the solution labeled “Fluorescein Reference” into a 4.5ml cuvette. 
This is Fluorescein in 0.1N NaOH with a lifetime of 4.3ns. Please load this into 
the sample turret in position ‘r’ 
3. Please place the 570nm bandpass filter in the emission channel and verify that the 
PMT gain is set to 7. 
4. Please configure the software with the following parameters and then run the 
lifetime measurement 
Integration Time = 5 seconds 
Modulation Frequency: Select 20 Frequencies between 10MHz and 100MHz 
Reference Lifetime: 4.3ns 
 
5. When the lifetime is complete, please measure a steady-state spectrum of the 
fluorescein selecting emission wavelengths from 530nm to 620nm with a step size 
of 10nm. Please turn off the RF amplifier for this measurement and please set the 
slit size on the emission monochromator to 8. 
6. Please repeat the same experiment using the Rhodamine B sample as the sample. 
Spectral Measurement 
 
1. Please prepare a solution containing 500ul of the student’s Fluorescein sample 
and 1.5ml of the student’s Rhodamine B solution. Load this solution into one of 
the 4.5ml cuvettes 
2. Please mix the sample thoroughly and place it in the sample turret in the position 
‘s’. The reference for this measurement will be the Fluorescein solution in 0.1N 
NaOH. 
3. The TAs have prepared a method for you. Please load “P552 Spectral” from the 
user defined methods. Please acquaint yourself with the protocol so that you know 
what will be happening. 
4. Please run the experiment. 
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5. When completed, please run a steady-state emission spectrum of the mixture 
selecting emission wavelengths from 530nm to 620nm with a step size of 10nm. 
Please turn off the blue RF amplifier for this measurement and please set the slit 
size on the emission monochromator to 8.  
Questions 
 
1. Prepare a polar plot at 60MHz. 
2. Plot on the polar plot the coordinate for pure Fluorescein (sample) and pure 
Rhodamine B (sample). Please use the measured lifetimes for this calculation. 
Show your calculation of the polar coordinates for full credit 
3. Plot the polar coordinates for all of the measured data points taken on the mixture 
at 60MHz from 530nm to 620nm. You can use the phase delay and modulation 
ratios directly from the *ifx file. 
4. Please comment on you data. Are the polar coordinates taken from the sample 
containing the mixture at the various emission wavelengths where you would 
expect? Why?  
5. On a single graph, please plot and label the emission spectra collected from the 
measurement of the fluorescein alone, the Rhodamine B alone and from the 
solution of the mixture. There are (3) spectra total for this graph. 
6. Please perform the unmixing calculation. Report the values of the abundance 
vector describing the contribution from the Fluorescein and separately the 
Rhodamine B. Show your calculation for full credit. If you have written a script, 
please print it, label it and attach it to your report. 
7. Please consider the measurement taken at 580nm and go through the following 
calculations. 
a. First, report the total intensity measured from the steady-state spectrum at 
this wavelength for the sample containing the mixture of Fluorescein and 
Rhodamine B 
b. Using the abundance coefficient for Fluorescein, calculate how much of 
the intensity from (A) is from Fluorescein. 
c. Using the abundance coefficient for Rhodamine B, calculate how much of 
the intensity from (A) is from Rhodamine B 
d. Using (A), (B), (C) and the known polar coordinates of Fluorescein and 
Rhodamine B, please simulate and plot the theoretical polar coordinate for 
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the sample containing the mixture of Fluorescein and Rhodamine B at the 
emission wavelength of 580nm and at a modulation frequency of 60MHz.  
e. How did the simulation from (D) compare to the data? What could be 
possible sources of error in either the calculation or the measurement? 
Reference 
[1] Tsuri et al., “Seven-color fluorescence imaging of tissue samples based on Fourier 
spectroscopy and singular value decomposition”  Journal of Histochemistry and 
Cytochemistry Vol. 48 No. 5, pp 653-662, 2000 
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Lab: Applying Mixing to Detect Lifetimes 
 
Introduction 
 
 In the previous lab studying lifetimes, the class measured the lifetime of ruby in 
some very fundamental ways to become acquainted with the time domain and frequency 
domain methods for detecting lifetimes. In this lab, we will study how frequency mixing 
can be used to detect lifetimes. Frequency mixing is essential in order to measure 
lifetimes on the order of nanoseconds and also for lifetime imaging applications. In 
today’s lab, you will learn to apply both the heterodyne and homodyne methods of 
frequency mixing to detect lifetimes. 
 
Background 
 
 As you learned previously, when a sample is excited with light having its intensity 
sinusoidally modulated, the resulting emission of the sample also has its intensity 
sinusoidally modulated at the same frequency as the excitation light. There is a phase 
shift and demodulation in the intensity-modulated light emitted from the sample relative 
to the excitation light which is a result of the convolution of the fundamental fluorescence 
response of the sample with the excitation light.  
Two mixing techniques called heterodyning and homodyning can be applied to 
simplify the frequency domain method for measuring lifetimes particularly when 
measuring lifetimes on the order of nanoseconds or using slow detectors such as CCDs . 
In both cases, the sinusoidally modulated emission signal of the sample is mixed with a 
signal being injected into the gain of the detector. For the homodyne case, the result of 
this mixing leads to a sequence of steady-state signals that can be observed to derive the 
lifetimes. For the case of heterodyning, a low frequency component is produced in the 
resulting mixed signal in the detector containing the relevant phase and modulation data 
to determine the lifetimes. As such, these mixing techniques simplify the analysis of a 
signal typically in the megahertz range to the detection of either a steady-state signal or a 
low frequency signal (on the order of hundreds of hertz).  
 
To explain the usefulness of the mixing techniques described above, we will be begin 
with the function describing the intensity-modulated excitation light E(t), that you have 
see before,  
 
( ) cos( )Eo EE t E E t      
 
In this case, ωE is the intensity modulation frequency of the exciting light and E  is the 
inherent phase of the instrument that will be corrected for with the reference standard.  
In our samples, it is assumed that there is the possibility of having many fluorescing 
species. Each of these species has a characteristic fluorescence response to delta pulse 
excitation that defines its lifetime as shown below, 
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Therefore, to determine the response of our samples to repetitively modulated excitation 
light, we need to convolute or spread Fδ(t) over the function describing the excitation 
light E(t) which leads to Fmeas 
 
2
cos( )
1 ( )
E E
Fi i
meas o i i i
i i i
F E E t    
      
 
The equation describing Fmeas should be fairly familiar to the analogous equation studied 
in the ruby lab. In this case, the constants Fo and Fw have been solved for analytically. As 
before, this equation shows that the emission of the sample in response to an intensity-
modulated excitation light also has its intensity modulated at the same frequency ωE as 
the exciting light. The phase and modulation percentages that we will measure today 
come from the above summations. 
The basis of the heterodyne and homodyne technique is to inject an additional radio 
frequency signal G(t), into the detector as the Fmeas is being recorded. Here is G(t),  
 
            ( ) cos( )o G GG t G G t         
 
The signal then that can be taken from the detector is therefore the product of G(t) and 
Fmeas. For the heterodyne case, the frequency of G(t) only differs from the frequency of 
E(t) by a few hundred hertz. On the other hand, when applying homodyne methods, the 
frequency of G(t) equals the frequency of E(t). After low pass filtering (plugging in a trig 
identity if you try this yourself), the signal that is taken from the detector is, 
 
       
2
cos(( ) )
{ ( )* ( )}
2 1 ( )
G E E G
F
i i i
meas LF o o i i E
i i i
tG EG t F t G E
       
             
 
Despite the many terms in the equation, you can see that this equation is centered around 
the cosine term with the frequency of ωE-ωG. In homodyne detection, the frequency of the 
cosine term goes to zero (ωE=ωG). Therefore to determine the resulting phase and 
modulation percentage, the phase shift of the waveform injected into the detector (φG) is 
varied relative to φE. Typically φG is varied over a full period and the result your are left 
is a full period of the cosine function described above. This can be fit to figure out the 
phase and modulation percentage. When heterodyning is applied, ωE-ωG is very small on 
the order of hundreds of hertz. This frequency, ωE-ωG, remains constant throughout the 
experiment and allows for this low frequency component to be filtered for and detected. 
An analysis of this low frequency waveform (in a manner similar in concept to the ruby 
lab) can also be used to extract the relevant phase and modulation data that you are after.  
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Experiment (Measuring Nanosecond Lifetimes by Homodyning) 
 
The experiment performed in this section will demonstrate how nanosecond lifetimes   
are detected using the homodyne method. For this, you will be using Prof. Clegg’s   
fluorescence lifetime imaging instrument. We will measure a sample having a  
lifetime on the order of nanoseconds. You will measure at a single modulation   
frequency and then project the lifetime data gathered on the polar plot for visual  
analysis. Your TA will operate the FLIM instrument. However, please take note of all  
relevant components and scope outputs. 
 
Data Acquisition 
  
1. Open the program “PhaseDelayImaging”.  
 
 2.  Collect images of the dish of Rhodamine 6G at the following phase shifts of    
           the detectors gain (0○, 45○, 90○, 135○, 180○, 225○, 270○, 315○). Your TA will    
           assist you with the exposure times.  
 
      Store the files with name “Rhod6G_##_degree” where ## is the detector    
           phase that you are measuring at 
 
       Please repeat (2) using the dish containing pure Rhodamine B.  
 
Store the files with name “Rhodb_##_degree” where ## is the detector phase    
that you are measuring at 
 
 
Data Analysis (In-Class) 
 
 1. Open the MatLab code “homodyne_analysis.m” located in the folder that  
      contains your data. As it runs, please select regions of interest on both the  
      Rhodamine 6G and the Rhodamine B images when prompted 
 
 2.  Please type “cftool” into the MatLab command window.  
 
Variables for fitting the Data 
 
Below is a description of the arrays that you will need for the fitting. 
 
Variable Name Description 
angle_radians detector phase written in radians 
for_fit_Rhod6G_array intensity data from Rhod6G's region 
for_fit_RhodB_array intensity data from RhodB's region 
 
 
Please write down the following in the space provided: 
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A) Equation (5) normalized to its DC offset with a single modulation 
depth (MSample) and phase (φSample) 
 
 
 
 
 
B) (MSample) for Rhodamine 6G at 40MHz 
 
 
 
 
 
C) (φSample) for Rhodamine 6G at 40MHz 
 
 
 
 
 
3. Fit the “angle radians” and “for_fit_Rhod6G_array” to the normalized version 
of  equation (5) derived above and  report the following values 
 
2
 
o o
G E
G E
 
 
E   
 
4. Please fit the “angle_radians” and “for_fit_RhodB_array” to the normalized 
version of equation (5) now with the information gathered from (3). Please 
indicate the (MSample) and (φSample) of the Rhodamine B below. 
 
,,Sample RhodBM   
,Sample RhodB   
 
 
Experiment (Measuring Lifetimes by Heterodyning) 
 
In this section of the lab we will demonstrate heterodyne technique visually by 
mixing the frequency applied to the excitation’s intensity modulation (LED) with the 
CCD frame rate (30 frames/sec). To have a heterodyne with the frame rate, the intensity 
of the excitation light (LED) will be intensity-modulated as we have done in the previous 
lab. The LED is simply turned on and off at a desired frequency to achieve intensity 
modulation. The signal from the mixing of excitation’s intensity modulation and the CCD 
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frame rate that we observe corresponds to the frequency ∆ω that was applied to the 
excitation’s intensity modulation. The low frequency heterodyne signal retains the 
modulation and phase information of the fluorescence response, which will allow us to 
extract the fluorescence lifetimes.  
In this experiment, the mixing using the frame rate of the camera can be 
understood if two consecutive frames acquired by the camera are considered. It is 
assumed at the excitation light is being intensity modulated at a frequency near 30Hz. In 
these two frames, the high frequency components from the mixing expansion essentially 
cannot be distinguished in the two frames. In other words, the average intensities of the 
high frequency terms in the mixing expansion are nearly identical in the two frames. 
However, the average intensity of the slow term oscillating at the difference frequency 
∆ω is not the same in these two frames. You will actually see this average intensity (of 
the term oscillating in intensity at a frequency ∆ω) change with your eyes. An example 
using just the ruby of this visual heterodyne is shown in Figure 4.2.  
 
Data Acquisition 
 
1.  Experiment with changing the frequency of the excitation’s intensity   
     modulation on the synthesizer. Try frequencies very close to 30Hz first and           
     then move to about 32Hz. Write down your observations. 
 
2.   Set your excitation modulation (intensity) frequency to 29.5Hz on the  
      synthesizer and record a movie using the Ken-A-Vision software 
 
Data Analysis (In-Class) 
 
1. Copy your movie (*.avi) onto the desktop of one of the data analysis 
computers. MatLab will already be open 
 
2. In the MatLab code (movie_analysis.m), enter the requested information from 
the user at the beginning of the script including the filename, cross-correlation 
frequency (∆f) and the number of frames. Run the code.  
  
 Running the Code 
  
1. Select at region of interest inside the ruby in the image by creating a   
 polygon with the mouse (left clicks). Triple-click when you have finished 
 (closed the polygon) 
 
2. Select a region of interest inside the Rhodamine cuvette in the image by 
creating a polygon with mouse in a similar manner. Triple-click to close 
the polygon. 
 
3. Save a copy of the image displaying your regions and the plot on the 
desktop with your names. 
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        4. Type “cftool” into the MatLab command window to enter the curve  
   fitting tool 
 
          Fitting the Data 
 
         1.  Below is a table of the three arrays you will need for the fitting. 
 
Variable Name Description 
time_arr time axis written in radians 
rhodb_arr intensity data from RhodB's region 
ruby_arr intensity data from Ruby's region 
 
2. Please fit the data describing the Rhodamine B according to equation (5) 
and assuming a lifetime of 0ms. Please report the value of    G E  =   _ 
 
       3.  Using the  G E determined previously, determine the phase F of the  
                   ruby below and determine its lifetime. 
 
,Sample Ruby   
 Ruby   
 
Experiment (References for Nanosecond Lifetimes) 
 
 Picking a fluorophore as the reference to measure a lifetime in the range of 
nanoseconds can dramatically influence your ability to resolve the lifetime of interest. In 
this section, you will be measuring the lifetime of acridine orange (lifetime = 1.8ns) using 
a fluorescent reference and scatter as a reference. The solution called scatter contains 
glycogen suspended in water. It is non-fluorescent and can be considered to have a 0ns 
lifetime. The fluorescent sample that will be also used as a reference is fluorescein in 
0.1N NaOH (lifetime = 4.3ns).  
 
Data Acquisition: Fluorescent Reference 
 
 1.  The Vinci software will already be open on the computer. Please place the  
       solution of Acridine Orange in the sample chamber in the position labeled ‘s’  
        and the solution of Fluorescein in the  position labeled ‘r’ 
 
 2.   Configure the software to scan 20 frequencies between 10MHz and 100MHz.  
   
       3.  Please set the emission wavelength on the left emission monochromator to  
       530nm Please open the slits on the left emission monochromator to 16 
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4.  Please enter the reference lifetime of fluorescein (4.3ns) into the software.  
 
      5.  Please see appendix at end of lab to verify your settings in the software. 
 
6.  Please hit the green play button and begin the experiment 
 
      7. Save your data 
 
Data Acquisition: Non-Fluorescent Reference 
 
             1. Please remove the solution of  Fluorescein and put the solution (scatter) of  
                 glycogen in the sample holder in the position labeled ‘r’.  
 
 2. Please set the emission wavelength for the reference to 440nm. Please keep the  
     emission wavelength for the sample at 530nm. 
 
             3. Please see the appendix to verify your settings in the software 
 
             4. Please hit the green play button and begin the experiment 
 
             5. Save your data 
  
Data Analysis (in-class) 
 
             1. Please enter the Vinci Analysis software. Please open one of your data files. 
 
             2. In the top toolbar, please select fitting and then lifetimes. 
 
             3. Please fit the data to a single component lifetime. 
 
             4. Please repeat steps (1-3) for both data sets 
 
                 Please record the lifetimes derived for each fit and the corresponding fit     
                 parameter in the following table 
 
 AcridineOrange   
2   
 
    
 AcridineOrange   
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2   
 
Questions  
 
             1. For the ruby lab, you used Rhodamine B as your reference. Rhodamine B has  
                 lifetime on the order of a few nanoseconds (as does Rhodamine 6G the  
                 reference for the homodyne experiment). Why can’t we call the reference  
                 lifetime 0sec here as you did in the ruby lab? 
 
             2. Mention two criteria (photophysical parameters) that you would need to  
                 consider when picking an appropriate reference for a nanosecond lifetime   
                 measurement.  
 
 3. Our FLIM instrument employs only a single modulation frequency. Please  
     think of an advantage to using a single modulation frequency. (You may   
     consider the fact that we use it for imaging applications). 
 
4.  Please plot the (MSample) and (φSample) for each of the two samples measured by 
     homodyning (Rhodamine 6G (use calculations done in class) and Rhodamine  
     B as polar coordinates on a polar plot with frequency of 40MHz. 
 
 
5. What happened to the heterodyne signal when the chopping frequency is very 
    close to 30 Hz? or right at 30 Hz? 
   
6. Please draw a simple schematic of the experimental set up that you see here.  
 
  7. What would be a disadvantage of using a higher cross-correlation frequency  
                 here? For example 2 Hz? (Remember frame rate is fixed at 30 frames/second) 
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Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Phosphorescence attachment for the steady-state fluorometer: The outer ring 
(labeled as ‘2’) of this device remains fixed during the experiment and contains three 
openings (windows) through which light can pass. The inner ring (labeled as ‘1’) has two 
windows. As the inner ring spins at speeds defined by the user, the fluorescence emission 
of the sample can be collected at variable intervals following excitation. When emission 
is observed however, the exciting light is blocked and cannot be incident on the sample. 
(Diagram created by Kai Wen Teng and used here with his consent) 
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Figure 4.2: The detection of ruby’s time-dependent fluorescence emission is performed 
by heterodyning using frame rate of the CCD camera ( 30HzGf = ): The low frequency 
response as a result of the frequency mixing is shown in the figure. When the excitation’s 
intensity is modulated at 30Hz, a constant fluorescence emission is observed (top row). 
As the frequency of the excitation’s intensity modulation is increased (two bottom rows), 
the detected fluorescence intensity oscillates more rapidly. The observed periods of 
oscillation are approximately consistent with the expected difference frequencies of 
0.4Hz and 1.2Hz respectively.   
 
 
